{"title":"Farmaci e Dispositivi Antiacidi e Antireflusso","description":"\u003cp\u003eFarmaci, dispositivi medici e integratori per l'acidità di stomaco, il bruciore e il reflusso gastroesofageo. Antiacidi a base di idrossido di magnesio e di alluminio, alginati, bicarbonato di sodio e inibitori di pompa protonica, in compresse masticabili, bustine, stick o sospensione orale. Neutralizzano l'acidità gastrica e proteggono la mucosa dell'esofago. Spedizione in 24\/48 ore in Italia e 48\/72 ore in Europa.\u003c\/p\u003e","products":[{"product_id":"maalox-plus-30-compresse-masticabili","title":"Maalox plus 30 chewable tablets","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptomatic treatment of hyperacidity (including burning and pain) even in case of esophagitis, and hyperacidity when accompanied by dyspepsia. Symptomatic treatment of gastro-intestinal swelling when accompanied by hyperacidity.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003e100 ml of suspension contain\u003c\/u\u003e: \u003ci\u003eActive ingredients\u003c\/i\u003e: magnesium hydroxide 3.65 g, aluminum hydroxide 3.25 g, dimethicone 0.50 g. \u003ci\u003eExcipient(s) with known effects\u003c\/i\u003e: methyl parahydroxybenzoate, propyl parahydroxybenzoate, ethanol, invert sugar, sucrose, sulfur dioxide (E 220), sorbitol (E420) 4.48 g\/ 100ml (see section 4.4). For the full list of excipients, see section 6.1. \u003cu\u003eOne tablet contains\u003c\/u\u003e: \u003ci\u003eActive ingredients:\u003c\/i\u003e magnesium hydroxide 200 mg, aluminum oxide, hydrate 200 mg, dimethicone 25 mg. \u003ci\u003eExcipient(s) with known effects\u003c\/i\u003e: glucose, sucrose, sorbitol (E420) 45 mg per tablet (see section 4.4). For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eMAALOX PLUS 3.65% + 3.25% + 0.5% oral suspension:\u003c\/i\u003e Methyl cellulose, methyl parahydroxybenzoate, propyl parahydroxybenzoate, carmellose, hydroxypropyl cellulose, citric acid, sodium saccharin, sorbitol (E420) non-crystallizable liquid, lemon flavor (containing ethanol), Swiss cream flavor (containing ethanol, invert sugar, sucrose, sulfur dioxide (E 220)), purified water. \u003ci\u003eMAALOX PLUS 200 mg + 200 mg + 25 mg chewable tablets:\u003c\/i\u003e Corn starch, citric acid, pregelatinized starch, glucose, mannitol, sucrose, sorbitol (E420), non-crystallizable liquid sorbitol, talc, magnesium stearate, sodium saccharin, lemon flavoring, Swiss cream flavoring, E 172.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e- Hypersensitivity to the active substances or to any of the excipients listed in paragraph 6.1; - Patients suffering from porphyria; - Severe forms of renal failure (creatinine clearance less than 30 mL\/min); - Generally contraindicated in pediatric age; - State of cachexia.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eMAALOX PLUS 3.65% + 3.25% + 0.5% oral suspension\u003c\/i\u003e \u003cu\u003eDosage \u003c\/u\u003e Do not exceed the maximum doses indicated unless prescribed by a doctor. Swallow 2-4 teaspoons (10-20 ml) 4 times a day, 20-60 minutes after meals and before bed. \u003cu\u003eMethod of administration \u003c\/u\u003e Shake well before use. It can be diluted in water or milk. \u003ci\u003eMAALOX PLUS 200 mg + 200 mg + 25 mg chewable tablets\u003c\/i\u003e\u003cu\u003eDosage \u003c\/u\u003e Do not exceed the maximum doses indicated unless prescribed by a doctor. 2-4 tablets 4 times a day, well chewed or sucked, 20-60 minutes after meals and before going to bed. \u003cu\u003eMethod of administration \u003c\/u\u003e The tablets should be well chewed or sucked. Their intake can be followed by ingestion of water or milk. \u003ci\u003ePediatric population\u003c\/i\u003e Administration of the medicine in pediatric age is not recommended.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eOral suspension\u003c\/i\u003e: Do not store below 4°C. Bottle: keep the bottle tightly closed. \u003ci\u003eChewable tablets\u003c\/i\u003e: Store below 25°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAluminum hydroxide can cause constipation and an overdose of magnesium salts can cause hypermotility of the intestine; high doses of this medicine may cause or aggravate intestinal and ileal obstruction in patients at higher risk, such as those with renal impairment, with underlying constipation, with alteration of intestinal motility, in children (0 to 24 months), or elderly. Aluminum hydroxide is not well absorbed from the gastrointestinal tract, and systemic effects are therefore rare in patients with normal renal function. However, excessive doses or long-term use, or even normal doses in patients on low-phosphorus diets or in children (0 to 24 months), can lead to phosphate elimination (due to an aluminium-phosphate bond) accompanied by increased bone resorption and hypercalciuria with risk of osteomalacia. It is advisable to consult your doctor in case of long-term use or in patients at risk of hypophosphatemia. In patients with renal impairment, plasma levels of aluminum and magnesium tend to increase, causing hyperaluminemia and hypermagnesemia, respectively. In these patients, long exposures to high doses of aluminum and magnesium salts can lead to encephalopathy, dementia, microcytic anemia or worsening of dialysis-induced osteomalacia. In the presence of mild and moderate forms of renal failure it is advisable to take the product under the supervision of a doctor. Prolonged use of antacids in patients with mild and moderate forms of renal insufficiency should be avoided. The administration of this medicine is contraindicated in subjects suffering from severe forms of renal failure (see section 4.3). Aluminum hydroxide may be unsafe in porphyria patients undergoing haemodialysis (see section 4.3). Maalox Plus, due to its composition, has no tendency to modify the behavior of the bird. However, in some particularly sensitive subjects and for high doses, an acceleration of intestinal transit may occur. \u003cu\u003eMAALOX PLUS 3.65% + 3.25% + 0.5% oral suspension contains\u003c\/u\u003e: - \u003cb\u003eparahydroxybenzoates\u003c\/b\u003e: may cause allergic reactions (even delayed); - 448 mg of \u003cstrong\u003esorbitol\u003c\/strong\u003e (E420) in 10 ml (2 teaspoons). Patients with hereditary fructose intolerance should not be given this medicine; - \u003cstrong\u003eethanol\u003c\/strong\u003e: This medicine contains 9.5 mg of ethanol in 10 ml (2 teaspoons). 10 ml of this medicine is equivalent to 0.2 ml of beer or 0.1 ml of wine. The small amount of alcohol in this medicine will not produce significant effects; - \u003cstrong\u003esucrose and invert sugar\u003c\/strong\u003e: patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase insufficiency should not take this medicine; - \u003cstrong\u003esulfur dioxide (E 220)\u003c\/strong\u003e: rarely can cause serious hypersensitivity reactions and bronchospasm; - less than 1 mmol (23 mg) of \u003cstrong\u003esodium\u003c\/strong\u003e per dose, i.e. it is essentially “sodium-free”. \u003cu\u003eMAALOX PLUS 200 mg + 200 mg + 25 mg chewable tablets contains\u003c\/u\u003e: - 45 mg of\u003cb\u003e sorbitol\u003c\/b\u003e, per tablet. The additive effect of co-administration of medicinal products containing sorbitol (or fructose) and daily dietary intake of sorbitol (or fructose) should be considered. The sorbitol content in oral medicinal products may modify the bioavailability of other co-administered oral medicinal products. Patients with hereditary fructose intolerance should not be given this medicine. - approximately 500 mg of \u003cb\u003eglucose\u003c\/b\u003e, per tablet: to be taken into consideration in people suffering from diabetes mellitus, if they take more than 10 tablets per day; Patients suffering from rare problems of glucose-galactose malabsorption should not take this medicine. - \u003cb\u003esucrose\u003c\/b\u003e; Patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase isomaltase insufficiency should not take this medicine. - less than 1 mmol (23 mg) of \u003cb\u003esodium\u003c\/b\u003e per tablet, i.e. it is essentially “sodium-free”. \u003cu\u003ePediatric population \u003c\/u\u003e In young children, the use of magnesium hydroxide can lead to hypermagnesemia, particularly if they have kidney damage or dehydration.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSince Al and Mg salts reduce the gastrointestinal absorption of tetracyclines, it is recommended to avoid taking Maalox Plus during oral tetracycline therapy. The use of aluminum-containing antacids may reduce the absorption of drugs in particular H2-antagonists, atenolol, bisphosphonates, cefdinir, cefpodoxime, chloroquine, tetracyclines, dasatinib monohydrate, diflunisal, digoxin, dexamethasone, eltrombopag olamine, elvitegravir, ethambutol, fluoroquinolones, glucocorticoids, indomethacin, iron salts, isoniazid, ketoconazole, levothyroxine, lincosamides, metoprolol, nilotinib, phenothiazine neuroleptics, penicillamines, propranolol, raltegravir potassium, rilpivirine, riociguat, rosuvastatin, sodium fluoride and antiviral treatments in combination with tenofovir alafenamide fumarate\/emtricitabine\/sodium bictegravir. • Polystyrene sulfonate (Kayexalate) Caution is advised when the medicinal product is taken together with polystyrene sulfonate (Kayexalate) due to the potential risk of reduced potassium-binding efficacy of the resin, metabolic alkalosis in patients with renal impairment (reported with aluminum hydroxide and magnesium hydroxide), and intestinal obstruction (reported with aluminum hydroxide). • Aluminum hydroxide and citrates can cause hyperaluminemia, especially in patients with renal impairment. The combination with the integrase inhibitors (dolutegravir, raltegravir, bictegravir) and MAALOX PLUS should be avoided (refer to the respective SmPCs for dose recommendations). Since the use of magnesium hydroxide causes alkalinization of the urine, increased excretion of salicylates has been observed when administered simultaneously. As a precaution, allow at least 2 hours (4 for fluoroquinolones) to pass between taking any oral medication and MAALOX PLUS. Concomitant use of quinidine may result in increased serum quinidine levels and lead to quinidine overdose. The simultaneous use of aluminum hydroxide and citrates can lead to an increase in aluminum levels, particularly in patients with renal failure. The alkalinization of the urine following the administration of magnesium hydroxide can modify the excretion of some drugs; therefore, increased excretion of salicylates was observed.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe frequency of the side effects reported below is defined using the following conventions: common (≥1\/100, \u003c1\/10); uncommon (≥1\/1,000, \u003c1\/100); rare (≥1\/10,000, \u003c1\/1,000); very rare (\u003c1\/10,000); not known (frequency cannot be estimated from the available data). \u003ci\u003e \u003cu\u003eImmune system disorders\u003c\/u\u003e \u003c\/i\u003e \u003ci\u003eFrequency not known (frequency cannot be estimated from the available data):\u003c\/i\u003e angioedema, anaphylactic reactions, hypersensitivity reactions, urticaria, pruritus. \u003ci\u003e \u003cu\u003eGastrointestinal disorders\u003c\/u\u003e \u003c\/i\u003e \u003ci\u003eUncommon\u003c\/i\u003e: diarrhea or constipation (see section 4.4); \u003ci\u003eFrequency not known\u003c\/i\u003e: abdominal pain. \u003ci\u003e \u003cu\u003eMetabolism and nutrition disorders\u003c\/u\u003e \u003c\/i\u003e \u003ci\u003eVery rare:\u003c\/i\u003e hypermagnesemia, including observations after prolonged administration to patients with renal impairment\u003ci\u003e;\u003c\/i\u003e \u003ci\u003eFrequency not known\u003c\/i\u003e: hyperaluminemia, hypophosphatemia, during prolonged use or at high doses or even at normal doses of the medicine in patients with low phosphorus diets or in children (0 to 24 months), which may cause increased bone resorption, hypercalciuria, osteomalacia (see section 4.4). \u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at: http:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eExperience with deliberate overdose is very limited. Cases of overdose with aluminum salts may occur more easily in patients with severe chronic renal impairment with the following symptoms: encephalopathy, convulsions and dementia, hypermagnesemia. The most frequently reported symptoms of acute overdose with aluminum hydroxide and in combination with magnesium salts include diarrhea, abdominal pain and vomiting. High doses of this medicinal product may cause or aggravate intestinal and ileal obstruction in patients at risk (see section 4.4). As in all cases of overdose, treatment must be symptomatic, adopting general supportive measures. Aluminum and magnesium are eliminated through urinary excretion; treatment of magnesium overdose involves rehydration and forced diuresis. In case of renal failure, hemodialysis or peritoneal dialysis is required.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no data on the use of MAALOX PLUS in pregnant women. It is not possible to establish whether or not the use of MAALOX PLUS during pregnancy is safe. \u003cu\u003ePregnancy \u003c\/u\u003e The medicine must be used only if necessary, under the direct supervision of a doctor, after evaluating the expected benefit for the mother in relation to the possible risk for the fetus or infant. \u003cu\u003eBreastfeeding \u003c\/u\u003e Due to limited maternal absorption when taken according to the indicated dosing regimen (see section 4.2), aluminum hydroxide and its combinations with magnesium salts are considered compatible with breastfeeding.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMAALOX PLUS does not alter the ability to drive and use machines.\u003c\/p\u003e","brand":"Sanofi","offers":[{"title":"Default Title","offer_id":40207823863923,"sku":"020702080","price":9.99,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/sanofi-spa-maalox-plus-30-compresse-masticabili-farmacia-dottor-tili-1213792745.webp?v=1767125889"},{"product_id":"t-reflux-mastice-di-chios-30-capsule-dr-tili","title":"T - Reflux Chios Mastic 30 capsules Dr.Tili ","description":"\u003cp\u003e\u003cimg height=\"125\" width=\"125\" alt=\"Supplement made in Italy\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/Made_in_Italy.png?v=1668012159\" style=\"float: none;\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003cimg data-mce-fragment=\"1\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/senza_glutine_480x480.png?v=1668012159\" alt=\"gluten-free supplement\" width=\"125\" height=\"125\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003cimg data-mce-fragment=\"1\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/senza_lattosio_480x480.png?v=1668012159\" alt=\"lactose-free supplement\" width=\"125\" height=\"125\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003cimg data-mce-fragment=\"1\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/ingredienti_vegani_480x480.png?v=1668012159\" alt=\"vegan supplement\" width=\"125\" height=\"125\"\u003e\u003cspan\u003e  \u003c\/span\u003e\u003cimg data-mce-fragment=\"1\" height=\"125\" width=\"125\" alt=\"T+complex treatment\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/T_complex_treatment_480x480.png?v=1668012160\"\u003e\u003c\/p\u003e\n\u003cp\u003eT-reflux mastic of chios is the supplement based on \u003cstrong\u003ehighly titrated phytotherapeutic extracts\u003c\/strong\u003e of Chios mastic, mallow titrated in polysaccharides and freeze-dried aloe vera without anthraquinones. These phytocomplexes are present at \u003cstrong\u003emaximum dosage \u003c\/strong\u003epermitted and the phytocomplex titrated in mallow polysaccharides \u003cstrong\u003efacilitates assimilation by the organism.\u003cbr\u003e\u003c\/strong\u003eChios mastic is one of the best natural remedies for \u003cstrong\u003eacidity\u003c\/strong\u003e e \u003cstrong\u003egastoesophageal reflux\u003c\/strong\u003e. Mallow and Aloe Vera are adjuvants for \u003cstrong\u003efunctionality of the digestive system\u003c\/strong\u003e, useful in case of excessive \u003cstrong\u003egastric acidity\u003c\/strong\u003e, \u003cstrong\u003eheartburn\u003c\/strong\u003e e \u003cstrong\u003epoor digestion\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eThe \u003cstrong\u003echios mastic\u003c\/strong\u003e is a precious gum resin extracted from Pistacia lentiscus. It has been used since ancient times for its excellent soothing properties of the gastric mucosa and for its rebalancing action in cases of excessive and disordered production of gastric juices. Its composition is rich in triterpene derivatives such as alpha terpineol, alpha pinene, myrcene, caryophyllene, methyl isoeugenol and germacrene. This composition makes it one of the best known and appreciated natural remedies for acidity and gastoesophageal reflux thanks to its emollient and soothing action on the gastric system. \u003cbr\u003eIndicated in case of: acidity, heartburn, gastroesophageal reflux, gastritis, peptic ulcers, Helicobacter Pylori\u003c\/p\u003e\n\u003cp\u003eThe\u003cstrong\u003ealoe vera\u003c\/strong\u003e it is a plant of the Aloaceae family. Aloe vera phytoextracts are \u003cstrong\u003erich in mucilage\u003c\/strong\u003e which can form one \u003cstrong\u003eprotective layer on the gastric mucosa. \u003c\/strong\u003eThey thus help to protect them from inflammation and soothe any damage to the walls. \u003cbr\u003eThe phytocomplexes originating from Aloe leaves are a \u003cstrong\u003econcentrated fatty acids\u003c\/strong\u003e. These help balance the degree of acidity of the stomach thanks to the natural alkalizing action. \u003cstrong\u003eThey promote correct digestion\u003c\/strong\u003e by stimulating enzymes such as amylase and lipase, involved in the digestion of fats, carbohydrates, starches and sugars. Aloe Vera also has known hepatoprotective and natural detoxifying properties for the liver.\u003cbr\u003eIndicated in case of: acidity, stomach pain, ulcer, gastroesophageal reflux.\u003c\/p\u003e\n\u003cp\u003eThe \u003cstrong\u003eMauve\u003c\/strong\u003e it is a plant rich in mucilage, flavonoids, tannins, vitamins and minerals. It has an emollient and soothing action on the digestive system, in particular for the intestine. In phytotherapy it is used in case of intestinal inflammation, colic and mild constipation, thanks to its properties \u003cstrong\u003enatural soothing and mildly laxative\u003c\/strong\u003e. \u003cbr\u003eThe mucilage contained in the plant can form a sort of gel that softens the stool, increases the fecal mass and promotes its elimination.\u003cbr\u003eIndicated in case of: poor digestion, constipation, heaviness and swelling.\u003c\/p\u003e\n\n\u003cp style=\"text-align: center;\"\u003eYou can also find T - reflux Chios mastic in the program \u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/T_COMPLEX_TREATMENT_ACIDITA_E_REFLUSSO.pdf?v=1668000378\" title=\"Download T+complex treatment Acidity and Reflux\" target=\"_blank\"\u003e\u003cspan style=\"text-decoration: underline; color: #0000ff;\"\u003eT+Complex Treatment Acidity and Reflux\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp style=\"text-align: center;\"\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/T_COMPLEX_TREATMENT_ACIDITA_E_REFLUSSO.pdf?v=1668000378\" title=\"Download T+complex treatment Acidity and Reflux\"\u003e\u003cimg data-mce-fragment=\"1\" alt=\"\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/BannerT_complexAciditaeReflusso_480x480.jpg?v=1668000866\"\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is T - Reflux Chios Mastic 30 Dr.Tili capsules used? What is it for?\u003c\/h3\u003e\u003cp\u003eFood supplement based on phytotherapeutic extracts of Chios mastic, mallow and aloe vera, assisting the functionality of the digestive system; useful in the presence of excessive gastric acidity, heartburn and digestive difficulties.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does T - Reflux Chios Mastic 30 Dr.Tili capsules contain?\u003c\/h3\u003e\u003cp\u003eChios mastic e.g. (pistacia lentiscus 1 resin). Freeze-dried aloe vera (aloe vera 1. succus ex foliis). Mallow es 25-30% polysaccharides (mallow sylvestris flos)\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does T - Reflux Chios Mastic 30 Dr.Tili capsules contain?\u003c\/h3\u003e\u003cp\u003eChios mastic 200mg.\u003c\/p\u003e\u003cp\u003eAloe vera 200mg.\u003c\/p\u003e\u003cp\u003eMallow 100mg of which polysaccharides 25-30mg.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use T - Reflux Chios Mastic 30 Dr.Tili capsules?\u003c\/h3\u003e\u003cp\u003eTake 1 capsule of T-reflux Chios mastic as needed, for a maximum of 3 capsules per day\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of T - Reflux Mastice di Chios 30 capsules Dr.Tili?\u003c\/h3\u003e\u003cp\u003eDo not exceed the indicated intake quantities. Supplements are not intended as substitutes for a varied, balanced diet and a healthy lifestyle. Do not use during pregnancy and breastfeeding. Keep away and do not give to children under 3 years of age. Do not administer to children under 12 years of age. Consult your doctor in case of pregnancy and breastfeeding. Do not use for prolonged periods without consulting your doctor. Store in a cool, dry place.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of T - Reflux Mastice di Chios 30 capsules Dr.Tili?\u003c\/h3\u003e\u003cp\u003e30 capsules\u003c\/p\u003e","brand":"Tilab","offers":[{"title":"Default Title","offer_id":40207842508915,"sku":"982144875","price":28.1,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/tilab-srl-t-reflux-mastice-di-chios-30-capsule-dr-tili-farmacia-dottor-tili-1213792685.jpg?v=1767118631"},{"product_id":"biochetasi-os-granulato-effervescente-18-bustine","title":"Biochetasi Os Effervescent Granules 18 Sachets","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e- Hyperacidity - Digestive difficulties - Liver insufficiency - Ketonemic states - Pregnant nausea.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eEffervescent granules.\u003c\/b\u003e One sachet contains: \u003cu\u003eActive ingredients\u003c\/u\u003e: sodium citrate mg 425 potassium citrate mg 50 thiamine diphosphate free ester mg 50 riboflavin monosodium 5-monophosphate mg 25 (equal to 23.8 mg of free acid) vitamin B\u003csub\u003e6\u003c\/sub\u003e hydrochloride 12.5 mg citric acid 100 mg Excipients with known effects: sorbitol (E420), sucrose, fructose, glucose, sodium. One sachet contains: sorbitol (E420): 125 mg sucrose: 1.7 g fructose: 650 mg glucose: 1.4 g sodium: 142 mg \u003cb\u003eEffervescent tablets\u003c\/b\u003e. One effervescent tablet contains: \u003cu\u003eActive ingredients\u003c\/u\u003e: sodium citrate mg 425 potassium citrate mg 50 free thiamine diphosphate ester mg 50 riboflavin monosodium 5-monophosphate mg 25 vitamin B6 hydrochloride mg 12.5 citric acid mg 70 Excipients with known effects: aspartame (E951), sucrose, sodium. One effervescent tablet contains: aspartame (E951): 20 mg sucrose: 737.5 mg sodium 238 mg\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eEffervescent granules\u003c\/b\u003e malic acid; sorbitol; tartaric acid; sodium bicarbonate; polyvinylpyrrolidone; orange aroma; saccharin; sodium edetate; propyl gallate; sucrose; fructose; glucose. \u003cb\u003eEffervescent tablets\u003c\/b\u003e tartaric acid; aspartame; orange aroma; sucrose; insoluble polyvinylpyrrolidone; polyvinylpyrrolidone; talc; precipitated silica; sodium bicarbonate.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substances or to any of the excipients listed in paragraph 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAdults and children over 12 years of age: 2 sachets or 2 effervescent tablets 3 times a day, dissolved in half a glass of water. Children under 12 years of age: half dose. \u003ci\u003eSpecial populations\u003c\/i\u003e. Patients with hepatic impairment: No studies have been conducted with Biochetase in patients with hepatic impairment. Patients with renal insufficiency: No studies have been conducted with Biochetase in patients with renal insufficiency.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIf symptoms persist, clinical reassessment should be considered. Medicines containing vitamin B1 or its derivatives can, especially if administered parenterally, induce the onset of atopic manifestations in patients with hypersensitivity. Important information about some excipients BIOCHETASI effervescent granules contains sorbitol and fructose. Patients with hereditary fructose intolerance should not be given this medicine. The additive effect of co-administration of medicinal products containing sorbitol or fructose and daily dietary intake of sorbitol or fructose should be considered. The sorbitol content in oral medicinal products may modify the bioavailability of other co-administered oral medicinal products. BIOCHETASI effervescent granules contain glucose. Patients suffering from rare problems of glucose-galactose malabsorption should not take this medicine. BIOCHETASI effervescent granules contains sucrose. Patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase isomaltase insufficiency should not take this medicine. BIOCHETASI effervescent granules contains approximately 1.7 g of sucrose and 1.4 g of glucose per dose (sachet). This should be taken into account in diabetic patients and in patients following low-calorie diets. BIOCHETASI effervescent granules contains 142 mg of sodium per sachet equivalent to 7.1% of the maximum daily intake recommended by WHO which corresponds to 2 g of sodium for an adult. The maximum daily dose of this product is equivalent to 42.6% of the WHO recommended maximum daily sodium intake. BIOCHETASI effervescent granules are considered to be high in sodium. To be taken into consideration especially in people following a low sodium diet. BIOCHETASI effervescent tablets contain aspartame, a source of phenylalanine, which can be harmful to patients suffering from phenylketonuria. There are no non-clinical or clinical studies available on the use of aspartame in children under 12 weeks of age. BIOCHETASI effervescent tablets contain sucrose. Patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase isomaltase insufficiency should not take this medicine. BIOCHETASI effervescent tablets contain 238 mg of sodium per dose equivalent to 11.9% of the maximum daily intake recommended by WHO which corresponds to 2 g of sodium for an adult. The maximum daily dose of this product is equivalent to 71.4% of the WHO recommended maximum daily sodium intake. BIOCHETASI effervescent granules are considered to be high in sodium. To be taken into consideration especially in people following a low sodium diet.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eRiboflavin absorption is affected by propantheline bromide. Particular caution is required in Parkinson's patients treated with levodopa because vitamin B6 (pyridoxine) can antagonize the therapeutic effects. The use of citrate preparations may increase the gastrointestinal absorption of aluminum (e.g. aluminum-containing antacids).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe following are the side effects organized according to the MedDRA System Organ classification. The adverse reactions derive from literature data and post-marketing reports. Since it was not possible to calculate their frequency they are indicated as not known (the frequency cannot be defined on the basis of the available data). \u003ci\u003eImmune system disorders\u003c\/i\u003e: Urticaria. Anaphylactic shock has been reported in patients treated with parenteral thiamine. \u003ci\u003eGastrointestinal disorders:\u003c\/i\u003e Nausea. \u003ci\u003ePathologies of the skin and subcutaneous tissue\u003c\/i\u003e: Skin rash, Lip edema. \u003ci\u003eRenal and urinary disorders:\u003c\/i\u003e Chromaturia. \u003cu\u003eReporting of suspected adverse reactions.\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at http:\/\/www.agenziafarmaco.gov.it\/content\/come-segnalare-una-sospetti-reazione-avversa\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eProlonged use of pyridoxine at high doses can cause neuropathy. High doses of potassium-containing products may cause hyperkalemia and alkalosis, particularly in patients with renal insufficiency. High doses of citrate preparations may have a saline-type laxative effect when administered orally.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBIOCHETASI can be administered both in case of pregnancy and during breastfeeding.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBIOCHETASI does not alter the ability to drive or use machines.\u003c\/p\u003e","brand":"Alfasigma","offers":[{"title":"Default Title","offer_id":40207843688563,"sku":"015784097","price":13.59,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/alfasigma-spa-biochetasi-os-granulato-effervescente-18-bustine-farmacia-dottor-tili-1213792664.jpg?v=1767119087"},{"product_id":"t-complex-treatment-acidita-e-reflusso","title":"T+complex treatment Acidity and Reflux ","description":"\u003cp\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/Made_in_Italy.png?v=1668012159\" alt=\"Supplement made in Italy\" style=\"float: none;\" width=\"125\" height=\"125\" data-mce-style=\"float: none;\"\u003e \u003cimg style=\"float: none;\" height=\"125\" width=\"125\" alt=\"gluten-free supplement\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/senza_glutine_480x480.png?v=1668012159\" data-mce-fragment=\"1\" data-mce-src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/senza_glutine_480x480.png?v=1668012159\" data-mce-style=\"float: none;\"\u003e \u003cimg style=\"float: none;\" height=\"125\" width=\"125\" alt=\"lactose-free supplement\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/senza_lattosio_480x480.png?v=1668012159\" data-mce-fragment=\"1\" data-mce-src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/senza_lattosio_480x480.png?v=1668012159\" data-mce-style=\"float: none;\"\u003e \u003cimg style=\"float: none;\" height=\"125\" width=\"125\" alt=\"vegan supplement\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/ingredienti_vegani_480x480.png?v=1668012159\" data-mce-fragment=\"1\" data-mce-src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/ingredienti_vegani_480x480.png?v=1668012159\" data-mce-style=\"float: none;\"\u003e  \u003cimg style=\"float: none;\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/T_complex_treatment_480x480.png?v=1668012160\" alt=\"T+complex treatment\" width=\"125\" height=\"125\" data-mce-fragment=\"1\" data-mce-src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/T_complex_treatment_480x480.png?v=1668012160\" data-mce-style=\"float: none;\"\u003e\u003c\/p\u003e\n\u003cdiv\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cp\u003eT+complex treatment Acidity and Reflux combines two specific natural supplements to control it naturally \u003cstrong\u003eexcessive acidity, heartburn and gastroesophageal reflux\u003c\/strong\u003e. Help \u003cstrong\u003enormalize bacterial flora and intestinal motility\u003c\/strong\u003e affected in their balance by excessive use of gastroprotective drugs. T+complex treatment Acidity and Reflux is designed for:\u003c\/p\u003e\n\u003cul style=\"list-style-type: disc;\" data-mce-style=\"list-style-type: disc;\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eControl excessive stomach acidity\u003c\/strong\u003e, the \u003cstrong\u003eburning\u003c\/strong\u003e and avoid episodes of \u003cstrong\u003egastroesophageal reflux\u003c\/strong\u003e. Restore the right level of stomach acidity to prevent further gastrointestinal disorders.\u003cbr\u003e \u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEliminate or limit the use of gastroprotective drugs\u003c\/strong\u003e which suppress the acid-gastric environment, which is important for eliminating parasites, harmful bacteria and fungi naturally present in ingested food. These drugs also penalize the condition of some good bacteria that perform beneficial functions on the intestine. In the long term they can favor the passage of some harmful microorganisms into the intestine which can cause a condition of intestinal dysbiosis.\u003cbr\u003e \u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAid digestion\u003c\/strong\u003e thanks to papaya enzymes which facilitate food absorption, reducing stress on the gastrointestinal mucosa\u003cbr\u003e \u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRestore the balance of the bacterial flora\u003c\/strong\u003e and natural intestinal motility.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eT+complex treatment Acidity and Reflux is your natural path studied by I Rimedi Del Dr.Tili to help you obtain the maximum benefits from the natural active ingredients contained in our highly titrated supplements in 15 days. In case of strong and persistent acidity, heartburn or gastroesophageal reflux, a second cycle of another 15 days is strongly recommended. This guarantees a prolonged and long-lasting effect of the natural active ingredients and greater overall effectiveness. Personalize your experience and find out everything about the products with the expert in chat.\u003c\/p\u003e\n\n\u003cp style=\"text-align: center;\" data-mce-style=\"text-align: center;\"\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/T_COMPLEX_TREATMENT_ACIDITA_E_REFLUSSO.pdf?v=1668000378\" title=\"Download T+complex treatment Acidity and Reflux\" target=\"_blank\"\u003e\u003cspan style=\"text-decoration: underline; color: #0000ff;\" data-mce-style=\"text-decoration: underline; color: #0000ff;\"\u003e\u003cspan style=\"color: #0000ff; text-decoration: underline;\" data-mce-style=\"color: #0000ff; text-decoration: underline;\"\u003eDOWNLOAD T+COMPLEX TREATMENT ACIDITY AND REFLUX\u003c\/span\u003e\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp style=\"text-align: center;\" data-mce-style=\"text-align: center;\"\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/T_COMPLEX_TREATMENT_ACIDITA_E_REFLUSSO.pdf?v=1668000378\" title=\"Download T+complex treatment Acidity and Reflux\" target=\"_blank\"\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/BannerT_complexAciditaeReflusso_480x480.jpg?v=1668000866\" alt=\"\" data-mce-fragment=\"1\" data-mce-src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/BannerT_complexAciditaeReflusso_480x480.jpg?v=1668000866\"\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONTENTS OF THE BOX\u003c\/h2\u003e\n\u003ch3\u003eWhat does the T+complex treatment Acidity and Reflux package contain?\u003c\/h3\u003e\u003cp\u003e1 Pack of T-Reflux: High bioavailability supplement based on Chios mastic, mallow titrated in polysaccharides and freeze-dried aloe vera without anthraquinones. Chios mastic is the best natural remedy for acidity, heartburn and gastoesophageal reflux. Mallow and Aloe Vera balance the degree of acidity of the stomach thanks to their natural alkalizing action. They promote correct digestion by stimulating enzymes involved in the digestion of fats, carbohydrates, starches and sugars.\u003c\/p\u003e\u003cp\u003e2 Packs of Fermented Papaya: Supplement based on highly titrated phytotherapeutic extracts of fermented papaya containing a high quantity of digestive enzymes. It facilitates the digestion and absorption of food by helping to reduce the production of metabolites, substances that are only partially digested. It reduces stress on the gastrointestinal mucosa, promotes the growth of good bacterial flora and helps intestinal motility.\u003c\/p\u003e","brand":"Tilab","offers":[{"title":"Default Title","offer_id":40207846801523,"sku":"914113411","price":45.04,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/tilab-srl-t-complex-treatment-acidita-e-reflusso-farmacia-dottor-tili-1213792554.jpg?v=1767121690"},{"product_id":"esoxx-one-reflusso-gastroesofageo-20-bustine","title":"Esoxx One Gastroesophageal Reflux 20 Sachets","description":"\u003cp\u003eEsoxx One is a mechanically operated medical device that allows you to \u003cstrong\u003erapidly reduce symptoms related to gastroesophageal reflux\u003c\/strong\u003e such as: heartburn, epigastric pain, acid regurgitation, irritative cough, dysphonia.\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003eGastroesophageal Reflux Disease, called GERD, is characterized by painful symptoms such as \u003cstrong\u003eheartburn, acid regurgitation, irritative cough and dysphagia\u003c\/strong\u003e which may or may not be associated with \u003cstrong\u003eerosive inflammatory lesions of the esophageal mucosa\u003c\/strong\u003e. GERD is typically exacerbated by lying on your back, so symptoms may become worse during sleep.\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003eEsoxx One associates with its formula \u003cstrong\u003ehyaluronic acid and chondroitin sulfate\u003c\/strong\u003e who exercise a \u003cstrong\u003eoriginal and innovative defense mechanism of the gastroesophageal mucosa\u003c\/strong\u003e. The presence of poloxamer 407 in the formulation with high bioadhesive capacity favors the \u003cstrong\u003epermanence of contact with the surface of the esophageal wall of hyaluronic acid and chondroitin sulfate\u003c\/strong\u003e. Esoxx One thus protects the stomach from the action of hydrochloric acid produced by the stomach.\u003c\/p\u003e\n\u003cp\u003eChondroitin sulfate also has an action that \u003cstrong\u003epromotes the repair processes of the gastroesophageal mucosa\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Esoxx One Gastroesophageal Reflux 20 Sachets used? What is it for?\u003c\/h3\u003e\u003cp\u003eEsoxx One is a mechanically operated medical device that allows you to \u003cstrong\u003erapidly reduce symptoms related to gastroesophageal reflux\u003c\/strong\u003e such as: heartburn, epigastric pain, acid regurgitation, irritative cough, dysphonia.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Esoxx One Gastroesophageal Reflux 20 Sachets contain?\u003c\/h3\u003e\u003cp\u003eHyaluronic acid, chondroitin sulphate, polyvinylpyrrolidone, xylitol, sodium benzoate, potassium sorbate, grape flavouring, demineralised water, poloxamer 407.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Esoxx One Gastroesophageal Reflux 20 Sachets?\u003c\/h3\u003e\u003cp\u003eOne stick (single-dose sachet) after main meals and at bedtime or according to medical advice. The solution can be drunk directly from the stick.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Esoxx One Gastroesophageal Reflux 20 Sachets?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eContraindications\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eNone in particular, except for cases of hypersensitivity towards one of its components. In this circumstance, stop treatment and contact your doctor. Even if there are no known side effects, it is recommended not to use the product during pregnancy or in the first months of breastfeeding. In any case, consult your doctor first. There are no known interactions with other oral products.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eDo not exceed the recommended dose. If symptoms persist, consult your doctor. Since no clinical data is available on children under 12 years of age, do not administer the product to children under 12 years of age. Do not use the product after the expiry date shown on the package. Keep out of reach of children.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/h2\u003e\n\u003ch3\u003eWhen should Esoxx One Gastroesophageal Reflux 20 Sachets not be used and what side effects can it cause?\u003c\/h3\u003e\u003cp\u003eNone in particular, except for cases of hypersensitivity towards one of its components. In this circumstance, stop treatment and contact your doctor. Even if there are no known side effects, it is recommended not to use the product during pregnancy or in the first months of breastfeeding. In any case, consult your doctor first.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Esoxx One Gastroesophageal Reflux 20 Sachets stored?\u003c\/h3\u003e\u003cp\u003eStore in a cool, dry place and away from heat sources. Do not freeze.\u003cbr\u003eValidity with intact packaging: 36 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Esoxx One Gastroesophageal Reflux 20 Sachets?\u003c\/h3\u003e\u003cp\u003e20 sticks (single-dose sachets) of 10 ml.\u003c\/p\u003e","brand":"Alfasigma","offers":[{"title":"Default Title","offer_id":46454827745607,"sku":"931660981","price":22.97,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/alfasigma-esoxx-one-reflusso-gastroesofageo-20-bustine-farmacia-dottor-tili-1254211116.jpg?v=1786730770"},{"product_id":"gaviscon-bruciore-e-indigestione-24-bustine","title":"Gaviscon Heartburn and Indigestion 24 Sachets","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTreatment of acid-related symptoms of gastro-oesophageal reflux, such as acid regurgitation, heartburn and indigestion, for example after meals or during pregnancy.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEach 10 ml dose (1 sachet) contains sodium alginate 500 mg, sodium bicarbonate 213 mg and calcium carbonate 325 mg. Excipients with known effects: Methyl parahydroxybenzoate (E218) 4O mg; Propyl parahydroxybenzoate (E216) 6 mg; Sodium 127.88 mg. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCarbomer 974P, Methyl parahydroxybenzoate (E218), Propyl parahydroxybenzoate (E216), Sodium saccharin, Mint flavouring, Sodium hydroxide, Purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product is contraindicated in patients with known or suspected hypersensitivity to the active substances or to any of the excipients listed in section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFor oral administration. Adults and children aged 12 years and over: 10-20 ml (1 to 2 sachets) after meals and in the evening before going to bed, up to four times a day. Children under 12 years: should only be administered on medical advice. Elderly: it is not necessary to change the doses for this age group.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDo not store above 30°C. Do not refrigerate or freeze.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product contains 127.88 mg sodium per 10ml\/ 1 sachet, equivalent to 6.39% of the WHO recommended maximum daily sodium intake. The maximum daily dose of this medicine is equivalent to 51.15% of the maximum daily sodium intake recommended by the WHO. This medicine is therefore considered to be high in sodium. This must be taken into account in cases where a particularly low-salt diet is recommended, for example in some cases of congestive heart failure and renal impairment. Each 10 ml dose (1 sachet) contains 130 mg (3.25 mmol) of calcium. Caution should be exercised when treating patients with hypercalcemia, nephrocalcinosis and recurrent calcium-containing renal stones. If symptoms do not improve after seven days, the clinical picture should be re-evaluated. Contains methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216), which may cause allergic reactions (possibly delayed). Prolonged use should be avoided. As with other antacid medicinal products, taking Gaviscon Burning and Indigestion mint flavor oral suspension in sachets can mask the symptoms of other more serious pre-existing pathologies. Gaviscon Heartburn and Indigestion mint flavor oral suspension in sachets must not be used in the following cases: - patients with severe impairment of renal function\/renal failure; - patients with hypophosphatemia. There is a possibility of reduced efficacy in patients with very low levels of gastric acid. There is an increased risk of hypernatremia in children with gastroenteritis or suspected renal failure. Treatment of children under 12 years of age is generally not recommended unless prescribed by a doctor.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDue to the presence of calcium and carbonates which act as antacids, it is necessary to consider a time interval of two hours between the intake of Gaviscon and the administration of other medicinal products, especially antihistamines-antiH2, tetracyclines, digoxin, fluoroquinolones, iron salts, thyroid hormones, ketoconazole, neuroleptics, tyrosine, penicillamine, beta-blockers (atenolol, metoprolol, propranolol), glucocorticoids, chloroquine, estramustine and bisphosphonates. See also paragraph 4.4.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAdverse reactions associated with the use of sodium alginate, sodium bicarbonate and calcium carbonate are reported below, according to system organ class and frequency. Frequencies are defined as: Very common (≥1\/10); Common (≥1\/100, \u003c1\/10); Uncommon (≥1\/1,000, \u003c1\/100); Rare (≥1\/10,000, \u003c1\/1,000); Very rare (\u003c 1\/10,000); Not known (frequency cannot be estimated from the available data). Within each frequency grouping, adverse reactions are reported in order of decreasing seriousness.\u003c\/p\u003e\n\u003cp\u003eImmune system disorders - Frequency: Very rare. Adverse reactions: Anaphylactic reaction, anaphylactoid reaction. Hypersensitivity reactions such as urticaria.\u003c\/p\u003e\n\u003cp\u003eMetabolism and nutrition disorders - Frequency: Not known. Adverse reactions: Alkalosis¹, Hypercalcemia¹, Lactealkali syndrome¹\u003c\/p\u003e\n\u003cp\u003eRespiratory, thoracic and mediastinal disorders - Frequency: Not known. Adverse reactions: Respiratory effects such as bronchospasm.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders - Frequency: Very rare. Adverse reactions: Abdominal pain, acid return, diarrhea, nausea, vomiting.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders - Frequency: Not known. Adverse reactions: Constipation¹\u003c\/p\u003e\n\u003cp\u003eSkin and subcutaneous tissue disorders - Frequency: Very rare. Adverse reactions: Itchy skin rash.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eDescription of selected adverse reactions:\u003c\/b\u003e \u003cb\u003e¹\u003c\/b\u003e They generally occur following the intake of doses higher than the recommended dose. \u003cb\u003e \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e \u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni- -reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eSymptoms\u003c\/b\u003e Abdominal distention may be evident. \u003cb\u003eManagement\u003c\/b\u003e In case of overdose, symptomatic treatment should be used.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ePregnancy\u003c\/b\u003e A moderate amount of data in pregnant women (between 300 and 1,000 exposed pregnancies) indicates that the active ingredients do not cause malformations or fetal\/neonatal toxicity. Based on this and previous experience, the medicine can be used during pregnancy if clinically necessary. However, given the presence of calcium carbonate, it is recommended to limit the duration of treatment as much as possible. \u003cb\u003eBreastfeeding\u003c\/b\u003e No effect of the active ingredients has been shown on newborns\/infants breast-fed by treated women. This product can be used during breastfeeding. \u003cb\u003eFertility\u003c\/b\u003e Pre-clinical animal investigations have found that alginate does not have an adverse effect on the fertility of the parental generation and offspring or on reproduction. Clinical data do not suggest that Gaviscon may have an effect on fertility in humans.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis product has no or negligible influence on the ability to drive and use machines.\u003c\/p\u003e","brand":"Reckitt Benckiser","offers":[{"title":"Default Title","offer_id":46472709800263,"sku":"041545031","price":15.72,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/reckitt-benckiser-h-it-spa-gaviscon-bruciore-e-indigestione-24-bustine-farmacia-dottor-tili-1213792496.jpg?v=1767112391"},{"product_id":"geffer-granulato-effervescente-24-bustine-5-g","title":"Geffer Effervescent Granules 24 Sachets 5 g","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptomatic treatment of hyperacidity (pain and heartburn), when accompanied by slowing of gastric transit, nausea, aerophagia and meteorism.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEach sachet of effervescent granules contains: \u003cb\u003eactive ingredients\u003c\/b\u003e: metoclopramide hydrochloride 5 mg, dimethicone 50 mg, potassium citrate 94.45 mg, citric acid 670 mg, tartaric acid 152 mg, sodium bicarbonate 1050 mg. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eOrange flavour, sucrose\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to any of the active substances or excipients. Patients suffering from glaucoma, pheochromocytoma, epileptic disease, Parkinson's disease and other established extrapyramidal diseases or undergoing therapy with anticholinergics. Cases in which the stimulation of intestinal motility may prove dangerous, for example in the presence of gastrointestinal haemorrhage, perforation, mechanical obstruction. Patients suffering from Porphyria. Children under 16 years old. Pregnancy and breastfeeding (see section 4.6).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e1 sachet in half a glass of water before meals or at the onset of symptoms, 2-3 times a day. Do not exceed the recommended doses: elderly patients in particular must adhere to the minimum dosages indicated above. The use of the product is limited to adult patients.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStore at a temperature not exceeding 25°C\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAvoid the simultaneous administration of neuroleptics - phenothiazines, butyrophenones, thioxanthenes, etc. - sedatives and alcohol (see section 4.5). Neuroleptic malignant syndrome has been reported with metoclopramide both as monotherapy and in combination with neuroleptics (see section 4.8). If symptoms of neuroleptic malignant syndrome appear, metoclopramide should be discontinued immediately and appropriate treatment instituted. The use of the product can give rise to disturbances that alter the normal state of vigilance; patients involved in driving motor vehicles or operating potentially dangerous machinery should take this into account (see paragraph 4.7). After a maximum of 3 days of treatment without appreciable results, consult your doctor. Elderly patients must not exceed 3 days of consecutive treatment (see section 4.8) and must adhere to the minimum dosages indicated (see section 4.2). \u003cu\u003eImportant information about some excipients.\u003c\/u\u003e This medicine contains 288 mg sodium per sachet, equivalent to 14.4% of the WHO recommended maximum daily intake of 2 g sodium per day for an adult. The medicine contains sucrose: Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase isomaltase insufficiency should not take this medicine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe sedative effects of metoclopramide are enhanced by alcohol. Anticholinergics and morphine derivatives antagonize the effect of metoclopramide on intestinal motility. The sedative effects of CNS depressant drugs (morphine derivatives, hypno-inducers, anxiolytics, sedative antihistamines, sedative antidepressants, barbiturates, etc.) and of metoclopramide are enhanced. The association of metoclopramide with drugs inducing extrapyramidal effects such as phenothiazines, butyrophenones and thioxanthenes should be avoided (in particular the activity of phenothiazines is increased, regardless of the appearance or strengthening of extrapyramidal effects). It increases the effects of MAOIs, sympathomimetics, tricyclic antidepressants. Due to the prokinetic effect of metoclopramide, the absorption of some drugs may be altered. Metoclopramide may reduce the bioavailability of digoxin, while increasing the bioavailability of ciclosporin. Reduces the CNS effects of apomorphine. It reduces the bioavailability of cimetidine by an average of approximately 22%, without however causing clinically relevant consequences. Metoclopramide interacts with serotonergic drugs (e.g. selective serotonin reuptake inhibitors), increasing the risk of serotonin syndrome.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe following side effects may occur following the use of Geffer: • \u003cb\u003eWith frequency: rare ≥1\/10,000, \u003c1\/1,000\u003c\/b\u003e \u003ci\u003eSystemic pathologies:\u003c\/i\u003e Tiredness \u003ci\u003eEndocrine disorders:\u003c\/i\u003e Hypertensive crises, sometimes with fatal outcomes, have been reported in patients with pheochromocytoma; therefore the use of Geffer is contraindicated in these patients. Following the use of the product, in relation to the prolactin secretion-promoting activity of metoclopramide, the following may occur: hyperprolactinemia, menstrual cycle disorders, galactorrhea and gynecomastia in men. \u003ci\u003eNervous system disorders:\u003c\/i\u003e Drowsiness, tiredness, dizziness and various types of extrapyramidal reactions, normally dystonic, have been reported with the use of metoclopramide. They may include facial spasms, trismus, extra-ocular muscle spasms with oculogyric crises, abnormal head positions; these reactions usually regress 24 hours after stopping treatment. The development of tardive dyskinesia, potentially irreversible, has been reported in some elderly patients treated for prolonged periods; therefore, in elderly patients, therapies that last longer than 3 days should be absolutely avoided. \u003ci\u003eMetabolism and nutrition disorders:\u003c\/i\u003e Cases of porphyria have been reported • \u003cb\u003eWith unknown frequency\u003c\/b\u003e (frequency cannot be estimated from available data) \u003ci\u003eNervous system disorders:\u003c\/i\u003e Neuroleptic malignant syndrome (see section 4.4) \u003ci\u003eVascular pathologies:\u003c\/i\u003e Transient increase in blood pressure \u003cb\u003eReporting of suspected adverse reactions.\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at http:\/\/www.agenziafarmaco.gov.it\/content\/come-segnalare-una-sospetti-reazione-avversa.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMetoclopramide can induce neurodystonic-type reactions, drowsiness, disorientation, especially at plasma levels \u003e 100 ng\/ml. Dyskinesias that respond to treatment with diazepam or anticholinergics may occur. Prolonged use of metoclopramide can also cause galactorrhea and amenorrhea, linked to the stimulation of prolactin secretion.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe product must not be used during pregnancy and breastfeeding (see section 4.3).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMetoclopramide, at high doses, can decrease the state of vigilance; this should be taken into account when driving motor vehicles or potentially dangerous machinery (see paragraph 4.4).\u003c\/p\u003e","brand":"Bayer","offers":[{"title":"Default Title","offer_id":46487421288775,"sku":"023358068","price":11.99,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/bayer-spa-geffer-granulato-effervescente-24-bustine-5-g-farmacia-dottor-tili-1213792493.webp?v=1767112494"},{"product_id":"t-gastro-calm-sciroppo-antiacido-naturale-200-ml-dr-tili","title":"T - Gastro Calm Natural Antacid Syrup 200 ml Dr.Tili","description":"\u003cp\u003e\u003cimg height=\"125\" width=\"125\" alt=\"Supplement made in Italy\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/Made_in_Italy.png?v=1668012159\" style=\"float: none;\" data-mce-style=\"float: none;\" data-mce-src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/Made_in_Italy.png?v=1668012159\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/senza_glutine_480x480.png?v=1668012159\" alt=\"gluten-free supplement\" width=\"125\" height=\"125\" data-mce-fragment=\"1\" data-mce-src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/senza_glutine_480x480.png?v=1668012159\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/senza_lattosio_480x480.png?v=1668012159\" alt=\"lactose-free supplement\" width=\"125\" height=\"125\" data-mce-fragment=\"1\" data-mce-src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/senza_lattosio_480x480.png?v=1668012159\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/ingredienti_vegani_480x480.png?v=1668012159\" alt=\"vegan supplement\" width=\"125\" height=\"125\" data-mce-fragment=\"1\" data-mce-src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/ingredienti_vegani_480x480.png?v=1668012159\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003cspan\u003e  \u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003eT-Gastro Calm Natural Antacid Syrup is a supplement based on high-titration extracts of \u003cstrong\u003eLicorice, Artichoke, Rhubarb, Angelica, Chamomile and Snail Slime\u003c\/strong\u003e. These high titer natural extracts support the \u003cstrong\u003eliver and digestive function with an emollient and soothing action\u003c\/strong\u003e on the digestive system, especially the stomach. Very useful in case of \u003cstrong data-mce-fragment=\"1\"\u003egastric acidity,\u003c\/strong\u003e\u003cspan data-mce-fragment=\"1\"\u003e \u003c\/span\u003e\u003cstrong data-mce-fragment=\"1\"\u003ereflux \u003cb data-mce-fragment=\"1\"\u003egastro-esophageal\u003c\/b\u003e\u003c\/strong\u003e\u003cspan data-mce-fragment=\"1\"\u003e,\u003c\/span\u003e\u003cspan data-mce-fragment=\"1\"\u003e \u003c\/span\u003e\u003cstrong data-mce-fragment=\"1\"\u003eheartburn\u003c\/strong\u003e\u003cspan data-mce-fragment=\"1\"\u003e e \u003c\/span\u003e\u003cstrong data-mce-fragment=\"1\"\u003epoor digestion\u003c\/strong\u003e\u003cspan data-mce-fragment=\"1\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan data-mce-fragment=\"1\"\u003eFrom \u003cstrong\u003eLicorice root\u003c\/strong\u003e a phytotherapeutic extract is obtained whose properties are linked to the presence of \u003cstrong\u003eflavonoids and saponins\u003c\/strong\u003e. In particular the \u003cstrong\u003eglycyrrhizin\u003c\/strong\u003e it has important properties \u003cstrong\u003eanti-inflammatory, protective and healing\u003c\/strong\u003e on the gastric and duodenal mucosa are widely recognized. \u003cbr\u003e\u003c\/span\u003e\u003cspan data-mce-fragment=\"1\"\u003eGlycyrrhizin and other liquorice flavonoids and saponins provide \u003cstrong\u003equick and clear benefits\u003c\/strong\u003e in the presence of \u003cstrong\u003egastric acidity, heartburn and poor digestion. \u003c\/strong\u003eThey contribute to \u003cstrong\u003equickly calm the symptoms of gastroesophageal reflux\u003c\/strong\u003e creating a \u003cstrong\u003eprotective biofilm on the stomach mucosa\u003c\/strong\u003e by direct contact e\u003cstrong\u003e stimulate the natural production of mucus\u003c\/strong\u003e by the cells of the stomach wall.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan data-mce-fragment=\"1\"\u003eThe extract of \u003cstrong\u003eSnail slime\u003c\/strong\u003e it is an excellent complement and support to the properties of licorice. Contains \u003cstrong\u003eallantoin\u003c\/strong\u003e, a powerful one \u003cstrong\u003enatural healing\u003c\/strong\u003e useful in the presence of \u003cstrong\u003einflammatory processes affecting the stomach\u003c\/strong\u003e, even ulcerative. Indicated in case of \u003cstrong\u003ediscomfort and heartburn and gastritis,\u003c\/strong\u003e as it soothes the inflammatory processes of the gastric system. \u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan data-mce-fragment=\"1\"\u003eLe \u003c\/span\u003e\u003cstrong data-mce-fragment=\"1\"\u003eArtichoke leaves,\u003c\/strong\u003e\u003cspan data-mce-fragment=\"1\"\u003e thanks to flavonoids and caffeic acid, it contributes to \u003cstrong\u003ebalance the production and secretion of bile\u003c\/strong\u003e in the stomach and a \u003c\/span\u003e\u003cstrong data-mce-fragment=\"1\"\u003eaid the digestive process\u003c\/strong\u003e\u003cspan data-mce-fragment=\"1\"\u003e and the elimination of bad cholesterol. The leaves of the Artichoke also have \u003c\/span\u003e\u003cstrong data-mce-fragment=\"1\"\u003eimportant diuretic properties for the liver\u003c\/strong\u003e\u003cspan data-mce-fragment=\"1\"\u003e. In fact, they promote purification and \u003c\/span\u003e\u003cstrong data-mce-fragment=\"1\"\u003eprotect against the harmful effects of alcohol\u003c\/strong\u003e\u003cspan data-mce-fragment=\"1\"\u003e, processed foods and other pollutants. The \u003cstrong\u003eRhubarb\u003c\/strong\u003e completes and supports its benefits with its own \u003cstrong\u003eproperties to support digestive and liver function\u003c\/strong\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003eThe\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003echamomile \u003c\/strong\u003eand the\u003cstrong\u003eangelica\u003c\/strong\u003e thanks to their compounds they have\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003ecarminative properties\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003ewhich contribute to\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eeliminate air from the stomach\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eand from the intestine, reducing swelling and abdominal pain. They are useful for combating flatulence, meteorism and for \u003cstrong\u003epromote proper digestion\u003c\/strong\u003e. \u003cbr data-mce-fragment=\"1\"\u003e\n\u003cbr\u003e\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy use T - Gastro Calm Natural Antacid Syrup 200 ml Dr.Tili? What is it for?\u003c\/h3\u003e\u003cp\u003eFood supplement based on extracts of Licorice, Artichoke, Rhubarb, Angelica, Chamomile and Snail Slime, which support liver and digestive function with an emollient and soothing action on the digestive system.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does T - Gastro Calm Natural Antacid Syrup 200 ml Dr.Tili contain?\u003c\/h3\u003e\u003cp\u003eWater, snail extract (Helix aspersa), humectant: Glycerol, dry chamomile extract (Matricaria chamomilla L., hours) tit. at 0.3% in total apigenins, deglycyrrhized dry extract of licorice (Glycyrrhiza glabra L., root), dry angelica extract (Angelica archangelica L., root), fig bud extract (water, alcohol, glycerol, Ficus carica L. gemma), emulsifier: sodium alginate, acidifier: citric acid; Preservative: potassium sorbate; dry artichoke extract (Cynara scolymus L., leaf) tit. at 10% in chlorogenic acid, dry extract of rhubarb (Rheum ofcinale Baill., root) tit. at 10% in rhine, dry extract of grapefruit (Citrus maxima (Burm.) Merr., seeds) tit. 50% bioavonoids, potassium bicarbonate, apple flavouring, sweetener: sucralose.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does T - Gastro Calm Natural Antacid Syrup 200 ml Dr.Tili contain?\u003c\/h3\u003e\u003cp\u003eSnail extract 1000 mg\u003cbr\u003eChamomile dry extract 200 mg of which total apigenins 0.6 mg\u003cbr\u003eLiquorice dry extract glic. 140 mg\u003cbr\u003eAngelica e.s. 100mg\u003cbr\u003eFig bud extract 70 mg\u003cbr\u003eArtichoke d.e. 40 mg\u003cbr\u003eof which chlorogenic acid 4 mg\u003cbr\u003eRhubarb d.e. 40 mg of which rhine 4 mg\u003cbr\u003eGrapefruit dry extract 40 mg\u003cbr\u003eof which bioavonoids 20 mg\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use T - Gastro Calm Natural Antacid Syrup 200 ml Dr.Tili?\u003c\/h3\u003e\u003cp\u003eTake one scoop (1 scoop = 10 ml) of product twice a day, before meals. Shake well before use.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of T - Gastro Calm Natural Antacid Syrup 200 ml Dr.Tili?\u003c\/h3\u003e\u003cp\u003eKeep out of reach of children under 3 years. Do not exceed the recommended daily dose. Food supplements are not intended as substitutes for a varied, balanced diet and a healthy lifestyle. Do not administer to children under 12 years of age. Consult your doctor in case of pregnancy and breastfeeding. Do not use for prolonged periods without consulting your doctor. The product is not filtered, any suspensions or sediments are a natural characteristic of the product and do not affect its quality.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of T - Gastro Calm Natural Antacid Syrup 200 ml Dr.Tili?\u003c\/h3\u003e\u003cp\u003e200ml\u003c\/p\u003e","brand":"Tilab","offers":[{"title":"Default Title","offer_id":46669618676039,"sku":"987033115","price":18.4,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/tilab-srl-t-gastro-calm-sciroppo-antiacido-naturale-200-ml-dr-tili-farmacia-dottor-tili-1213792480.jpg?v=1767112630"},{"product_id":"citrosodina-effervescente-granulato-150g","title":"Citrosodina effervescent granules 150g","description":"\u003cp\u003eThe \u003cstrong\u003eCitrosodine effervescent granules 150g\u003c\/strong\u003e is a natural remedy formulated to offer rapid relief from digestive disorders such as heaviness in the stomach, hyperacidity and abdominal swelling. Thanks to its composition based on \u003cstrong\u003esodium bicarbonate\u003c\/strong\u003e e \u003cstrong\u003ecitric acid\u003c\/strong\u003e, this product acts as an effective antacid, neutralizing excess gastric acidity and relieving heartburn.\u003c\/p\u003e\n\u003cp\u003eThe effervescent granules are enriched with sucrose and coloring E132, offering a pleasant and refreshing tasting experience. Its formulation is designed to be easily soluble in water, allowing for practical and quick intake. Citrosodine is particularly suitable for those looking for an immediate and natural remedy to improve intestinal function and counteract digestion-related discomfort.\u003c\/p\u003e\n\u003cp\u003eProduced by \u003cstrong\u003eBayer\u003c\/strong\u003e, a brand synonymous with quality and reliability, effervescent Citrosodine is available in a practical 150 g jar, ideal for prolonged use. Perfect for those who wish to maintain digestive well-being even during pregnancy, this effervescent granules are a precious ally for those who suffer from occasional digestive disorders.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Citrosodine effervescent granules 150g used? What is it for?\u003c\/h3\u003e\u003cp\u003eAntacid based on sodium bicarbonate and citric acid, indicated for rapid relief from heartburn, gastric hyperacidity and heaviness linked to occasional digestive difficulties.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Citrosodine effervescent granules 150g contain?\u003c\/h3\u003e\u003cp\u003eSucrose, sodium bicarbonate, citric acid, color E132.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eACTIVE INGREDIENTS AND EXCIPIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat is the composition of Citrosodine effervescent granules 150g?\u003c\/h3\u003e\u003cp\u003eSucrose, sodium bicarbonate, citric acid, color E132.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does Citrosodine effervescent granules 150g contain?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eAverage values per 100 g\u003c\/strong\u003e\u003cbr\u003eEnergy value: 1.96 kJ, 352 kcal\u003cbr\u003eFat: 0 g\u003cbr\u003e-of which saturated fatty acids: 0 g\u003cbr\u003eCarbohydrates: 88 g\u003cbr\u003e-of which sugars: 70.8 g\u003cbr\u003eProtein: 0 g\u003cbr\u003eSalt: 11.25 g\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Citrosodine effervescent granules 150g?\u003c\/h3\u003e\u003cp\u003eDissolve two teaspoons of granulated Citrosodine in a glass of water and drink during the effervescence.\u003cbr\u003eOpening method: grab the tab and pull it upwards and to the right to free the lid, detaching the ring that holds it. After each withdrawal, carefully close the jar.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eDOSAGE\u003c\/h2\u003e\n\u003ch3\u003eHow to take Citrosodine effervescent granules 150g?\u003c\/h3\u003e\u003cp\u003eDissolve two teaspoons of granulated Citrosodine in a glass of water and drink during the effervescence. How to open: grab the tab and pull it upwards and to the right to free the lid, detaching the ring that holds it. After each withdrawal, carefully close the jar.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Citrosodine effervescent granules 150g?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eExcessive consumption can have laxative effects.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eLegal warnings\u003c\/strong\u003e\u003cbr\u003eDo not exceed the recommended daily dose.\u003cbr\u003eKeep out of reach of children under three years of age.\u003cbr\u003eSupplements are not intended as substitutes for a varied and balanced diet and a healthy lifestyle.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Citrosodine effervescent granules 150g stored?\u003c\/h3\u003e\u003cp\u003eTo be stored in a cool, dry place.\u003cbr\u003eValidity with intact packaging: 36 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Citrosodine effervescent granules 150g?\u003c\/h3\u003e\u003cp\u003eNet weight: 150g.\u003c\/p\u003e","brand":"Bayer","offers":[{"title":"Default Title","offer_id":51131195916615,"sku":"938181462","price":6.42,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/bayer-spa-citrosodina-effervescente-granulato-150g-farmacia-dottor-tili-1213792389.jpg?v=1767132628"},{"product_id":"neobianacid-70-compresse-masticabili","title":"Neobianacid 70 chewable tablets","description":"\u003cp\u003eLe \u003cstrong\u003eNeobianacid 70 chewable tablets\u003c\/strong\u003e they are an innovative and natural product, designed to offer immediate relief from the symptoms of \u003cstrong\u003egastroesophageal reflux\u003c\/strong\u003e and of \u003cstrong\u003eheartburn\u003c\/strong\u003e. Thanks to the plant and mineral complex \u003cstrong\u003ePolyprotect\u003c\/strong\u003e, these tablets create a barrier film that protects the gastric mucosa, relieving pain and irritation. They are particularly effective in the treatment of \u003cstrong\u003edyspepsia\u003c\/strong\u003e, whether painful or not, and digestive disorders such as acidity, heaviness and post-meal bloating.\u003c\/p\u003e\n\n\u003cp\u003eMade with ingredients from \u003cstrong\u003eorganic farming\u003c\/strong\u003e, the tablets contain extracts of mallow, marshmallow, aloe vera, chamomile and licorice, known for their soothing and antioxidant properties. The presence of minerals such as limestone and nahcolite helps to neutralize acidity, improving the well-being of the gastrointestinal system. Furthermore, the product is \u003cstrong\u003egluten and lactose free\u003c\/strong\u003e, making it also suitable for those with food intolerances.\u003c\/p\u003e\n\n\u003cp\u003eNeobianacid 70 chewable tablets are safe for use in \u003cstrong\u003epregnancy\u003c\/strong\u003e, during the\u003cstrong\u003ebreastfeeding\u003c\/strong\u003e and in \u003cstrong\u003echildren\u003c\/strong\u003e over 6 years, offering a natural and versatile solution for the whole family. Also ideal for \u003cstrong\u003eprevention\u003c\/strong\u003e in situations that can cause irritation of the mucosa, these tablets represent a valid support for those looking for a \u003cstrong\u003enatural supplement\u003c\/strong\u003e for digestive well-being.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Neobianacid 70 chewable tablets used? What is it for?\u003c\/h3\u003e\u003cp\u003eLe \u003cstrong\u003eNeobianacid 70 chewable tablets\u003c\/strong\u003e they are an innovative and natural product, designed to offer immediate relief from the symptoms of \u003cstrong\u003egastroesophageal reflux\u003c\/strong\u003e and of \u003cstrong\u003eheartburn\u003c\/strong\u003e. Thanks to the plant and mineral complex \u003cstrong\u003ePolyprotect\u003c\/strong\u003e, these tablets create a barrier film that protects the gastric mucosa, relieving pain and irritation. They are particularly effective in the treatment of \u003cstrong\u003edyspepsia\u003c\/strong\u003e, whether painful or not, and digestive disorders such as acidity, heaviness and post-meal bloating.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Neobianacid 70 chewable tablets contain?\u003c\/h3\u003e\u003cp\u003eA 1.55 g tablet contains: natural complex Poliprotect 528 mg based on polysaccharides (Lpme extractive fractions of mallow* and marshmallow*, dehydrated leaf gel of aloe vera* 105 mg) and minerals (limestone and nahcolite 423 mg), Lpme extractive flavonoid fraction of chamomile* and liquorice* 46 mg, cane sugar*, gum arabica, natural mint flavour.\u003cbr\u003e*Ingredient from organic farming\u003c\/p\u003e\u003cp\u003eWithout \u003cstrong\u003egluten and lactose\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Neobianacid 70 chewable tablets?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eDo not use if there is individual hypersensitivity or allergy to one or more components.\u003cbr\u003eIf symptoms persist, consult your doctor.\u003cbr\u003eIt is advisable to take the product at least two hours after taking drugs, in particular tetracyclines.\u003cbr\u003eThe glycyrrhizin content due to liquorice is lower than what has been reported to cause a possible increase in blood pressure.\u003cbr\u003eKeep out of reach of children.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Neobianacid 70 chewable tablets stored?\u003c\/h3\u003e\u003cp\u003eStore in a cool, dry place, away from heat sources and away from light.\u003cbr\u003eThe expiry date refers to the intact and correctly stored product. Do not use after the indicated expiry date.\u003cbr\u003eValidity in unopened package: 30 months.\u003cbr\u003eValidity after first opening: 6 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Neobianacid 70 chewable tablets?\u003c\/h3\u003e\u003cp\u003ePack of 70 tablets of 1.55 g.\u003cbr\u003eNet Weight: 108.5g.\u003c\/p\u003e","brand":"Aboca","offers":[{"title":"Default Title","offer_id":51131201651015,"sku":"980423610","price":24.23,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/aboca-spa-societa-agricola-neobianacid-70-compresse-masticabili-farmacia-dottor-tili-1213792394.jpg?v=1767132730"},{"product_id":"marial-20-oral-stick-15ml","title":"Marial 20 oral stick 15ml","description":"\u003cp\u003eThe \u003cstrong\u003eMarial 20 oral stick 15ml\u003c\/strong\u003e is an innovative medical device designed for the effective treatment of \u003cstrong\u003egastroesophageal reflux\u003c\/strong\u003e and of \u003cstrong\u003elaryngopharyngeal reflux\u003c\/strong\u003e. Thanks to its advanced formulation, this product offers a practical and targeted solution for those suffering from stomach acid-related disorders, such as \u003cstrong\u003eheartburn\u003c\/strong\u003e, \u003cstrong\u003eindigestion\u003c\/strong\u003e e \u003cstrong\u003eacid regurgitation\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003cp\u003eThe composition of Marial 20 oral stick is based on natural ingredients such as \u003cstrong\u003etare gum\u003c\/strong\u003e and the \u003cstrong\u003exanthan gum\u003c\/strong\u003e, which form a protective barrier adhering to the esophageal mucosa. This protective layer allows the\u003cstrong\u003ehyaluronic acid\u003c\/strong\u003e and to \u003cstrong\u003ehydrolyzed keratin\u003c\/strong\u003e to act locally, protecting the mucosa from the aggression of gastric acid and promoting its repair. Furthermore, the product is enriched with \u003cstrong\u003emagnesium alginate\u003c\/strong\u003e, which helps to neutralize acidity and reduce associated symptoms.\u003c\/p\u003e\n\n\u003cp\u003eThe Marial 20 oral stick is ideal for those looking for a GMO-free, lactose-free and gluten-free remedy, thus guaranteeing wide tolerability. It is particularly suitable for those suffering from symptoms such as \u003cstrong\u003ecough\u003c\/strong\u003e, \u003cstrong\u003erhinorrhea\u003c\/strong\u003e, \u003cstrong\u003edyspnoea\u003c\/strong\u003e, \u003cstrong\u003enasal obstruction\u003c\/strong\u003e, \u003cstrong\u003ebad breath\u003c\/strong\u003e, \u003cstrong\u003easthma\u003c\/strong\u003e e \u003cstrong\u003eodynophagia\u003c\/strong\u003e, often related to reflux. Its practical 15 ml single-dose package makes it easy to use at any time of the day, offering quick and long-lasting relief.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Marial 20 oral stick 15ml used? What is it for?\u003c\/h3\u003e\u003cp\u003eOral stick based on tara gum, xanthan gum, hyaluronic acid, hydrolyzed keratin and magnesium alginate, indicated for the relief of the symptoms of gastroesophageal and laryngopharyngeal reflux such as heartburn, indigestion and acid regurgitation; forms a protective barrier on the esophageal mucosa and helps to neutralize acidity.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Marial 20 oral stick 15ml contain?\u003c\/h3\u003e\u003cp\u003eE-gastryal (hyaluronic acid, hydrolyzed keratin, tara gum, xanthan gum, purified water), magnesium alginate, sucralose, potassium sorbate, sodium benzoate, E-polylysine, aroma, purified water.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Marial 20 oral stick 15ml?\u003c\/h3\u003e\u003cp\u003eAdults and children over 12 years: 1 single-dose stick (or 15 ml) after main meals or according to medical advice.\u003cbr\u003eShake before use.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Marial 20 oral stick 15ml?\u003c\/h3\u003e\u003cp\u003ePack containing 20 oral sticks of 15 ml.\u003c\/p\u003e","brand":"Aurora Biofarma","offers":[{"title":"Default Title","offer_id":51131217674567,"sku":"971277874","price":22.52,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/aurora-biofarma-marial-20-oral-stick-15ml-farmacia-dottor-tili-1258975844.jpg?v=1789561781"},{"product_id":"citrosodina-classica-30-compresse-masticabili","title":"Classic Citrosodine 30 chewable tablets","description":"\u003cp\u003eThe \u003cstrong\u003eClassic Citrosodine 30 chewable tablets\u003c\/strong\u003e it is the ideal solution for those looking for a practical and quick remedy against difficult digestion and heaviness in the stomach. These chewable tablets, from \u003cstrong\u003erefreshing lemon flavour\u003c\/strong\u003e, are formulated with sodium bicarbonate and citric acid, known for their antacid and effervescent properties. Thanks to their sugar-free and lactose-free composition, they are also suitable for those following a vegan diet.\u003c\/p\u003e\n\n\u003cp\u003eThe tablets are perfect to always carry with you, thanks to their practical and portable format, and can be used at any time of the day, especially after meals, to relieve symptoms such as \u003cstrong\u003ebloating, heartburn and nausea\u003c\/strong\u003e. Classic Citrosodine is a precious ally for those who want effective and uncompromising digestive support, guaranteeing rapid relief from stomach acid.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Citrosodine Classic 30 chewable tablets used? What is it for?\u003c\/h3\u003e\u003cp\u003eAntacid based on sodium bicarbonate and citric acid in lemon-flavoured chewable tablets, indicated for rapid relief from difficult digestion, heavy stomach, bloating, heartburn and nausea linked to gastric acidity.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Classic Citrosodine 30 chewable tablets contain?\u003c\/h3\u003e\u003cp\u003eSweeteners: xylitol, mannitol; sodium bicarbonate, anhydrous citric acid; aroma: lemon; anti-caking agent: magnesium stearate.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does Classic Citrosodine 30 chewable tablets contain?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eAverage values per 100 g\u003c\/strong\u003e\u003cbr\u003eEnergy value: 980 kJ, 234 kcal\u003cbr\u003eFat: 0.9 g\u003cbr\u003e-of which saturated fatty acids: 0.9 g\u003cbr\u003eCarbohydrates: 85.37 g\u003cbr\u003e-of which sugars: 0 g\u003cbr\u003eProtein: 0.1 g\u003cbr\u003eSalt: 11 g\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Classic Citrosodine 30 chewable tablets?\u003c\/h3\u003e\u003cp\u003eOral use. The chewable tablets are indicated at any time of the day, particularly at the end of meals.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Classic Citrosodine 30 chewable tablets?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eExcessive consumption can have laxative effects.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eLegal warnings\u003c\/strong\u003e\u003cbr\u003eDo not exceed the recommended daily dose.\u003cbr\u003eKeep out of reach of children under three years of age.\u003cbr\u003eSupplements are not intended as substitutes for a varied and balanced diet and a healthy lifestyle.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Citrosodine Classic 30 chewable tablets stored?\u003c\/h3\u003e\u003cp\u003eTo be stored in a cool, dry place.\u003cbr\u003eValidity with intact packaging: 24 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Classic Citrosodine 30 chewable tablets?\u003c\/h3\u003e\u003cp\u003e30 tablets.\u003c\/p\u003e","brand":"Bayer","offers":[{"title":"Default Title","offer_id":51131228848455,"sku":"939466900","price":7.53,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/bayer-spa-citrosodina-classica-30-compresse-masticabili-farmacia-dottor-tili-1213792337.jpg?v=1767143009"},{"product_id":"gaviscon-500mg-10ml-267mg-10ml-sospensione-orale-aroma-menta-24-bustine-10ml","title":"Gaviscon 500mg\/10ml + 267mg\/10ml oral suspension mint flavour 24 sachets 10ml","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptomatic treatment of occasional heartburn\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e \u003ci\u003eGaviscon 500 mg + 267 mg mint flavor chewable tablets\u003c\/i\u003e. \u003c\/b\u003e One tablet contains: \u003cu\u003eActive ingredients\u003c\/u\u003e: sodium alginate 500 mg; sodium bicarbonate 267 mg. Excipient with known effects: aspartame 7.5 mg sodium 126.5 mg \u003cb\u003e \u003ci\u003eGaviscon 250 mg + 133.5 mg mint flavor chewable tablets.\u003c\/i\u003e \u003c\/b\u003e One tablet contains: \u003cu\u003eActive ingredients\u003c\/u\u003e: sodium alginate 250 mg; sodium bicarbonate 133.5 mg. Excipient with known effects: aspartame 3.75 mg sodium 63.25 mg \u003cb\u003e \u003ci\u003eGaviscon 250 mg + 133.5 mg strawberry flavor chewable tablets\u003c\/i\u003e. \u003c\/b\u003e One tablet contains: \u003cu\u003eActive ingredients\u003c\/u\u003e: sodium alginate 250 mg, sodium bicarbonate 133.5 mg. Excipient with known effects: aspartame 8.80 mg sodium 63.25 mg \u003cb\u003e \u003ci\u003eGaviscon 500 mg\/10 ml + 267 mg\/10 ml oral suspension\u003c\/i\u003e \u003c\/b\u003e. 10ml contains: \u003cu\u003eActive ingredients\u003c\/u\u003e: sodium alginate 500 mg; sodium bicarbonate 267 mg. Excipients with known effects: methyl parahydroxybenzoate 40 mg propyl parahydroxybenzoate 6 mg benzyl alcohol 1.1 mg sodium 142.6 mg \u003cb\u003e \u003ci\u003eGaviscon 500 mg\/10 ml + 267 mg\/10 ml oral suspension mint flavour\u003c\/i\u003e. \u003c\/b\u003e 10ml contains: \u003cu\u003eActive ingredients\u003c\/u\u003e: sodium alginate 500 mg; sodium bicarbonate 267 mg. Excipients with known effects: methyl parahydroxybenzoate 40 mg propyl parahydroxybenzoate 6 mg sodium 142.6 mg For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e \u003ci\u003eMint flavor chewable tablets\u003c\/i\u003e: \u003c\/b\u003e Mannitol (E421), calcium carbonate, magnesium stearate, copovidone, aspartame (E951), acesulfame potassium, macrogol 20,000, mint flavouring. \u003cb\u003e \u003ci\u003eStrawberry flavor chewable tablets\u003c\/i\u003e: \u003c\/b\u003e Xylitol, mannitol (E421), calcium carbonate, macrogol 20,000, strawberry flavouring, aspartame (E951), magnesium stearate, red iron oxide. \u003cb\u003e \u003ci\u003eOral suspension\u003c\/i\u003e: \u003c\/b\u003e Calcium carbonate, carbomers, methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), sodium saccharin, fennel flavouring, sodium hydroxide, erythrosine, purified water. \u003cb\u003e \u003ci\u003eMint flavor oral suspension:\u003c\/i\u003e \u003c\/b\u003e Calcium carbonate, carbomers, methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), sodium saccharin, mint flavouring, sodium hydroxide, purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substances or to any of the excipients listed in section 6.1, such as methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216) (parabens).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003e \u003cu\u003eChewable tablets (strawberry flavor and mint flavour).\u003c\/u\u003e \u003c\/i\u003e Dosage. \u003cb\u003eAdults and adolescents (12-18 years)\u003ci\u003e:\u003c\/i\u003e \u003c\/b\u003e 1-2 tablets of 500 mg + 267 mg after meals and at bedtime; 2-4 tablets of 250 mg + 133.5 mg after meals and at bedtime. Method of administration: For oral administration. The tablets must be chewed well (they can be broken and chewed a little at a time). Afterwards you can drink some water. \u003ci\u003e \u003cu\u003eOral suspension\u003c\/u\u003e \u003c\/i\u003e. Dosage. \u003cb\u003eAdults and adolescents (12-18 years)\u003ci\u003e:\u003c\/i\u003e \u003c\/b\u003e 10-20 ml (second-fourth notch of the measuring cup or 2-4 measuring spoons or 1-2 single-dose sachets) after meals and at bedtime. Method of administration: For oral administration. Shake the suspension before use. Take the medicine orally without water. \u003cb\u003e \u003ci\u003eSpecial populations. \u003c\/i\u003e \u003c\/b\u003e \u003cb\u003eElderly:\u003c\/b\u003e it is not necessary to change the doses for this age group. \u003cb\u003ePatients with renal failure\u003c\/b\u003e: the reduced ability to eliminate the exogenous salt supplement provided by antacids in the urine can lead to potentially severe electrolyte imbalances (see section 4.4).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eOral suspension and mint flavor oral suspension: do not store above 30°C. Store in the original packaging. Do not refrigerate. Mint flavor oral suspension in sachets: do not store above 25°C. Store in the original packaging. Do not refrigerate. Mint flavor chewable tablets: do not store above 30°C. Store in the original packaging. Strawberry flavor chewable tablets: do not store above 25°C. Store in the original packaging.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn adolescents (12-18 years) use only in case of real need and under strict medical supervision. \u003cb\u003eKidney failure: \u003c\/b\u003e In case of renal insufficiency, the medicine should be used with caution since the exogenous salt supplement provided by antacids can cause potentially serious electrolyte imbalances. This medicine contains: \u003cb\u003eSodium\u003c\/b\u003e: • 126.5mg (5.5 mmol) of sodium for each 500 mg + 267 mg chewable tablet, equivalent to approximately 6% of the maximum daily intake recommended by the WHO which corresponds to 2 g of sodium for an adult. • 63.25 mg (2.75 mmol) of sodium for each 250 mg +133.5 mg chewable tablet, equivalent to approximately 3% of the maximum daily intake recommended by the WHO which corresponds to 2 g of sodium for an adult. • 142.6 mg (6.2 mmol) of sodium for each 10 ml dose of oral suspension and mint flavor oral suspension, equivalent to approximately 7% of the maximum daily intake recommended by the WHO which corresponds to 2 g of sodium for an adult. 391 mg sodium (17 mmol) corresponds to approximately 20% of the WHO recommended maximum daily dietary intake of 2 g for an adult; this medicine is therefore considered to be high in sodium. This should be taken into account in cases where a particularly low-salt diet is recommended, for example in some cases of congestive heart failure and renal impairment. \u003cb\u003eFootball\u003c\/b\u003e: Each 500 mg + 267 mg chewable tablet contains 160 mg (1.6 mmol) calcium carbonate. Each 250 mg +133.5 mg chewable tablet contains 80 mg (0.8 mmol) of calcium carbonate. Each 10 ml dose of oral suspension and mint flavor oral suspension contains 160 mg (1.6 mmol) of calcium carbonate. Each maximum recommended dose (2 tablets of 500 mg + 267 mg, 4 tablets of 250 mg +133.5 mg, 20 ml of oral suspension and mint flavor oral suspension) contains 320 mg of calcium carbonate. Caution should be exercised when treating patients with hypercalcemia, nephrocalcinosis, and recurrent calcium-containing renal stones. \u003cb\u003eAspartame: \u003c\/b\u003e Each 500 mg + 267 mg chewable tablet contains 7.5 mg of aspartame. Each 250 mg +133.5 mg mint flavor chewable tablet contains 3.75 mg of aspartame. Each 250 mg +133.5 mg strawberry flavor chewable tablet contains 8.8 mg of aspartame. Aspartame is a source of phenylalanine and may be harmful to patients with phenylketonuria. \u003cb\u003eParahydroxybenzoates: \u003c\/b\u003e The oral suspension and the mint flavor oral suspension contain methyl parahydroxybenzoate (40 mg\/10 ml of suspension) and propyl parahydroxybenzoate (6 mg\/10 ml of suspension) which may cause allergic reactions (even delayed) \u003cb\u003eBenzyl alcohol\u003c\/b\u003e: GAVISCON 500 mg\/10 ml + 267 mg\/10 ml oral suspension contains fennel flavour, which in turn contains benzyl alcohol. Each 10 ml dose of oral suspension contains 1.1 mg of benzyl alcohol. Benzyl alcohol can cause allergic reactions. Large volumes should be used with caution and only if necessary, especially in patients who are pregnant, breastfeeding, with hepatic or renal insufficiency due to the risk of accumulation and toxicity (metabolic acidosis). \u003cb\u003eDuration of treatment: \u003c\/b\u003e If symptoms do not improve after seven days, the clinical picture should be re-evaluated.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIt is advisable to place an interval of at least two hours between taking Gaviscon and other medicines, especially tetracyclines, fluoroquinolones, iron salts, thyroid hormones, chloroquine, bisphosphonates and estramustine (See also section 4.4).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBelow are the side effects of Gaviscon, organized according to the MedDRA system organic classification. They are divided by frequency (very common (≥ 1\/10), common (≥ 1\/100 to ≤ 1\/10), uncommon (≥ 1\/1,000 to ≤ 1\/100), rare (≥ 1\/10,000 to 1\/1,000), very rare (≤ 1\/10,000), not known (the frequency cannot be estimated on the basis of available data)).\u003c\/p\u003e\n\u003cp\u003eImmune system disorders - Frequency: Very rare. Adverse Reaction: anaphylactic or anaphylactoid reactions. Hypersensitivity reactions (such as urticaria).\u003c\/p\u003e\n\u003cp\u003eRespiratory, thoracic and mediastinal disorders - Frequency: Very rare. Adverse Reaction: respiratory symptoms such as bronchospasm.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders - Frequency: Very rare. Adverse Reaction: flatulence, nausea.\u003c\/p\u003e\n\u003cp\u003eGeneral disorders and conditions relating to the administration site - Frequency: Very rare. Adverse Reaction: edema.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e \u003cu\u003eReporting of suspected adverse reactions.\u003c\/u\u003e \u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eExperience with overdose is very limited. The only possible consequence of overdose is abdominal distension: in this case, resort to symptomatic treatment by adopting generic support measures.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ePregnancy:\u003c\/b\u003e Clinical studies on more than 500 pregnant women, as well as a large number of data from post-marketing experience, indicate that the active ingredients do not cause malformations or fetal\/neonatal toxicity. Gaviscon can be used during pregnancy if clinically necessary. \u003cb\u003eBreastfeeding:\u003c\/b\u003e No effect of the active ingredients has been shown on newborns\/infants breastfed by treated mothers. Gaviscon can be used during breastfeeding. \u003cb\u003eFertility: \u003c\/b\u003e Preclinical studies have shown that alginate has no negative effect on fertility and reproduction. Clinical data do not suggest that Gaviscon has an effect on human fertility.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eGaviscon has no or negligible influence on the ability to drive or use machines.\u003c\/p\u003e","brand":"Reckitt Benckiser","offers":[{"title":"Default Title","offer_id":51131247755591,"sku":"024352142","price":13.02,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/reckitt-benckiser-h-it-spa-gaviscon-500mg-10ml-267mg-10ml-sospensione-orale-aroma-menta-24-bustine-10ml-farmacia-dottor-tili-1213792313.jpg?v=1767143489"},{"product_id":"biochetasi-digestione-pocket-18-compresse","title":"Biochetasi Digestion Pocket 18 tablets","description":"\u003cp\u003eThe \u003cstrong\u003eBiochetase Digestion Pocket 18 tablets\u003c\/strong\u003e is a food supplement designed to support the health of the gastrointestinal tract, offering effective help in cases of slow and tiring digestion, often associated with gastric acidity. Thanks to its advanced formulation, this product combines the power of \u003cstrong\u003efootball\u003c\/strong\u003e, which contributes to the normal function of digestive enzymes, with vitamins B2, B6 and B1, essential for normal energy metabolism.\u003c\/p\u003e\n\n\u003cp\u003eEnriched with \u003cstrong\u003ecitrates\u003c\/strong\u003e and a delicious orange aroma, Biochetasi Digestion Pocket is practical to carry with you thanks to its pocket size, making it ideal for use as needed. The chewable tablets are gluten and sugar free, making them suitable for the whole family. Additionally, the supplement is formulated with sweeteners to ensure a pleasant taste without compromising your dental health.\u003c\/p\u003e\n\n\u003cp\u003eProduced by \u003cstrong\u003eAlphasigma\u003c\/strong\u003e, Biochetase Digestion Pocket is a convenient solution for those looking for quick and practical relief from stomach acid problems and gastric reflux. Thanks to its balanced composition, this supplement represents a valid support for improving daily digestive well-being.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Biochetasi Digestion Pocket 18 tablets used? What is it for?\u003c\/h3\u003e\u003cp\u003eFood supplement in pocket size, useful in case of slow and tiring digestion associated with gastric acidity; contains calcium, which contributes to the normal function of digestive enzymes, and vitamins B1, B2 and B6 for normal energy metabolism.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Bioketasi Digestion Pocket 18 tablets contain?\u003c\/h3\u003e\u003cp\u003eSweeteners: mannitol, sorbitol, aspartame, sucralose, saccharin sodium salt, acesulfame K; calcium carbonate, monosodium citrate; acidity regulator: sodium hydrogen carbonate; anhydrous citric acid, tripotassium citrate; aroma: orange; anti-caking agents: magnesium salts of fatty acids, silicon dioxide; riboflavin 5'-sodium phosphate (vitamin B2), pyridoxine hydrochloride (vitamin B6), thiamine hydrochloride (vitamin B1).\u003c\/p\u003e\u003cp\u003eWithout \u003cstrong\u003egluten\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does Biochetasi Digestion Pocket 18 tablets contain?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eAverage values per tablet (1.5 g)\u003c\/strong\u003e\u003cbr\u003eCalcium: 120 mg (15% NRV*)\u003cbr\u003eVitamin B2: 0.7 mg (50% VNR*)\u003cbr\u003eVitamin B6: 0.7 mg (50% NRV*)\u003cbr\u003eVitamin B1: 0.56 mg (50% NRV*)\u003cbr\u003eCitrates (expressed as citric acid): 224 mg\u003c\/p\u003e\u003cp\u003e*VNR: Nutrient Reference Values.\u003c\/p\u003e\u003cp\u003e*VNR: Nutrient Reference Values\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Biochetasi Digestion Pocket 18 tablets?\u003c\/h3\u003e\u003cp\u003eThe recommended dose is 2-4 chewable tablets as needed.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Biochetasi Digestion Pocket 18 tablets?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eContains a source of phenylalanine. Contains sugar alcohols, excessive consumption can have laxative effects.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eLegal warnings\u003c\/strong\u003e\u003cbr\u003eDo not exceed the recommended daily dose.\u003cbr\u003eKeep out of reach of children under three years of age.\u003cbr\u003eSupplements are not intended as substitutes for a varied and balanced diet and a healthy lifestyle.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Biochetasi Digestion Pocket 18 tablets stored?\u003c\/h3\u003e\u003cp\u003eStore in a cool, dry place at a temperature not exceeding 25°C.\u003cbr\u003eThe end of validity date refers to the product correctly stored, in intact packaging.\u003cbr\u003eValidity with intact packaging: 24 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Biochetasi Digestion Pocket 18 tablets?\u003c\/h3\u003e\u003cp\u003e18 chewable tablets.\u003cbr\u003eNet Weight: 27g.\u003c\/p\u003e","brand":"Alfasigma","offers":[{"title":"Default Title","offer_id":51131297759559,"sku":"974034439","price":12.09,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/alfasigma-spa-biochetasi-digestione-pocket-18-compresse-farmacia-dottor-tili-1213792196.jpg?v=1767127188"},{"product_id":"maalox-reflurapid-20-bustine","title":"Maalox Reflurapid 20 sachets","description":"\u003cp\u003eMaalox Reflurapid 20 sachets is a \u003cstrong\u003emedical device\u003c\/strong\u003e innovatively designed to offer rapid relief from the symptoms of \u003cstrong\u003egastroesophageal reflux\u003c\/strong\u003e. Thanks to its advanced formulation, which combines \u003cstrong\u003esodium alginate\u003c\/strong\u003e, \u003cstrong\u003esodium bicarbonate\u003c\/strong\u003e, \u003cstrong\u003esodium carbonate\u003c\/strong\u003e e \u003cstrong\u003ecalcium carbonate\u003c\/strong\u003e, Maalox Reflurapid acts synergistically to \u003cstrong\u003eblock acid reflux\u003c\/strong\u003e, reduce the \u003cstrong\u003eheartburn\u003c\/strong\u003e and protect the mucosa of the esophagus.\u003c\/p\u003e\n\n\u003cp\u003eThe product is particularly suitable for those who suffer from \u003cstrong\u003eheartburn\u003c\/strong\u003e, \u003cstrong\u003ereflux esophagitis\u003c\/strong\u003e, \u003cstrong\u003eacid regurgitation\u003c\/strong\u003e e \u003cstrong\u003epoor digestion\u003c\/strong\u003e. Furthermore, it is effective in the treatment of \u003cstrong\u003enocturnal symptoms\u003c\/strong\u003e from reflux, such as \u003cstrong\u003ecough\u003c\/strong\u003e and the\u003cstrong\u003elaryngopharyngeal inflammation\u003c\/strong\u003e. Its rapid action, which can begin in just 3 minutes, is made possible by the reaction of sodium alginate with stomach acid, forming a gel that floats and creates a \u003cstrong\u003eprotective cap\u003c\/strong\u003e against the rise of gastric juices.\u003c\/p\u003e\n\n\u003cp\u003eMaalox Reflurapid is formulated to be \u003cstrong\u003egluten free\u003c\/strong\u003e e \u003cstrong\u003elactose free\u003c\/strong\u003e, making it also suitable for those with food intolerances. Its ability to reduce the\u003cstrong\u003ehyperacidity\u003c\/strong\u003e and to protect the esophageal mucosa helps to prevent the risk of relapses, promoting tissue regeneration. This product is also ideal for women \u003cstrong\u003epregnancy\u003c\/strong\u003e who suffer from heartburn.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Maalox Reflurapid 20 sachets used? What is it for?\u003c\/h3\u003e\u003cp\u003eMedical device based on sodium alginate, sodium bicarbonate, sodium carbonate and calcium carbonate, indicated for the rapid relief of the symptoms of gastroesophageal reflux such as heartburn, gastric pyrosis, acid regurgitation and reflux esophagitis; it forms a protective barrier that counteracts the rise of gastric juices.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Maalox Reflurapid 20 sachets contain?\u003c\/h3\u003e\u003cp\u003eSodium alginate, sodium bicarbonate, sodium carbonate, calcium carbonate, purified water, flavouring, polyacrylic acid, ethyl paraben, sodium methyl-p-hydroxybenzoate, sodium saccharin.\u003c\/p\u003e\u003cp\u003eWithout \u003cstrong\u003egluten\u003c\/strong\u003e e \u003cstrong\u003elactose\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Maalox Reflurapid 20 sachets?\u003c\/h3\u003e\u003cp\u003eAdults and children over 12 years: 1 or 2 sachets (10 ml each) after main meals and at bedtime. Shake before use. Children under 12 years: should only be administered on medical advice. For how to take the product, carefully follow the instructions recommended by your doctor.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Maalox Reflurapid 20 sachets?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eDo not use in case of severe renal insufficiency. Do not use in case of hypersensitivity to the components. In case of unwanted reactions, discontinue treatment and consult your doctor. The product may interfere with the absorption of oral medicines. It is therefore advisable to consult your doctor if you are taking oral medicines at the same time, which must in any case be administered at least 2 hours apart. If you do not notice any improvement after 7 days of treatment, it is advisable to consult your doctor. The product may cause a feeling of swelling. Compliance with the instructions for use reported reduces the probability of this happening. This product contains a quantity of sodium equal to approximately 100 mg (4.4 mmol) and calcium equal to approximately 36 mg (0.9 mmol) per sachet (10 ml). Consult your doctor if you follow a low-salt diet, such as in case of hypertension, heart, liver and kidney problems and in case of hypercalcemia, nephrocalcinosis and recurrent kidney stones containing calcium.\u003cbr\u003eKeep out of the reach and sight of children. Do not use the product after the expiry date indicated on the packaging and sachets. Do not refrigerate.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Maalox Reflurapid 20 sachets stored?\u003c\/h3\u003e\u003cp\u003eStore at a temperature between 8°C and 25°C, protected from light and away from heat sources.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Maalox Reflurapid 20 sachets?\u003c\/h3\u003e\u003cp\u003ePack containing 20 sachets.\u003c\/p\u003e","brand":"Opella Healthcare","offers":[{"title":"Default Title","offer_id":51131300675911,"sku":"934480195","price":12.93,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/opella-healthcare-italy-srl-maalox-reflurapid-20-bustine-farmacia-dottor-tili-1213792178.webp?v=1767127313"},{"product_id":"biochetasi-acidita-digestione-20-compresse","title":"Biochetasi Acidity\/Digestion 20 tablets","description":"\u003cp\u003eThe product \u003cstrong\u003eBiochetase Acidity\/Digestion 20 tablets\u003c\/strong\u003e is a food supplement designed to support digestive function and counteract stomach acidity. Thanks to its advanced formulation, this supplement combines a mix of \u003cstrong\u003edigestive enzymes\u003c\/strong\u003e, plant extracts and minerals that work synergistically to improve gastrointestinal well-being.\u003c\/p\u003e\n\n\u003cp\u003eBiochetasi chewable tablets are enriched with \u003cstrong\u003eartichoke and fennel extracts\u003c\/strong\u003e, known for their properties in promoting digestion and reducing abdominal swelling. The presence of \u003cstrong\u003erice powder\u003c\/strong\u003e helps control gastric acidity, while the \u003cstrong\u003ecalcium carbonate\u003c\/strong\u003e and i \u003cstrong\u003ecitrates\u003c\/strong\u003e They help maintain acid-base balance in the stomach.\u003c\/p\u003e\n\n\u003cp\u003eThis supplement is particularly suitable for those who suffer from \u003cstrong\u003eheaviness\u003c\/strong\u003e e \u003cstrong\u003eswelling\u003c\/strong\u003e after meals, offering effective and rapid digestive support. Furthermore, Biochetase is free of \u003cstrong\u003egluten\u003c\/strong\u003e e \u003cstrong\u003elactose\u003c\/strong\u003e, making it also suitable for those who follow specific diets or have food intolerances.\u003c\/p\u003e\n\n\u003cp\u003eThe taste at \u003cstrong\u003elemon\u003c\/strong\u003e chewable tablets make taking them pleasant, while the formulation is designed to be used by adults and children aged 6 and over. Biochetasi Acidity\/Digestion is a precious ally for those looking for a natural and practical remedy to improve their digestion and reduce stomach acidity.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Biochetasi Acidity\/Digestion 20 tablets used? What is it for?\u003c\/h3\u003e\u003cp\u003eFood supplement based on digestive enzymes, artichoke and fennel extracts, rice powder and calcium carbonate, indicated in case of heaviness and bloating after meals; promotes digestion and helps to counteract stomach acidity, maintaining the acid-base balance.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Bioketase Acidity\/Digestion 20 tablets contain?\u003c\/h3\u003e\u003cp\u003eBulking agent: isomalt; calcium carbonate (calcium carbonate, corn starch), artichoke (Cynara scolymus L., leaves) dry extract, potassium hydrogen carbonate, citric acid, natural flavourings, tripotassium citrate, sweet fennel (Foeniculum vulgare Miller, fruits) dry extract; anti-caking agents: magnesium salts of fatty acids, silicon dioxide; rice powder (Oryza sativa, L., seeds), enzyme complexes from fermented plant substrates (proteases), enzyme complexes from fermented plant substrates (lipases), alpha-galactosidase, beta-galactosidase; sweetener: sucralose.\u003c\/p\u003e\u003cp\u003eWithout \u003cstrong\u003egluten\u003c\/strong\u003e e \u003cstrong\u003elactose\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does Bioketase Acidity\/Digestion 20 tablets contain?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eAverage values per daily dose (1 tablet)\u003c\/strong\u003e\u003cbr\u003eProtease: 20 mg (4,000 PC**)\u003cbr\u003eLipase: 20 mg (3,000 FIP**)\u003cbr\u003eBeta-galactosidase: 10 mg (1,000 ALU**)\u003cbr\u003eAlpha-galactosidase: 10 mg (300 GaIU**)\u003cbr\u003eCitrates: 224 mg\u003cbr\u003eCalcium: 120 mg (15% NRV*)\u003cbr\u003eArtichoke dry extract: 200 mg\u003cbr\u003eSweet fennel dry extract: 80 mg\u003cbr\u003eRice powder: 50 mg\u003c\/p\u003e\u003cp\u003e*VNR: Nutrient Reference Values.\u003c\/p\u003e\u003cp\u003e*VNR: Nutrient Reference Values\u003cbr\u003e**: Unit of enzymatic activity\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Bioketase Acidity\/Digestion 20 tablets?\u003c\/h3\u003e\u003cp\u003eIntended for adults and children aged 6 and over. One or two chewable tablets as needed, before or after meals.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Biochetase Acidity\/Digestion 20 tablets?\u003c\/h3\u003e\u003cp\u003eIt can be taken by those following low sodium diets. Furthermore, it can be used during pregnancy and breastfeeding.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eLegal warnings\u003c\/strong\u003e\u003cbr\u003eDo not exceed the recommended daily dose.\u003cbr\u003eKeep out of reach of children under three years of age.\u003cbr\u003eSupplements are not intended as substitutes for a varied and balanced diet and a healthy lifestyle.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Biochetase Acidity\/Digestion 20 tablets stored?\u003c\/h3\u003e\u003cp\u003eStore the product in a cool, dry place at a temperature below 25°C, away from light, humidity and direct sources of heat.\u003cbr\u003eThe end of validity date refers to the product correctly stored, in intact packaging.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Biochetase Acidity\/Digestion 20 tablets?\u003c\/h3\u003e\u003cp\u003eCase containing 20 chewable tablets.\u003cbr\u003eNet Weight: 38g.\u003c\/p\u003e","brand":"Alfasigma","offers":[{"title":"Default Title","offer_id":51131302478151,"sku":"979332400","price":13.3,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/alfasigma-spa-biochetasi-acidita-digestione-20-compresse-farmacia-dottor-tili-1213792179.jpg?v=1767136710"},{"product_id":"magnesia-s-pellegrino-45-polvere-effervescente-gusto-limone-100g","title":"Magnesia S.Pellegrino 45% effervescent powder lemon flavour 100g","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of occasional constipation. Antacid.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e100 g of powder contains: Magnesia S. Pellegrino 90% powder for oral suspension Active ingredient: magnesium hydroxide 90 g Excipient with known effects: sucrose. Magnesia S. Pellegrino 45% effervescent powder Active ingredient: magnesium hydroxide 45 g Excipient with known effects: sucrose and sodium. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMagnesia S. Pellegrino 90% powder for oral suspension: without flavouring: sucrose. lemon flavour: sucrose, natural lemon flavour. Magnesia S. Pellegrino 45% effervescent powder: without flavouring: sodium bicarbonate, tartaric acid, sucrose. anise flavour: sodium bicarbonate, tartaric acid, sucrose, anethole. fruit flavour: sodium bicarbonate, tartaric acid, sucrose, natural fruit flavour. lemon flavour: sodium bicarbonate, tartaric acid, sucrose, natural lemon flavour. mandarin flavour: sodium bicarbonate, tartaric acid, sucrose, natural mandarin flavour.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients, listed in paragraph 6.1. Laxatives are contraindicated in subjects with acute abdominal pain or pain of unknown origin, nausea or vomiting, intestinal obstruction or stenosis, rectal bleeding of unknown origin, severe dehydration. Children under 6 years of age. Severe renal insufficiency (creatinine clearance less than 30 mL\/min)\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e \u003cu\u003eDosage\u003c\/u\u003e \u003c\/b\u003e \u003cu\u003eAdults\u003c\/u\u003e: as an antacid 1 teaspoon; as a laxative 1 teaspoon; as a purgative 1 tbsp. \u003cu\u003eChildren\u003c\/u\u003e: between 6 and 12 years: half the doses. Magnesia S. Pellegrino is contraindicated in children under 6 years of age (see section 4.3). Dilute the powder in half a glass of water and ingest. The correct dose is the minimum sufficient to produce an easy evacuation of loose stools. It is advisable to initially use the minimum doses provided. When necessary, the dose can then be increased, but without ever exceeding the maximum indicated. Take preferably in the evening. Laxatives should be used as infrequently as possible and for no longer than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case. Swallow together with an adequate quantity of water (a large glass). A diet rich in liquids favors the effect of the medicine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eMagnesia S. Pellegrino 90% powder for oral suspension\u003c\/i\u003e:without aroma: Store below 25°C. lemon flavour: This medicine does not require any special storage conditions. \u003ci\u003eMagnesia S. Pellegrino 45% effervescent powder\u003c\/i\u003e:\u003c\/p\u003e\n\u003cp\u003eunflavored: This medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003eanise flavour: This medicine does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003efruit flavour: This medicine does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003elemon flavour: Store below 25°C.\u003c\/p\u003e\n\u003cp\u003emandarin flavour: Store below 25°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eWarnings The abuse of laxatives (frequent or prolonged use or with excessive doses) can cause persistent diarrhea with consequent loss of water, mineral salts (especially potassium) and other essential nutritional factors. In more severe cases, the onset of dehydration or hypokalemia is possible which can cause cardiac or neuromuscular dysfunction, especially in case of simultaneous treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially contact ones (stimulant laxatives), can cause dependence (need to progressively increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atony). The treatment of chronic or recurrent constipation always requires the formulation of a diagnosis, the prescription of drugs and monitoring during the course of therapy. When the need for the laxative derives from a sudden change in previous intestinal habits (frequency and characteristics of evacuations) that lasts for more than two weeks or when the use of the laxative fails to produce effects, a clinical reassessment is necessary. \u003cu\u003eAdminister with caution in the elderly and in subjects with impaired renal function\u003c\/u\u003e. In young children, the use of magnesium hydroxide can lead to hypermagnesemia, particularly if they have kidney damage or dehydration. \u003cb\u003eMagnesia S. Pellegrino contains sucrose\u003c\/b\u003e Patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase isomaltase insufficiency should not take this medicine. \u003cb\u003eMagnesia S. Pellegrino 45% effervescent powder contains sodium salts\u003c\/b\u003e. This medicine contains: • approximately 386 mg of sodium per 1 teaspoon (approximately 7 g of product) equivalent to 19.3% of the maximum daily intake recommended by WHO which corresponds to 2 g of sodium for an adult. • approximately 552 mg of sodium per 1 teaspoon (approximately 10 g of product) of substance taken equivalent to 27.6% of the maximum daily intake recommended by the WHO which corresponds to 2 g of sodium for an adult. • approximately 1.1 g of sodium per 1 tablespoon (approximately 20 g of product) equivalent to 55% of the maximum daily intake recommended by the WHO which corresponds to 2 g of sodium for an adult. To be taken into consideration in people with reduced renal function or who follow a low-sodium diet (low sodium diet).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLaxatives can reduce the residence time in the intestine, and therefore the absorption, of other drugs administered simultaneously orally. Therefore, avoid taking laxatives and other medicines at the same time: after taking a medicine, leave an interval of at least 2 hours before taking the laxative. Magnesium hydroxide, like all antacids, should not be taken at the same time as antibiotics of the tetracycline class as it reduces their absorption. Milk or antacids can change the effect of the medicine; leave an interval of at least one hour before taking the laxative. The alkalinization of the urine following the administration of magnesium hydroxide can modify the excretion of some drugs; therefore, increased excretion of salicylates was observed. Association to avoid: - tetracyclines: formation of insoluble complexes with reduction in the absorption and activity of these antibiotics. Association not recommended: - quinidine: increase in quinidine plasma levels and risk of overdose due to decreased excretion. Associations requiring precautions for use: - indomethacin, phosphorus, dexamethasone, digitalis, iron salts, nitrofurantoin, lincomycin: decreased absorption in the digestive system.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eUndesirable effects are reported below with the following frequencies: very common (≥ 1\/10), common (≥ 1\/100, \u003c 1\/10), uncommon (≥ 1\/1,000, \u003c 1\/100), rare (≥ 1\/10,000, \u003c 1\/1,000), very rare (\u003c 1\/10,000), not known (the frequency cannot be estimated from the available data). \u003cb\u003e \u003cu\u003eGastrointestinal disorders\u003c\/u\u003e \u003c\/b\u003e \u003ci\u003eNot known\u003c\/i\u003e: Abdominal pain, diarrhea, isolated cramping pain or abdominal colic, more frequent in cases of severe constipation. \u003cb\u003e \u003cu\u003eMetabolism and nutrition disorders\u003c\/u\u003e \u003c\/b\u003e \u003ci\u003eVery rare\u003c\/i\u003e: Hypermagnesemia. Observed after prolonged administration of magnesium hydroxide to patients with renal impairment. \u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at \u003cu\u003ewww.agenziafarmaco.gov.it\/content\/come-segnalare-una-sospetti-reazione-avversa\u003c\/u\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eExcessive doses can cause abdominal pain and diarrhea; the resulting losses of fluids and electrolytes must be replaced. Treatment of magnesium overdose: rehydration, forced diuresis. In case of renal failure, hemodialysis or peritoneal dialysis is necessary.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePregnancy Magnesia S. Pellegrino must be used only if necessary after evaluating the expected benefit for the mother in relation to the possible risk for the fetus. Breastfeeding Magnesium is considered compatible with breastfeeding.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMagnesia S. Pellegrino does not alter the ability to drive and use machinery.\u003c\/p\u003e","brand":"Vemedia","offers":[{"title":"Default Title","offer_id":51131313881415,"sku":"006570257","price":9.21,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/vemedia-manufacturing-b-v-magnesia-s-pellegrino-45-polvere-effervescente-gusto-limone-100g-farmacia-dottor-tili-1213792126.jpg?v=1767135827"},{"product_id":"maalox-400mg-400mg-40-compresse-masticabili","title":"Maalox 400mg + 400mg 40 chewable tablets","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptomatic treatment of occasional heartburn and hyperacidity in the stomach.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003e100 ml of suspension contain\u003c\/u\u003e: \u003ci\u003e- Active ingredients:\u003c\/i\u003e magnesium hydroxide 3.65 g aluminum hydroxide 3.25 g Excipient(s) with known effects: methyl parahydroxybenzoate, propyl parahydroxybenzoate, sorbitol. For the full list of excipients, see section 6.1. \u003cu\u003eOne tablet contains\u003c\/u\u003e: \u003ci\u003e- Active ingredients:\u003c\/i\u003e magnesium hydroxide 400 mg aluminum oxide hydrate 400 mg Excipient(s) with known effects: sucrose powder with starch, sucrose, sorbitol, benzyl alcohol (contained in the excipient mint flavor powder) (see sections 4.4 and 4.6). For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eMAALOX 3.65% + 3.25% oral suspension\u003c\/i\u003e Methyl parahydroxybenzoate, propyl parahydroxybenzoate, citric acid monohydrate, non-crystallizable liquid sorbitol, mannitol, mint essence, sodium saccharin, purified water. \u003ci\u003eMAALOX 400 mg + 400 mg chewable tablets\u003c\/i\u003e Sucrose powder with starch, sorbitol, mannitol, magnesium stearate, mint flavor powder (contains benzyl alcohol), sodium saccharin, sucrose.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e- Hypersensitivity to the active substances or to any of the excipients listed in paragraph 6.1. - Patients suffering from porphyria. - Severe forms of renal failure (see section 4.4). - Generally contraindicated in pediatric age. - State of cachexia.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eMAALOX 3.65% + 3.25% oral suspension\u003c\/i\u003e \u003cu\u003eDosage\u003c\/u\u003e Swallow 2 to 4 teaspoons (10-20 ml), 4 times a day, 20-60 minutes after meals and before bed. \u003cu\u003eMethod of administration\u003c\/u\u003e Shake well before use. It can also be taken in water or milk. \u003ci\u003eMAALOX 400 mg + 400 mg chewable tablets\u003c\/i\u003e \u003cu\u003eDosage\u003c\/u\u003e 1-2 tablets 4 times a day well chewed or sucked, 20-60 minutes after meals and before bedtime. \u003cu\u003eMethod of administration\u003c\/u\u003e The tablets should be well chewed or sucked. Their intake can be followed by the ingestion of water or milk. \u003ci\u003ePediatric population\u003c\/i\u003e Administration of the medicine in pediatric age is not recommended. Do not exceed the maximum indicated dose.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eMAALOX 3.65% + 3.25% oral suspension\u003c\/i\u003e: Do not store below 4°C. Keep the bottle tightly closed. \u003ci\u003eMAALOX 400 mg + 400 mg chewable tablets\u003c\/i\u003e This medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAluminum hydroxide can cause constipation and an overdose of magnesium salts can cause hypomotility of the intestine; high doses of this medicine may cause or aggravate intestinal and ileal obstruction in patients at higher risk, such as those with renal impairment, with underlying constipation, with alteration of intestinal motility, in children (0 to 24 months), or elderly. Aluminum hydroxide is not well absorbed from the gastrointestinal tract, and systemic effects are therefore rare in patients with normal renal function. However, excessive doses or long-term use, or even normal doses in patients on low-phosphorus diets or in children (0 to 24 months), can lead to phosphate elimination (due to an aluminium-phosphate bond) accompanied by increased bone resorption and hypercalciuria with risk of osteomalacia. It is advisable to consult your doctor in case of long-term use or in patients at risk of hypophosphatemia. In patients with renal impairment, plasma levels of aluminum and magnesium tend to increase, causing hyperaluminemia and hypermagnesemia, respectively. In these patients, long exposures to high doses of aluminum and magnesium salts can lead to encephalopathy, dementia, microcytic anemia or worsening of dialysis-induced osteomalacia. In the presence of mild and moderate forms of renal failure it is advisable to take the product under the direct supervision of a doctor. Prolonged use of the medicine should be avoided in these patients. Aluminum hydroxide may be unsafe in porphyria patients undergoing haemodialysis (see section 4.3). \u003cu\u003ePediatric population\u003c\/u\u003e In young children, the use of magnesium hydroxide can lead to hypermagnesemia, particularly if they have kidney damage or dehydration. \u003ci\u003eMAALOX 3.65% + 3.25% oral suspension contains\u003c\/i\u003e: • \u003cb\u003eparahydroxybenzoates\u003c\/b\u003e: may cause allergic reactions (even delayed). • approximately 98 mg of\u003cb\u003e I know\u003c\/b\u003e \u003cb\u003erbitol\u003c\/b\u003e in 10 ml (2 teaspoons). Patients with hereditary fructose intolerance should not be given this medicine. • less than 1 mmol (23 mg) of \u003cb\u003esodium\u003c\/b\u003e per dose, i.e. it is essentially “sodium-free”. \u003ci\u003eMAALOX 400 mg + 400 mg chewable tablets contains\u003c\/i\u003e: • approximately 125 mg of \u003cb\u003esorbitol\u003c\/b\u003e per tablet. Patients with hereditary fructose intolerance should not be given this medicine. • \u003cb\u003eSucrose\u003c\/b\u003e, patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase isomaltase insufficiency should not take this medicine. • less than 1 mmol (23 mg) of \u003cb\u003esodium\u003c\/b\u003e per dose, i.e. it is essentially “sodium-free”. • 0.000072 mg of \u003cb\u003ebenzyl alcohol\u003c\/b\u003e per tablet. Benzyl alcohol can cause allergic reactions. • Large volumes should be used with caution and only if necessary, during pregnancy and breastfeeding and in patients with hepatic or renal insufficiency, due to the risk of accumulation and toxicity (metabolic acidosis).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSince Al and Mg salts reduce the gastrointestinal absorption of tetracyclines, it is recommended to avoid taking Maalox during oral tetracycline therapy. The use of aluminum-containing antacids may reduce the absorption of drugs such as H\u003csub\u003e2\u003c\/sub\u003e-antagonists, atenolol, cefdinir, cefpodoxime, chloroquine, tetracyclines, diflunisal, digoxin, bisphosphonates, ethambutol, fluoroquinolones, sodium fluoride, glucocorticoids, indomethacin, isoniazid, ketoconazole, levothyroxine, lincosamides, metoprolol, phenothiazine neuroleptics, penicillamines, propranolol, rosuvastatin, iron salts. • Polystyrene sulfonate (Kayexalate) Caution is advised when the medicinal product is taken together with polystyrene sulfonate (Kayexalate) due to the potential risk of reduced potassium-binding efficacy of the resin, metabolic alkalosis in patients with renal impairment (reported with aluminum hydroxide and magnesium hydroxide), and intestinal obstruction (reported with aluminum hydroxide). • Aluminum hydroxide and citrates can cause hyperaluminemia, especially in patients with renal impairment. Leave at least two hours to pass (4 for fluoroquinolones) before taking MAALOX to avoid interaction with other drugs. Concomitant use of quinidine may result in increased serum quinidine levels and lead to quinidine overdose. The simultaneous use of aluminum hydroxide and citrates can lead to an increase in aluminum levels, particularly in patients with renal failure. The alkalinization of the urine following the administration of magnesium hydroxide can modify the excretion of some drugs; therefore, increased excretion of salicylates was observed.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe frequency of the side effects reported below is defined using the following conventions: common (≥1\/100, \u003c1\/10); uncommon (≥1\/1,000, \u003c1\/100); rare (≥1\/10,000, \u003c1\/1,000); very rare (\u003c1\/10,000); not known (frequency cannot be estimated from the available data). \u003ci\u003e \u003cu\u003eImmune system disorders.\u003c\/u\u003e \u003c\/i\u003e \u003ci\u003eFrequency not known\u003c\/i\u003e: angioedema, anaphylactic reactions, hypersensitivity reactions, urticaria, pruritus. \u003ci\u003e \u003cu\u003eGastrointestinal disorders.\u003c\/u\u003e \u003c\/i\u003e \u003ci\u003eUncommon\u003c\/i\u003e: diarrhea or constipation (see section 4.4); \u003ci\u003eFrequency not known\u003c\/i\u003e: abdominal pain. \u003ci\u003e \u003cu\u003eMetabolism and nutrition disorders.\u003c\/u\u003e \u003c\/i\u003e \u003ci\u003eVery rare\u003c\/i\u003e: hypermagnesemia, including observations after prolonged administration in patients with renal impairment; \u003ci\u003eFrequency not known:\u003c\/i\u003e hyperaluminemia, hypophosphatemia, during prolonged use or at high doses or even at normal doses of the medicine in patients with low phosphorus diets or in children (0 to 24 months), which may cause increased bone resorption, hypercalciuria, osteomalacia (see section 4.4). \u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at: http:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eExperience with deliberate overdose is very limited. Cases of overdose with aluminum salts may occur more easily in patients with severe chronic renal impairment with the following symptoms: encephalopathy, convulsions and dementia, hypermagnesemia. The most frequently reported symptoms of acute overdose with aluminum hydroxide and in combination with magnesium salts include diarrhea, abdominal pain and vomiting. High doses of this medicinal product may cause or aggravate intestinal and ileal obstruction in patients at risk (see section 4.4). As in all cases of overdose, treatment must be symptomatic, adopting general supportive measures. Aluminum and magnesium are eliminated through urinary excretion; treatment of magnesium overdose involves rehydration and forced diuresis. In case of renal failure, hemodialysis or peritoneal dialysis is required.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e The medicine must be used only if necessary, under the direct supervision of a doctor, after evaluating the expected benefit for the mother in relation to the possible risk for the fetus or infant. \u003cu\u003eBreastfeeding\u003c\/u\u003e Due to limited maternal absorption when taken according to the indicated dosing regimen (see section 4.2), aluminum hydroxide and its combinations with magnesium salts are considered compatible with breastfeeding. Large volumes of benzyl alcohol should be used with caution and only if necessary during pregnancy and breastfeeding, due to the risk of accumulation and toxicity (metabolic acidosis) (see section 4.4).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMAALOX does not alter the ability to drive and use machines.\u003c\/p\u003e","brand":"Opella Healthcare","offers":[{"title":"Default Title","offer_id":51131324203335,"sku":"020702054","price":13.21,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/opella-healthcare-italy-srl-maalox-400mg-400mg-40-compresse-masticabili-farmacia-dottor-tili-1213792089.jpg?v=1767136550"},{"product_id":"leniref-24-stick-pack-15ml","title":"Leniref 24 sticks 15ml","description":"\u003cp\u003eThe \u003cstrong\u003eLeniref 24 stick pack 15ml\u003c\/strong\u003e is a Class IIA medical device, designed to provide relief from the symptoms of gastroesophageal and laryngopharyngeal reflux. Thanks to its advanced formulation, based on \u003cstrong\u003eMagnesium alginate\u003c\/strong\u003e, \u003cstrong\u003eMucosave HC Plus\u003c\/strong\u003e, \u003cstrong\u003eCalcium Carbonate\u003c\/strong\u003e e \u003cstrong\u003ePotassium bicarbonate\u003c\/strong\u003e, Leniref acts effectively against heartburn, esophagitis, acid regurgitation and heartburn. Furthermore, it is indicated to relieve the symptoms of laryngopharyngeal reflux, such as change in voice, dry cough, sensation of a foreign body in the throat and irritation of the upper airways.\u003c\/p\u003e\n\n\u003cp\u003eThe practical pack of \u003cstrong\u003e24 stick packs of 15 ml\u003c\/strong\u003e makes Leniref easy to use and transport, ensuring continuous and targeted treatment. This product is ideal for those looking for an effective and convenient remedy to manage reflux-related disorders, improving the quality of daily life. Trust Leniref for safe, tested support, developed by \u003cstrong\u003ePHARMA LINE Srl\u003c\/strong\u003e, leader in the medical devices and antacids sector.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Leniref 24 stick 15ml used? What is it for?\u003c\/h3\u003e\u003cp\u003eMedical device based on magnesium alginate, Mucosave HC Plus, calcium carbonate and potassium bicarbonate, indicated for the relief of the symptoms of gastroesophageal and laryngopharyngeal reflux, such as heartburn, acid regurgitation, heartburn and irritation of the upper airways.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Leniref 24 stick 15ml?\u003c\/h3\u003e\u003cp\u003e1 stick pack after main meals and 1 in the evening before bed.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Leniref 24 stick 15ml?\u003c\/h3\u003e\u003cp\u003e24 stick packs of 15 ml.\u003c\/p\u003e","brand":"Pharma Line","offers":[{"title":"Default Title","offer_id":51131326759239,"sku":"978936781","price":20.43,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/pharma-line-leniref-24-stick-15ml-farmacia-dottor-tili-1258975898.jpg?v=1789561423"},{"product_id":"aroe-20-stick-pack-monodose","title":"Aroè 20 single-dose sticks","description":"\u003cp\u003e\u003cstrong\u003eAroè 20 single-dose stick packs\u003c\/strong\u003e is an innovative oral solution, developed by Italchimici, specifically formulated for the treatment of \u003cstrong\u003egastroesophageal reflux\u003c\/strong\u003e and related symptoms. This medical device is ideal for those who suffer from \u003cstrong\u003ereflux esophagitis\u003c\/strong\u003e, \u003cstrong\u003eacid regurgitation\u003c\/strong\u003e, \u003cstrong\u003egastric acidity\u003c\/strong\u003e, \u003cstrong\u003eburning\u003c\/strong\u003e, \u003cstrong\u003eabdominal pain\u003c\/strong\u003e e \u003cstrong\u003eirritative cough\u003c\/strong\u003e. Thanks to its multiple action, Aroè offers a \u003cstrong\u003ebarrier effect\u003c\/strong\u003e, an action \u003cstrong\u003emucoprotective\u003c\/strong\u003e, \u003cstrong\u003eregenerative\u003c\/strong\u003e e \u003cstrong\u003eanti-acid\u003c\/strong\u003e, ensuring quick and long-lasting relief.\u003c\/p\u003e\n\n\u003cp\u003eThe Aroè formulation is enriched with \u003cstrong\u003enatural ingredients\u003c\/strong\u003e of proven efficacy and safety, including a standardized complex of \u003cstrong\u003egalactomannans of plant origin\u003c\/strong\u003e, \u003cstrong\u003ecalcium carbonate\u003c\/strong\u003e, \u003cstrong\u003esodium bicarbonate\u003c\/strong\u003e, \u003cstrong\u003eMalva sylvestris\u003c\/strong\u003e e \u003cstrong\u003esodium hyaluronate\u003c\/strong\u003e. These components work synergistically to protect and regenerate the gastric mucosa, without the use of alginates or GMOs. Furthermore, Aroè is free of \u003cstrong\u003egluten\u003c\/strong\u003e, \u003cstrong\u003elactose\u003c\/strong\u003e e \u003cstrong\u003eadded sugars\u003c\/strong\u003e, making it also suitable for those who follow specific diets.\u003c\/p\u003e\n\n\u003cp\u003eEach single-dose stick is designed for practical and quick use, ensuring simple and discreet intake. The presence of \u003cstrong\u003eStevia rebaudiana\u003c\/strong\u003e as a natural sweetener it ensures a pleasant taste without compromising health. Aroè represents a safe and natural choice for those looking for an effective remedy against the discomfort of gastroesophageal reflux, improving the quality of daily life.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Aroè 20 single-dose sticks used? What is it for?\u003c\/h3\u003e\u003cp\u003eOral solution medical device based on galactomannans, calcium carbonate, sodium bicarbonate, mallow and sodium hyaluronate, indicated for the treatment of gastroesophageal reflux and related symptoms, such as acid regurgitation, gastric acidity, heartburn, abdominal pain and irritative cough; acts with a barrier effect and a mucoprotective and regenerating action on the gastric mucosa.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Aroè 20 single-dose sticks contain?\u003c\/h3\u003e\u003cp\u003eWater, Standardized complex of galactomannans of plant origin, Calcium carbonate, Sodium bicarbonate, Flavouring, Malva sylvestris dry extract, Sodium hyaluronate, Stevia rebaudiana dry extract, Sodium methyl-p-hydroxybenzoate, Sodium propyl-p-hydroxybenzoate.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Aroè 20 single-dose sticks?\u003c\/h3\u003e\u003cp\u003eThe product must be taken orally.\u003cbr\u003eIt is recommended to take 1-2 sticks after main meals and before bed or as advised by your doctor.\u003cbr\u003eNo adverse effects deriving from the intake of galactomannans in pregnant women are described in the literature.\u003cbr\u003eTo use Aroè during breastfeeding, consult your doctor. In the case of children under 12 years of age, consult your doctor before using the product.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Aroè 20 single-dose sticks?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eDo not exceed the recommended dose and follow the instructions for use. In case of side effects, stop treatment and consult your doctor. Keep out of reach of children. Do not use beyond the expiry date shown on the package. The expiry date refers to the product in intact packaging and correctly stored.\u003cbr\u003eDo not use the product in case of hypersensitivity to one of its components.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Aroè 20 single-dose sticks stored?\u003c\/h3\u003e\u003cp\u003eStore in a cool, dry place and away from heat sources. Do not freeze.\u003cbr\u003eValidity with intact packaging: 24 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Aroè 20 single-dose sticks?\u003c\/h3\u003e\u003cp\u003e20 single-dose sticks for oral use.\u003c\/p\u003e","brand":"Italchimici","offers":[{"title":"Default Title","offer_id":51131341242695,"sku":"935696916","price":19.48,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/italchimici-aroe-20-stick-monodose-farmacia-dottor-tili-1254215784.jpg?v=1786736802"},{"product_id":"magnesia-bisurata-aromatic-40-pastiglie","title":"Magnesia Bisurata Aromatic 40 tablets","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptomatic treatment of upper digestive tract pathologies characterized by hyperacidity.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEach tablet contains: Active ingredients: Magnesium Carbonate 71.0 mg, Sodium bicarbonate 64.2 mg, Calcium carbonate 525.0 mg. \u003cu\u003eExcipients with known effects\u003c\/u\u003e: sucrose, sodium saccharin. For the full list of excipients, see section 6.1\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSodium saccharin, sucrose, corn starch, calcium stearate, mint essential oil.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substances or to any of the excipients, listed in paragraph 6.1. Renal failure. Do not administer simultaneously with tetracyclines (see section 4.5). Do not administer other drugs within 1 or 2 hours of using the product (see section 4.5). Administration of the medicine in pediatric age is not recommended.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eOne tablet to dissolve slowly in the mouth after meals and whenever you feel pain. If necessary, repeat after a quarter of an hour. DO NOT EXCEED THE RECOMMENDED DOSES Use only for short treatment periods. \u003cb\u003ePatients with renal insufficiency: \u003c\/b\u003ethe reduced ability to eliminate the exogenous salt supplement provided by antacids with urine can lead to potentially severe electrolyte imbalances. Treatment with magnesium and calcium salts requires periodic checks of magnesium and calcium levels.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn patients with severe renal insufficiency, plasma magnesium levels tend to increase. In these patients, long exposures to high doses of magnesium can lead to encephalopathy or worsening of dialysis-induced osteomalacia. Generally, caution should be exercised in patients with impaired renal function. In these patients, plasma calcium and magnesium levels should be monitored regularly. \u003cu\u003eImportant information about some excipients\u003c\/u\u003e \u003cb\u003eMagnesia Bisurata Aromatic contains sucrose\u003c\/b\u003e. Patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase isomaltase insufficiency should not take this medicine. \u003cb\u003eMagnesia Bisurata Aromatic contains less than 1 mmol (23 mg) sodium per tablet\u003c\/b\u003e, i.e. essentially 'sodium-free'.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIt should be kept in mind that antacids can, through different mechanisms, interfere with the oral administration of other drugs. In particular, the simultaneous administration of tetracyclines can give rise to insoluble complexes, with a reduction in the absorption of these antibiotics. However, it is advisable not to administer other drugs within 1 or 2 hours of using the product. \u003ci\u003eAssociations to avoid:\u003c\/i\u003e tetracyclines: formation of insoluble complexes with reduction in the absorption and activity of these antibiotics. \u003ci\u003eAssociation not recommended:\u003c\/i\u003e quinidine: increased plasma levels of quinidine and risk of overdose due to decreased excretion. \u003ci\u003eAssociations that require precautions for use:\u003c\/i\u003e indomethacin, phosphorus, dexamethasone, digitalis, iron salts, nitrofurantoin, lincomycin.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBased on the available bibliographic data, there are no known side effects related to the specialty. \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e. Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eExperience with deliberate overdose is very limited. As in all cases of overdose, treatment should be symptomatic, adopting general supportive measures.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAlthough no adverse reactions are known, the product must be used under direct medical supervision in pregnant and breastfeeding women.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMagnesia Bisurata Aromatic does not alter the ability to drive and use machines.\u003c\/p\u003e","brand":"Haleon","offers":[{"title":"Default Title","offer_id":51131349926215,"sku":"005781036","price":11.69,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/haleon-italy-srl-magnesia-bisurata-aromatic-40-pastiglie-farmacia-dottor-tili-1213791959.jpg?v=1767149829"},{"product_id":"maalox-4-3-5-250-ml-sospensione-orale-aroma-menta","title":"Maalox 4% + 3.5% 250 ml oral suspension mint flavour","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptomatic treatment of occasional heartburn and hyperacidity in the stomach.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003e100 ml of suspension contain\u003c\/u\u003e: \u003ci\u003e- Active ingredients:\u003c\/i\u003e magnesium hydroxide 4.00 g aluminum hydroxide 3.5 g equivalent to aluminum oxide 2.3 g Excipients with known effects: 10 ml contain 0.31 mg of sodium and 100.03 mg of sorbitol. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHydrochloric acid (10%), citric acid (monohydrate), mint essence, mannitol (E421), domiphene bromide, \u003cb\u003esodium saccharin\u003c\/b\u003e, \u003cb\u003esorbitol\u003c\/b\u003e 70% non-crystallizable liquid (E420), 30% hydrogen peroxide solution and purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e- Hypersensitivity to the active substances or to any of the excipients listed in paragraph 6.1. - Patients suffering from porphyria (see section 4.4). - Severe forms of renal failure (see section 4.4). - Contraindicated in pediatric age (see section 4.2). - State of cachexia.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eDosage\u003c\/u\u003e Ingest 2 to 4 teaspoons (10-20 ml) of oral suspension 4 times a day, 20-60 minutes after meals and before bedtime. Do not exceed the maximum indicated dose of 16 teaspoons. \u003ci\u003ePediatric population \u003c\/i\u003e MAALOX is contraindicated in children and adolescents under 18 years of age (see section 4.3). \u003cu\u003eMethod of administration\u003c\/u\u003e For oral use. Shake well before use.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStore below 25°C. For storage conditions after first opening, see paragraph 6.3.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAluminum hydroxide can cause constipation and an overdose of magnesium salts can cause hypomotility of the intestine (see section 4.8); high doses of this medicinal product may cause or aggravate intestinal and ileal obstruction in patients at higher risk, such as those with renal impairment, with underlying constipation, with impaired intestinal motility, in children (0 to 24 months), or elderly (see section 4.9). Aluminum hydroxide is not well absorbed from the gastrointestinal tract, and systemic effects are therefore rare in patients with normal renal function. However, excessive doses or long-term use, or even normal doses in patients on low phosphorus diets or in children (0 to 24 months), may lead to phosphate elimination (due to an aluminium-phosphate bond) accompanied by increased bone resorption and hypercalciuria with risk of osteomalacia (see section 4.8). It is advisable to monitor patients in case of long-term use or patients at risk of hypophosphatemia. In patients with renal impairment, plasma levels of aluminum and magnesium tend to increase, causing hyperaluminemia and hypermagnesemia, respectively. In these patients, long exposures to high doses of aluminum and magnesium salts can lead to encephalopathy, dementia, microcytic anemia or worsening of dialysis-induced osteomalacia. In the presence of mild and moderate forms of renal impairment, the medicine must be taken under the supervision of the doctor and prolonged use of the medicine must be avoided. The administration of this medicine in subjects suffering from severe forms of renal failure is contraindicated (see section 4.3). Aluminum hydroxide may be unsafe in porphyria patients undergoing hemodialysis. MAALOX is contraindicated in patients suffering from porphyria (see section 4.3). This medicine contains approximately 100 mg of \u003cb\u003esorbitol\u003c\/b\u003e in 10 ml (2 teaspoons). Patients with hereditary fructose intolerance should not be given this medicine. This medicinal product contains less than 1 mmol (23 mg) of \u003cb\u003esodium\u003c\/b\u003e per dose, i.e. it is essentially “sodium-free”. \u003cu\u003ePediatric population\u003c\/u\u003e In young children, the use of magnesium hydroxide can lead to hypermagnesemia, particularly if they have kidney damage or dehydration.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSince Al and Mg salts reduce the gastrointestinal absorption of tetracyclines, it is recommended to avoid taking MAALOX during oral tetracycline therapy. The use of aluminum-containing antacids may reduce the absorption of drugs such as H\u003csub\u003e2\u003c\/sub\u003e-antagonists, atenolol, cefdinir, cefpodoxime, chloroquine, tetracyclines, diflunisal, digoxin, bisphosphonates, ethambutol, fluoroquinolones, sodium fluoride, glucocorticoids, indomethacin, isoniazid, ketoconazole, levothyroxine, lincosamides, metoprolol, phenothiazine neuroleptics, penicillamines, propranolol, rosuvastatin, iron salts. Caution is advised when the medicinal product is taken together with polystyrene sulfonate (Kayexalate) due to the potential risk of reduced potassium-binding efficacy of the resin, metabolic alkalosis in patients with renal impairment (reported with aluminum hydroxide and magnesium hydroxide) and intestinal obstruction (reported with aluminum hydroxide). Aluminum hydroxide and citrates can cause hyperaluminemia, especially in patients with renal impairment. Leave at least two hours to pass (4 for fluoroquinolones) before taking MAALOX to avoid interaction with other drugs. Concomitant use of quinidine may result in increased serum quinidine levels and lead to quinidine overdose. The simultaneous use of aluminum hydroxide and citrates can lead to an increase in aluminum levels, particularly in patients with renal failure. The alkalinization of the urine following the administration of magnesium hydroxide can modify the excretion of some drugs; therefore, increased excretion of salicylates was observed.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe frequency of the side effects reported below is defined using the following conventions: common (≥1\/100, \u003c1\/10); uncommon (≥1\/1,000, \u003c1\/100); rare (≥1\/10,000, \u003c1\/1,000); very rare (\u003c1\/10,000); not known (frequency cannot be estimated from the available data). \u003ci\u003e \u003cu\u003eImmune system disorders.\u003c\/u\u003e \u003c\/i\u003e \u003ci\u003eFrequency not known\u003c\/i\u003e: angioedema, anaphylactic reactions, hypersensitivity reactions, urticaria, pruritus. \u003ci\u003e \u003cu\u003eGastrointestinal disorders.\u003c\/u\u003e \u003c\/i\u003e \u003ci\u003eUncommon\u003c\/i\u003e: diarrhea or constipation (see section 4.4); \u003ci\u003eFrequency not known\u003c\/i\u003e: abdominal pain. \u003ci\u003e \u003cu\u003eMetabolism and nutrition disorders.\u003c\/u\u003e \u003c\/i\u003e \u003ci\u003eVery rare\u003c\/i\u003e: hypermagnesemia, including observations after prolonged administration in patients with renal impairment; \u003ci\u003eFrequency not known:\u003c\/i\u003e hyperaluminemia, hypophosphatemia, during prolonged use or at high doses or even at normal doses of the medicine in patients with low phosphorus diets or in children (0 to 24 months), which may cause increased bone resorption, hypercalciuria, osteomalacia (see section 4.4). \u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at: http:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eExperience with deliberate overdose is very limited. Cases of overdose with aluminum salts may occur more easily in patients with severe chronic renal impairment with the following symptoms: encephalopathy, convulsions and dementia, hypermagnesemia. The most frequently reported symptoms of acute overdose with aluminum hydroxide and in combination with magnesium salts include diarrhea, abdominal pain and vomiting. High doses of this medicinal product may cause or aggravate intestinal and ileal obstruction in patients at risk (see section 4.4). Treatment should be symptomatic, adopting generic supportive measures. Aluminum and magnesium are eliminated through urinary excretion; treatment of magnesium overdose involves rehydration and forced diuresis. In case of renal failure, hemodialysis or peritoneal dialysis is required.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e The medicine must be used only if necessary, under the direct supervision of a doctor, after evaluating the expected benefit for the mother in relation to the possible risk for the fetus or infant. \u003cu\u003eBreastfeeding\u003c\/u\u003e Due to limited maternal absorption when taken according to the indicated dosing regimen (see section 4.2), aluminum hydroxide and its combinations with magnesium salts are considered compatible with breastfeeding.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMAALOX does not alter the ability to drive and use machines.\u003c\/p\u003e","brand":"Opella Healthcare","offers":[{"title":"Default Title","offer_id":51730204819783,"sku":"020702282","price":13.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/opella-healthcare-italy-srl-maalox-4-3-5-250-ml-sospensione-orale-aroma-menta-farmacia-dottor-tili-1213791392.jpg?v=1767139297"},{"product_id":"maalox-plus-4-3-5-0-5-250-ml-sospensione-orale-limone-e-menta","title":"Maalox Plus 4% + 3.5% + 0.5% 250 ml oral suspension lemon and mint","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptomatic treatment of hyperacidity (including burning and pain) even in case of esophagitis, and hyperacidity when accompanied by dyspepsia. Symptomatic treatment of gastro-intestinal swelling when accompanied by hyperacidity.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003e100 ml of suspension contain\u003c\/u\u003e: \u003ci\u003eActive ingredients\u003c\/i\u003e: magnesium hydroxide 4.0 g, aluminum hydroxide 3.5 g, equivalent to aluminum oxide 2.3 g, simethicone 0.50 g. \u003ci\u003eExcipients with known effects\u003c\/i\u003e: sorbitol (E420), ethanol, invert sugar, sucrose, sulfur dioxide (E220) (see section 4.4). For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDomiphene bromide, citric acid monohydrate, sodium saccharin, sorbitol (E420) 70% non-crystallizable liquid, methylcellulose, hydroxypropylcellulose, microcrystalline cellulose and sodium carmellose, hydrogen peroxide solution 30%, lemon flavor (containing ethanol), Swiss cream flavor (containing ethanol, invert sugar, sucrose, hydrogen dioxide sulfur (E220)) and purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e-Hypersensitivity to the active substances or to any of the excipients, listed in paragraph 6.1; -Patients suffering from porphyria (see section 4.4); -Severe forms of renal failure (creatinine clearance less than 30 mL\/min) (see section 4.4); -Contraindicated in pediatric age (see paragraph 4.2); -State of cachexia.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eDosage\u003c\/u\u003e Swallow 2-4 teaspoons (10-20 ml) of oral suspension 4 times a day, 20-60 minutes after meals and before bedtime. It can be diluted in water or milk. Do not exceed the maximum indicated dose of 16 teaspoons. \u003ci\u003ePediatric population\u003c\/i\u003e MAALOX PLUS is contraindicated in children and adolescents under 18 years of age (see section 4.3). \u003cu\u003eMethod of administration\u003c\/u\u003e For oral use. Shake well before use.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStore below 30°C. For storage conditions after first opening, see paragraph 6.3.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAluminum hydroxide can cause constipation and an overdose of magnesium salts can cause intestinal hypermotility (see section 4.8); high doses of this medicinal product may cause or aggravate intestinal and ileal obstruction in patients at higher risk, such as those with renal impairment, with underlying constipation, with impaired intestinal motility, in children (0 to 24 months), or elderly (see section 4.9). Aluminum hydroxide is not well absorbed from the gastrointestinal tract, and systemic effects are therefore rare in patients with normal renal function. However, excessive doses or long-term use, or even normal doses in patients on low phosphorus diets or in children (0 to 24 months), may lead to phosphate elimination (due to an aluminium-phosphate bond) accompanied by increased bone resorption and hypercalciuria with risk of osteomalacia (see section 4.8). It is advisable to monitor patients in case of long-term use or patients at risk of hypophosphatemia. In patients with renal impairment, plasma levels of aluminum and magnesium tend to increase, causing hyperaluminemia and hypermagnesemia, respectively. In these patients, long exposure to high doses of aluminum and magnesium salts can lead to encephalopathies, dementia, microcytic anemia or worsening of dialysis-induced osteomalacia. In the presence of mild and moderate forms of renal impairment, the medicine must be taken under medical supervision and prolonged use of the medicine must be avoided. The administration of this medicine in subjects suffering from severe forms of renal failure is contraindicated (see section 4.3). Aluminum hydroxide may be unsafe in porphyria patients undergoing hemodialysis; MAALOX PLUS is contraindicated in patients suffering from porphyria (see section 4.3). MAALOX PLUS, due to its composition, has no tendency to modify the behavior of the bird. However, in some particularly sensitive subjects and for high doses, an acceleration of intestinal transit may occur. This medicine contains 448 mg of \u003cb\u003esorbitol (E420)\u003c\/b\u003e in 10 ml (2 teaspoons). Patients with hereditary fructose intolerance should not be given this medicine. This medicine contains 8.2 mg of \u003cb\u003eethanol\u003c\/b\u003e in 10 ml (2 teaspoons). 10 ml of this medicine is equivalent to 0.2 ml of beer or 0.1 ml of wine. The small amount of alcohol in this medicine will not produce any noticeable effects. This medicine contains \u003cb\u003einvert sugar and sucrose\u003c\/b\u003e: Patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase insufficiency should not take this medicine. This medicine contains \u003cb\u003esulfur dioxide (E220):\u003c\/b\u003e rarely it can cause serious hypersensitivity reactions and bronchospasm. This medicinal product contains less than 1 mmol (23 mg) of \u003cb\u003esodium\u003c\/b\u003e per dose, i.e. it is essentially 'sodium-free'. \u003cu\u003ePediatric population\u003c\/u\u003e In young children, the use of magnesium hydroxide can lead to hypermagnesemia, particularly if they have kidney damage or dehydration.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSince Al and Mg salts reduce the gastrointestinal absorption of tetracyclines, it is recommended to avoid taking MAALOX PLUS during oral tetracycline therapy. The use of aluminum-containing antacids may reduce the absorption of drugs in particular H2-antagonists, atenolol, bisphosphonates, cefdinir, cefpodoxime, chloroquine, tetracyclines, dasatinib monohydrate, diflunisal, digoxin, dexamethasone, eltrombopag olamine, elvitegravir, ethambutol, fluoroquinolones, glucocorticoids, indomethacin, iron salts, isoniazid, ketoconazole, levothyroxine, lincosamides, metoprolol, nilotinib, phenothiazine neuroleptics, penicillamines, propranolol, raltegravir potassium, rilpivirine, riociguat, rosuvastatin, sodium fluoride and antiviral treatments in combination with tenofovir alafenamide fumarate\/emtricitabine\/sodium bictegravir. Since the use of magnesium hydroxide causes alkalinization of the urine, increased excretion of salicylates has been observed when administered simultaneously. Caution is advised when the medicinal product is taken together with polystyrene sulfonate (Kayexalate) due to the potential risk of reduced potassium-binding efficacy of the resin, metabolic alkalosis in patients with renal impairment (reported with aluminum hydroxide and magnesium hydroxide) and intestinal obstruction (reported with aluminum hydroxide). Aluminum hydroxide and citrates can cause hyperaluminemia, especially in patients with renal impairment. The combination with the integrase inhibitors (dolutegravir, raltegravir, bictegravir) and MAALOX PLUS should be avoided (refer to the respective SmPCs for dose recommendations). As a precaution, allow at least 2 hours (4 for fluoroquinolones) to pass between taking any oral medication and MAALOX PLUS. Concomitant use of quinidine may result in increased serum quinidine levels and lead to quinidine overdose. The simultaneous use of aluminum hydroxide and citrates can lead to an increase in aluminum levels, particularly in patients with renal failure. The alkalinization of the urine following the administration of magnesium hydroxide can modify the excretion of some drugs; therefore, increased excretion of salicylates was observed.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe frequency of the side effects reported below is defined using the following conventions: common (≥1\/100, \u003c1\/10); uncommon (≥1\/1,000, \u003c1\/100); rare (≥1\/10,000, \u003c1\/1,000); very rare (\u003c1\/10,000); not known (frequency cannot be estimated from the available data). \u003ci\u003e \u003cu\u003eImmune system disorders\u003c\/u\u003e \u003c\/i\u003e \u003ci\u003eFrequency not known:\u003c\/i\u003e angioedema, anaphylactic reactions, hypersensitivity reactions, urticaria, pruritus. \u003ci\u003e \u003cu\u003eGastrointestinal disorders\u003c\/u\u003e \u003c\/i\u003e \u003ci\u003eUncommon\u003c\/i\u003e: diarrhea or constipation (see section 4.4); \u003ci\u003eFrequency not known\u003c\/i\u003e: abdominal pain. \u003ci\u003e \u003cu\u003eMetabolism and nutrition disorders\u003c\/u\u003e \u003c\/i\u003e \u003ci\u003eVery rare:\u003c\/i\u003e hypermagnesemia, including observations after prolonged administration to patients with renal impairment\u003ci\u003e;\u003c\/i\u003e \u003ci\u003eFrequency not known\u003c\/i\u003e: hyperaluminemia, hypophosphatemia, during prolonged use or at high doses or even at normal doses of the medicine in patients with low phosphorus diets or in children (0 to 24 months), which may cause increased bone resorption, hypercalciuria, osteomalacia (see section 4.4). \u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at http:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eExperience with deliberate overdose is very limited. Cases of overdose with aluminum salts may occur more easily in patients with severe chronic renal impairment with the following symptoms: encephalopathy, convulsions and dementia, hypermagnesemia. The most frequently reported symptoms of acute overdose with aluminum hydroxide and in combination with magnesium salts include diarrhea, abdominal pain and vomiting. High doses of this medicinal product may cause or aggravate intestinal and ileal obstruction in patients at risk (see section 4.4). Treatment should be symptomatic, adopting generic supportive measures. Aluminum and magnesium are eliminated through urinary excretion; treatment of magnesium overdose involves rehydration and forced diuresis. In case of renal failure, hemodialysis or peritoneal dialysis is required.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eThere are no data on the use of MAALOX PLUS in pregnant women. It is not possible to establish whether or not the use of MAALOX PLUS during pregnancy is safe\u003c\/u\u003e. \u003cu\u003ePregnancy\u003c\/u\u003e The medicine must be used only if necessary, under the direct supervision of a doctor, after evaluating the expected benefit for the mother in relation to the possible risk for the fetus or infant. \u003cu\u003eBreastfeeding\u003c\/u\u003e Due to limited maternal absorption when taken according to the indicated dosing regimen (see section 4.2), aluminum hydroxide and its combinations with magnesium salts are considered compatible with breastfeeding.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMAALOX PLUS does not alter the ability to drive and use machines.\u003c\/p\u003e","brand":"Opella Healthcare","offers":[{"title":"Default Title","offer_id":51730206097735,"sku":"020702270","price":11.31,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/opella-healthcare-italy-srl-maalox-plus-4-3-5-0-5-250-ml-sospensione-orale-limone-e-menta-farmacia-dottor-tili-1213791361.jpg?v=1767139889"},{"product_id":"gaviscon-250-mg-133-5-mg-24-compresse-masticabili-gusto-menta","title":"Gaviscon 250 mg + 133.5 mg 24 mint flavor chewable tablets","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptomatic treatment of occasional heartburn\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e \u003ci\u003eGaviscon 500 mg + 267 mg mint flavor chewable tablets\u003c\/i\u003e. \u003c\/b\u003e One tablet contains: \u003cu\u003eActive ingredients\u003c\/u\u003e: sodium alginate 500 mg; sodium bicarbonate 267 mg. Excipient with known effects: aspartame 7.5 mg sodium 126.5 mg \u003cb\u003e \u003ci\u003eGaviscon 250 mg + 133.5 mg mint flavor chewable tablets.\u003c\/i\u003e \u003c\/b\u003e One tablet contains: \u003cu\u003eActive ingredients\u003c\/u\u003e: sodium alginate 250 mg; sodium bicarbonate 133.5 mg. Excipient with known effects: aspartame 3.75 mg sodium 63.25 mg \u003cb\u003e \u003ci\u003eGaviscon 250 mg + 133.5 mg strawberry flavor chewable tablets\u003c\/i\u003e. \u003c\/b\u003e One tablet contains: \u003cu\u003eActive ingredients\u003c\/u\u003e: sodium alginate 250 mg, sodium bicarbonate 133.5 mg. Excipient with known effects: aspartame 8.80 mg sodium 63.25 mg \u003cb\u003e \u003ci\u003eGaviscon 500 mg\/10 ml + 267 mg\/10 ml oral suspension\u003c\/i\u003e \u003c\/b\u003e. 10ml contains: \u003cu\u003eActive ingredients\u003c\/u\u003e: sodium alginate 500 mg; sodium bicarbonate 267 mg. Excipients with known effects: methyl parahydroxybenzoate 40 mg propyl parahydroxybenzoate 6 mg benzyl alcohol 1.1 mg sodium 142.6 mg \u003cb\u003e \u003ci\u003eGaviscon 500 mg\/10 ml + 267 mg\/10 ml oral suspension mint flavour\u003c\/i\u003e. \u003c\/b\u003e 10ml contains: \u003cu\u003eActive ingredients\u003c\/u\u003e: sodium alginate 500 mg; sodium bicarbonate 267 mg. Excipients with known effects: methyl parahydroxybenzoate 40 mg propyl parahydroxybenzoate 6 mg sodium 142.6 mg For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e \u003ci\u003eMint flavor chewable tablets\u003c\/i\u003e: \u003c\/b\u003e Mannitol (E421), calcium carbonate, magnesium stearate, copovidone, aspartame (E951), acesulfame potassium, macrogol 20,000, mint flavouring. \u003cb\u003e \u003ci\u003eStrawberry flavor chewable tablets\u003c\/i\u003e: \u003c\/b\u003e Xylitol, mannitol (E421), calcium carbonate, macrogol 20,000, strawberry flavouring, aspartame (E951), magnesium stearate, red iron oxide. \u003cb\u003e \u003ci\u003eOral suspension\u003c\/i\u003e: \u003c\/b\u003e Calcium carbonate, carbomers, methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), sodium saccharin, fennel flavouring, sodium hydroxide, erythrosine, purified water. \u003cb\u003e \u003ci\u003eMint flavor oral suspension:\u003c\/i\u003e \u003c\/b\u003e Calcium carbonate, carbomers, methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), sodium saccharin, mint flavouring, sodium hydroxide, purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substances or to any of the excipients listed in section 6.1, such as methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216) (parabens).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003e \u003cu\u003eChewable tablets (strawberry flavor and mint flavour).\u003c\/u\u003e \u003c\/i\u003e Dosage. \u003cb\u003eAdults and adolescents (12-18 years)\u003ci\u003e:\u003c\/i\u003e \u003c\/b\u003e 1-2 tablets of 500 mg + 267 mg after meals and at bedtime; 2-4 tablets of 250 mg + 133.5 mg after meals and at bedtime. Method of administration: For oral administration. The tablets must be chewed well (they can be broken and chewed a little at a time). Afterwards you can drink some water. \u003ci\u003e \u003cu\u003eOral suspension\u003c\/u\u003e \u003c\/i\u003e. Dosage. \u003cb\u003eAdults and adolescents (12-18 years)\u003ci\u003e:\u003c\/i\u003e \u003c\/b\u003e 10-20 ml (second-fourth notch of the measuring cup or 2-4 measuring spoons or 1-2 single-dose sachets) after meals and at bedtime. Method of administration: For oral administration. Shake the suspension before use. Take the medicine orally without water. \u003cb\u003e \u003ci\u003eSpecial populations. \u003c\/i\u003e \u003c\/b\u003e \u003cb\u003eElderly:\u003c\/b\u003e it is not necessary to change the doses for this age group. \u003cb\u003ePatients with renal failure\u003c\/b\u003e: the reduced ability to eliminate the exogenous salt supplement provided by antacids in the urine can lead to potentially severe electrolyte imbalances (see section 4.4).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eOral suspension and mint flavor oral suspension: do not store above 30°C. Store in the original packaging. Do not refrigerate. Mint flavor oral suspension in sachets: do not store above 25°C. Store in the original packaging. Do not refrigerate. Mint flavor chewable tablets: do not store above 30°C. Store in the original packaging. Strawberry flavor chewable tablets: do not store above 25°C. Store in the original packaging.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn adolescents (12-18 years) use only in case of real need and under strict medical supervision. \u003cb\u003eKidney failure: \u003c\/b\u003e In case of renal insufficiency, the medicine should be used with caution since the exogenous salt supplement provided by antacids can cause potentially serious electrolyte imbalances. This medicine contains: \u003cb\u003eSodium\u003c\/b\u003e: • 126.5mg (5.5 mmol) of sodium for each 500 mg + 267 mg chewable tablet, equivalent to approximately 6% of the maximum daily intake recommended by the WHO which corresponds to 2 g of sodium for an adult. • 63.25 mg (2.75 mmol) of sodium for each 250 mg +133.5 mg chewable tablet, equivalent to approximately 3% of the maximum daily intake recommended by the WHO which corresponds to 2 g of sodium for an adult. • 142.6 mg (6.2 mmol) of sodium for each 10 ml dose of oral suspension and mint flavor oral suspension, equivalent to approximately 7% of the maximum daily intake recommended by the WHO which corresponds to 2 g of sodium for an adult. 391 mg sodium (17 mmol) corresponds to approximately 20% of the WHO recommended maximum daily dietary intake of 2 g for an adult; this medicine is therefore considered to be high in sodium. This should be taken into account in cases where a particularly low-salt diet is recommended, for example in some cases of congestive heart failure and renal impairment. \u003cb\u003eFootball\u003c\/b\u003e: Each 500 mg + 267 mg chewable tablet contains 160 mg (1.6 mmol) calcium carbonate. Each 250 mg +133.5 mg chewable tablet contains 80 mg (0.8 mmol) of calcium carbonate. Each 10 ml dose of oral suspension and mint flavor oral suspension contains 160 mg (1.6 mmol) of calcium carbonate. Each maximum recommended dose (2 tablets of 500 mg + 267 mg, 4 tablets of 250 mg +133.5 mg, 20 ml of oral suspension and mint flavor oral suspension) contains 320 mg of calcium carbonate. Caution should be exercised when treating patients with hypercalcemia, nephrocalcinosis, and recurrent calcium-containing renal stones. \u003cb\u003eAspartame: \u003c\/b\u003e Each 500 mg + 267 mg chewable tablet contains 7.5 mg of aspartame. Each 250 mg +133.5 mg mint flavor chewable tablet contains 3.75 mg of aspartame. Each 250 mg +133.5 mg strawberry flavor chewable tablet contains 8.8 mg of aspartame. Aspartame is a source of phenylalanine and may be harmful to patients with phenylketonuria. \u003cb\u003eParahydroxybenzoates: \u003c\/b\u003e The oral suspension and the mint flavor oral suspension contain methyl parahydroxybenzoate (40 mg\/10 ml of suspension) and propyl parahydroxybenzoate (6 mg\/10 ml of suspension) which may cause allergic reactions (even delayed) \u003cb\u003eBenzyl alcohol\u003c\/b\u003e: GAVISCON 500 mg\/10 ml + 267 mg\/10 ml oral suspension contains fennel flavour, which in turn contains benzyl alcohol. Each 10 ml dose of oral suspension contains 1.1 mg of benzyl alcohol. Benzyl alcohol can cause allergic reactions. Large volumes should be used with caution and only if necessary, especially in patients who are pregnant, breastfeeding, with hepatic or renal insufficiency due to the risk of accumulation and toxicity (metabolic acidosis). \u003cb\u003eDuration of treatment: \u003c\/b\u003e If symptoms do not improve after seven days, the clinical picture should be re-evaluated.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIt is advisable to place an interval of at least two hours between taking Gaviscon and other medicines, especially tetracyclines, fluoroquinolones, iron salts, thyroid hormones, chloroquine, bisphosphonates and estramustine (See also section 4.4).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBelow are the side effects of Gaviscon, organized according to the MedDRA system organic classification. They are divided by frequency (very common (≥ 1\/10), common (≥ 1\/100 to ≤ 1\/10), uncommon (≥ 1\/1,000 to ≤ 1\/100), rare (≥ 1\/10,000 to 1\/1,000), very rare (≤ 1\/10,000), not known (the frequency cannot be estimated on the basis of available data)).\u003c\/p\u003e\n\u003cp\u003eImmune system disorders - Frequency: Very rare. Adverse Reaction: anaphylactic or anaphylactoid reactions. Hypersensitivity reactions (such as urticaria).\u003c\/p\u003e\n\u003cp\u003eRespiratory, thoracic and mediastinal disorders - Frequency: Very rare. Adverse Reaction: respiratory symptoms such as bronchospasm.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders - Frequency: Very rare. Adverse Reaction: flatulence, nausea.\u003c\/p\u003e\n\u003cp\u003eGeneral disorders and conditions relating to the administration site - Frequency: Very rare. Adverse Reaction: edema.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e \u003cu\u003eReporting of suspected adverse reactions.\u003c\/u\u003e \u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eExperience with overdose is very limited. The only possible consequence of overdose is abdominal distension: in this case, resort to symptomatic treatment by adopting generic support measures.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ePregnancy:\u003c\/b\u003e Clinical studies on more than 500 pregnant women, as well as a large number of data from post-marketing experience, indicate that the active ingredients do not cause malformations or fetal\/neonatal toxicity. Gaviscon can be used during pregnancy if clinically necessary. \u003cb\u003eBreastfeeding:\u003c\/b\u003e No effect of the active ingredients has been shown on newborns\/infants breastfed by treated mothers. Gaviscon can be used during breastfeeding. \u003cb\u003eFertility: \u003c\/b\u003e Preclinical studies have shown that alginate has no negative effect on fertility and reproduction. Clinical data do not suggest that Gaviscon has an effect on human fertility.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eGaviscon has no or negligible influence on the ability to drive or use machines.\u003c\/p\u003e","brand":"Reckitt Benckiser","offers":[{"title":"Default Title","offer_id":51730209734983,"sku":"024352167","price":10.88,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/reckitt-benckiser-h-it-spa-gaviscon-250-mg-133-5-mg-24-compresse-masticabili-gusto-menta-farmacia-dottor-tili-1213791067.jpg?v=1767154548"},{"product_id":"gaviscon-500-mg-267-mg-24-compresse-masticabili","title":"Gaviscon 500 mg + 267 mg 24 chewable tablets","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptomatic treatment of occasional heartburn\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e \u003ci\u003eGaviscon 500 mg + 267 mg mint flavor chewable tablets\u003c\/i\u003e. \u003c\/b\u003e One tablet contains: \u003cu\u003eActive ingredients\u003c\/u\u003e: sodium alginate 500 mg; sodium bicarbonate 267 mg. Excipient with known effects: aspartame 7.5 mg sodium 126.5 mg \u003cb\u003e \u003ci\u003eGaviscon 250 mg + 133.5 mg mint flavor chewable tablets.\u003c\/i\u003e \u003c\/b\u003e One tablet contains: \u003cu\u003eActive ingredients\u003c\/u\u003e: sodium alginate 250 mg; sodium bicarbonate 133.5 mg. Excipient with known effects: aspartame 3.75 mg sodium 63.25 mg \u003cb\u003e \u003ci\u003eGaviscon 250 mg + 133.5 mg strawberry flavor chewable tablets\u003c\/i\u003e. \u003c\/b\u003e One tablet contains: \u003cu\u003eActive ingredients\u003c\/u\u003e: sodium alginate 250 mg, sodium bicarbonate 133.5 mg. Excipient with known effects: aspartame 8.80 mg sodium 63.25 mg \u003cb\u003e \u003ci\u003eGaviscon 500 mg\/10 ml + 267 mg\/10 ml oral suspension\u003c\/i\u003e \u003c\/b\u003e. 10ml contains: \u003cu\u003eActive ingredients\u003c\/u\u003e: sodium alginate 500 mg; sodium bicarbonate 267 mg. Excipients with known effects: methyl parahydroxybenzoate 40 mg propyl parahydroxybenzoate 6 mg benzyl alcohol 1.1 mg sodium 142.6 mg \u003cb\u003e \u003ci\u003eGaviscon 500 mg\/10 ml + 267 mg\/10 ml oral suspension mint flavour\u003c\/i\u003e. \u003c\/b\u003e 10ml contains: \u003cu\u003eActive ingredients\u003c\/u\u003e: sodium alginate 500 mg; sodium bicarbonate 267 mg. Excipients with known effects: methyl parahydroxybenzoate 40 mg propyl parahydroxybenzoate 6 mg sodium 142.6 mg For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e \u003ci\u003eMint flavor chewable tablets\u003c\/i\u003e: \u003c\/b\u003e Mannitol (E421), calcium carbonate, magnesium stearate, copovidone, aspartame (E951), acesulfame potassium, macrogol 20,000, mint flavouring. \u003cb\u003e \u003ci\u003eStrawberry flavor chewable tablets\u003c\/i\u003e: \u003c\/b\u003e Xylitol, mannitol (E421), calcium carbonate, macrogol 20,000, strawberry flavouring, aspartame (E951), magnesium stearate, red iron oxide. \u003cb\u003e \u003ci\u003eOral suspension\u003c\/i\u003e: \u003c\/b\u003e Calcium carbonate, carbomers, methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), sodium saccharin, fennel flavouring, sodium hydroxide, erythrosine, purified water. \u003cb\u003e \u003ci\u003eMint flavor oral suspension:\u003c\/i\u003e \u003c\/b\u003e Calcium carbonate, carbomers, methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), sodium saccharin, mint flavouring, sodium hydroxide, purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substances or to any of the excipients listed in section 6.1, such as methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216) (parabens).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003e \u003cu\u003eChewable tablets (strawberry flavor and mint flavour).\u003c\/u\u003e \u003c\/i\u003e Dosage. \u003cb\u003eAdults and adolescents (12-18 years)\u003ci\u003e:\u003c\/i\u003e \u003c\/b\u003e 1-2 tablets of 500 mg + 267 mg after meals and at bedtime; 2-4 tablets of 250 mg + 133.5 mg after meals and at bedtime. Method of administration: For oral administration. The tablets must be chewed well (they can be broken and chewed a little at a time). Afterwards you can drink some water. \u003ci\u003e \u003cu\u003eOral suspension\u003c\/u\u003e \u003c\/i\u003e. Dosage. \u003cb\u003eAdults and adolescents (12-18 years)\u003ci\u003e:\u003c\/i\u003e \u003c\/b\u003e 10-20 ml (second-fourth notch of the measuring cup or 2-4 measuring spoons or 1-2 single-dose sachets) after meals and at bedtime. Method of administration: For oral administration. Shake the suspension before use. Take the medicine orally without water. \u003cb\u003e \u003ci\u003eSpecial populations. \u003c\/i\u003e \u003c\/b\u003e \u003cb\u003eElderly:\u003c\/b\u003e it is not necessary to change the doses for this age group. \u003cb\u003ePatients with renal failure\u003c\/b\u003e: the reduced ability to eliminate the exogenous salt supplement provided by antacids in the urine can lead to potentially severe electrolyte imbalances (see section 4.4).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eOral suspension and mint flavor oral suspension: do not store above 30°C. Store in the original packaging. Do not refrigerate. Mint flavor oral suspension in sachets: do not store above 25°C. Store in the original packaging. Do not refrigerate. Mint flavor chewable tablets: do not store above 30°C. Store in the original packaging. Strawberry flavor chewable tablets: do not store above 25°C. Store in the original packaging.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn adolescents (12-18 years) use only in case of real need and under strict medical supervision. \u003cb\u003eKidney failure: \u003c\/b\u003e In case of renal insufficiency, the medicine should be used with caution since the exogenous salt supplement provided by antacids can cause potentially serious electrolyte imbalances. This medicine contains: \u003cb\u003eSodium\u003c\/b\u003e: • 126.5mg (5.5 mmol) of sodium for each 500 mg + 267 mg chewable tablet, equivalent to approximately 6% of the maximum daily intake recommended by the WHO which corresponds to 2 g of sodium for an adult. • 63.25 mg (2.75 mmol) of sodium for each 250 mg +133.5 mg chewable tablet, equivalent to approximately 3% of the maximum daily intake recommended by the WHO which corresponds to 2 g of sodium for an adult. • 142.6 mg (6.2 mmol) of sodium for each 10 ml dose of oral suspension and mint flavor oral suspension, equivalent to approximately 7% of the maximum daily intake recommended by the WHO which corresponds to 2 g of sodium for an adult. 391 mg sodium (17 mmol) corresponds to approximately 20% of the WHO recommended maximum daily dietary intake of 2 g for an adult; this medicine is therefore considered to be high in sodium. This should be taken into account in cases where a particularly low-salt diet is recommended, for example in some cases of congestive heart failure and renal impairment. \u003cb\u003eFootball\u003c\/b\u003e: Each 500 mg + 267 mg chewable tablet contains 160 mg (1.6 mmol) calcium carbonate. Each 250 mg +133.5 mg chewable tablet contains 80 mg (0.8 mmol) of calcium carbonate. Each 10 ml dose of oral suspension and mint flavor oral suspension contains 160 mg (1.6 mmol) of calcium carbonate. Each maximum recommended dose (2 tablets of 500 mg + 267 mg, 4 tablets of 250 mg +133.5 mg, 20 ml of oral suspension and mint flavor oral suspension) contains 320 mg of calcium carbonate. Caution should be exercised when treating patients with hypercalcemia, nephrocalcinosis, and recurrent calcium-containing renal stones. \u003cb\u003eAspartame: \u003c\/b\u003e Each 500 mg + 267 mg chewable tablet contains 7.5 mg of aspartame. Each 250 mg +133.5 mg mint flavor chewable tablet contains 3.75 mg of aspartame. Each 250 mg +133.5 mg strawberry flavor chewable tablet contains 8.8 mg of aspartame. Aspartame is a source of phenylalanine and may be harmful to patients with phenylketonuria. \u003cb\u003eParahydroxybenzoates: \u003c\/b\u003e The oral suspension and the mint flavor oral suspension contain methyl parahydroxybenzoate (40 mg\/10 ml of suspension) and propyl parahydroxybenzoate (6 mg\/10 ml of suspension) which may cause allergic reactions (even delayed) \u003cb\u003eBenzyl alcohol\u003c\/b\u003e: GAVISCON 500 mg\/10 ml + 267 mg\/10 ml oral suspension contains fennel flavour, which in turn contains benzyl alcohol. Each 10 ml dose of oral suspension contains 1.1 mg of benzyl alcohol. Benzyl alcohol can cause allergic reactions. Large volumes should be used with caution and only if necessary, especially in patients who are pregnant, breastfeeding, with hepatic or renal insufficiency due to the risk of accumulation and toxicity (metabolic acidosis). \u003cb\u003eDuration of treatment: \u003c\/b\u003e If symptoms do not improve after seven days, the clinical picture should be re-evaluated.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIt is advisable to place an interval of at least two hours between taking Gaviscon and other medicines, especially tetracyclines, fluoroquinolones, iron salts, thyroid hormones, chloroquine, bisphosphonates and estramustine (See also section 4.4).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBelow are the side effects of Gaviscon, organized according to the MedDRA system organic classification. They are divided by frequency (very common (≥ 1\/10), common (≥ 1\/100 to ≤ 1\/10), uncommon (≥ 1\/1,000 to ≤ 1\/100), rare (≥ 1\/10,000 to 1\/1,000), very rare (≤ 1\/10,000), not known (the frequency cannot be estimated on the basis of available data)).\u003c\/p\u003e\n\u003cp\u003eImmune system disorders - Frequency: Very rare. Adverse Reaction: anaphylactic or anaphylactoid reactions. Hypersensitivity reactions (such as urticaria).\u003c\/p\u003e\n\u003cp\u003eRespiratory, thoracic and mediastinal disorders - Frequency: Very rare. Adverse Reaction: respiratory symptoms such as bronchospasm.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders - Frequency: Very rare. Adverse Reaction: flatulence, nausea.\u003c\/p\u003e\n\u003cp\u003eGeneral disorders and conditions relating to the administration site - Frequency: Very rare. Adverse Reaction: edema.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e \u003cu\u003eReporting of suspected adverse reactions.\u003c\/u\u003e \u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eExperience with overdose is very limited. The only possible consequence of overdose is abdominal distension: in this case, resort to symptomatic treatment by adopting generic support measures.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ePregnancy:\u003c\/b\u003e Clinical studies on more than 500 pregnant women, as well as a large number of data from post-marketing experience, indicate that the active ingredients do not cause malformations or fetal\/neonatal toxicity. Gaviscon can be used during pregnancy if clinically necessary. \u003cb\u003eBreastfeeding:\u003c\/b\u003e No effect of the active ingredients has been shown on newborns\/infants breastfed by treated mothers. Gaviscon can be used during breastfeeding. \u003cb\u003eFertility: \u003c\/b\u003e Preclinical studies have shown that alginate has no negative effect on fertility and reproduction. Clinical data do not suggest that Gaviscon has an effect on human fertility.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eGaviscon has no or negligible influence on the ability to drive or use machines.\u003c\/p\u003e","brand":"Reckitt Benckiser","offers":[{"title":"Default Title","offer_id":51730210095431,"sku":"024352054","price":13.02,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/reckitt-benckiser-h-it-spa-gaviscon-500-mg-267-mg-24-compresse-masticabili-farmacia-dottor-tili-1213791056.jpg?v=1767154689"},{"product_id":"sodio-bicarbonato-sella-500-mg-50-compresse","title":"Sodium bicarbonate Sella 500 mg 50 tablets","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of gastric hyperacidity.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEach tablet contains: Active ingredient: sodium bicarbonate 500 mg. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHydroxypropyl cellulose, hydrogenated vegetable oil, crospovidone.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e- Hypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1; - severe renal insufficiency; - respiratory alkalosis; - hypocalcemia, due to an increased risk of tetany; - diuretic-induced hypochloremia (see section 4.5); - excessive loss of chlorine, due to vomiting or continuous gastrointestinal suction, due to the greater risk of metabolic alkalosis; - children under 12 years of age. Generally contraindicated during pregnancy (see section 4.6).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eAdults:\u003c\/i\u003e The usual dose in adults varies between 500 mg to 5 g per day. \u003ci\u003eAdolescents (12-18 years):\u003c\/i\u003e 1-2 tablets after meals and at bedtime. The medicine is not indicated for children under 12 years of age\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStore in the original packaging, tightly closed to protect the medicine from humidity, since sodium bicarbonate decomposes slowly in the presence of humidity.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eParticular caution is required when administering sodium bicarbonate in case of: - history of congestive heart failure; - renal impairment; - hypertension; - liver cirrhosis; - concomitant use of corticosteroids (see section 4.5). The tablets contain sodium, therefore this must be taken into account in cases where a particularly low-salt diet is recommended, for example in some cases of congestive heart failure, renal impairment, hypertension. This medicine contains 137 mg sodium per tablet, equivalent to 6.8% of the WHO recommended maximum daily intake of 2 g sodium for an adult. Sodium bicarbonate should be used with caution in cases of anuria or oliguria, due to the increased risk of sodium retention. Additionally, caution should be exercised in edematous conditions with sodium retention, such as liver cirrhosis, congestive heart failure, renal failure, toxemia, or pregnancy. In patients with very low levels of gastric acid, the effectiveness of sodium bicarbonate on stomach acid may be less. Furthermore, in such subjects there is the possibility of an increase in its absorption into the plasma with the possibility of unwanted systemic effects. In patients with potassium depletion, sodium bicarbonate should be administered with caution and cardiac and electrolyte parameters should be monitored repeatedly. In patients with gastric and small intestinal inflammation or kidney failure, sodium bicarbonate increases the risk of excess sodium levels in the blood. Sodium bicarbonate can cause changes in the pH of the stomach and urine, thus altering the absorption and elimination processes of many drugs (see section 4.5). \u003cu\u003eIt is advisable to allow at least 2 hours to pass between taking sodium bicarbonate and other medicines\u003c\/u\u003e.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSodium bicarbonate when administered orally at recommended doses is absorbed only in small quantities with minimal systemic effects. However, the possible interactions due to the presence of the drug in circulation are listed below. Sodium bicarbonate, by increasing the pH of the stomach, can cause a reduction in the absorption of acidic drugs, with a consequent decrease in their effect. This interaction has been found, for example, for: itraconazole, ketoconazole, atazanavir, cefpodoxime proxetile, dasatinib and iron. With the same mechanism, sodium bicarbonate can cause an increase in the absorption of basic drugs with a consequent increase in their toxicity. Sodium bicarbonate, by alkalinizing the urine, can decrease the elimination of basic drugs by increasing their duration of action and toxicity. This interaction has been found, for example, for: quinidine, amphetamines, ephedrine, pseudoephedrine, memantine, flecainide and mecamylamine. With the same mechanism, sodium bicarbonate can cause a greater elimination of some drugs, with a consequent decrease in their effect. This interaction has been found, for example, for: aspirin, chlorpropamide, lithium methenamine and tetracyclines (especially doxycycline). If sodium bicarbonate is used in combination with diuretics that promote potassium excretion such as bumetamide, ethacrynic acid, furosemide and thiazides, hypochloremic alkalosis may occur. Since sodium bicarbonate can cause sodium retention (see section 4.8 Side effects), concomitant use with other drugs that cause an increase in sodium in the body, such as corticosteroids, can aggravate this effect.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBelow are the side effects of sodium bicarbonate administered orally, organized according to the MedDRA system organic classification. There is insufficient data to establish the frequency of the individual effects listed. \u003ci\u003eImmune system disorders\u003c\/i\u003e: Allergic manifestations such as urticaria and bronchospasm, anaphylactic or anaphylactoid reactions. \u003ci\u003eGastrointestinal disorders\u003c\/i\u003e: Stomach cramps, flatulence, vomiting and gastric lesions. \u003ci\u003eVascular pathologies\u003c\/i\u003e: Water retention (edema), especially in elderly patients and in the presence of cardiac or renal insufficiency. Sodium bicarbonate when administered orally at recommended doses is absorbed only in small quantities with minimal systemic effects. However, the adverse reactions due to a systemic effect of the drug are listed below. \u003ci\u003eMetabolism and nutrition disorders\u003c\/i\u003e: Metabolic alkalosis, especially in patients with renal failure; symptoms include shortness of breath (due to compensatory hyperventilation, which can last up to 48 hours), muscle weakness associated with potassium depletion, muscle hypertonicity, muscle spasms and tetany which can occur especially in hypocalcemic patients. Hypernatremia. Hyperosmolarity, with increased fluid volume and pulmonary edema. \u003ci\u003eCardiac diseases\u003c\/i\u003e: Decreased cardiac output. \u003ci\u003eVascular pathologies\u003c\/i\u003e: Hypotension. Cerebral edema. Intracranial hemorrhage. \u003ci\u003eRespiratory, thoracic and mediastinal disorders\u003c\/i\u003e: Hypercapnia. Reporting of suspected adverse reactions. Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at http:\/\/www.agenziafarmaco.gov.it\/content\/come-segnalare-una-sospetti-reazione-avversa.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eExperience on deliberate overdose with oral sodium bicarbonate is very limited. The only possible consequence of overdose is abdominal distension caused by excess carbon dioxide generated by the splitting of sodium bicarbonate in the stomach. In this case it is necessary to resort to symptomatic treatment by adopting generic support measures.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003ePregnancy:\u003c\/i\u003e For sodium bicarbonate no clinical data on exposed pregnancies are available. Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonic\/foetal development, parturition or postnatal development (see section 5.3). Caution should be exercised when prescribing the medicine to pregnant women. Furthermore, it should be considered that the sodium contained in the medicine can worsen the edematous conditions of pregnancy. Therefore, to treat stomach acid, it is recommended to use alternative medications that do not contain sodium. \u003ci\u003eBreastfeeding:\u003c\/i\u003e The use of sodium bicarbonate is considered compatible with breastfeeding.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSodium bicarbonate does not affect the ability to drive or use machines.\u003c\/p\u003e","brand":"Sella","offers":[{"title":"Default Title","offer_id":51730210160967,"sku":"029816016","price":5.3,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/sella-srl-sodio-bicarbonato-sella-500-mg-50-compresse-farmacia-dottor-tili-1213791054.jpg?v=1767154768"},{"product_id":"maalox-reflusso-20-mg-14-compresse-gastroresistenti","title":"Maalox Reflux 20 mg 14 gastro-resistant tablets","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of reflux symptoms (e.g. heartburn, acid regurgitation) in adults.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEach gastro-resistant tablet contains 20 mg pantoprazole (as sodium sesquihydrate). Excipients with known effects: 38.425 mg maltitol and 0.345 mg soy lecithin (derived from soybean oil) and a maximum of 1.84 mg sodium. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eCore\u003c\/i\u003e: maltitol (E965), crospovidone type B, carmellose sodium, anhydrous sodium carbonate, calcium stearate. \u003ci\u003eCoating\u003c\/i\u003e: Poly(vinyl alcohol), talc, titanium dioxide (E 171), macrogol 3350, soy lecithin, yellow iron oxide (E 172), anhydrous sodium carbonate, methacrylic acid ethyl acrylate copolymer (1:1) (dispersion containing polysorbate 80 and sodium lauryl sulphate), triethyl citrate.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance, substituted benzimidazoles, to peanuts, to soya or to any of the other excipients listed in paragraph 6.1. The simultaneous administration of \u003ci\u003eMAALOX REFLUX\u003c\/i\u003e with HIV protease inhibitors whose absorption depends on the acidity of the intragastric pH, such as atazanavir and nelfinavir, is contraindicated due to the significant reduction in their bioavailability (see section 4.5).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eDosage\u003c\/u\u003e The recommended dose is 20 mg pantoprazole (one tablet) per day. You may need to take the tablets for 2-3 consecutive days to get an improvement in your symptoms. Once complete healing of symptoms has been achieved, treatment should be discontinued. Treatment should not exceed 4 weeks without consulting a doctor. If no improvement in symptoms is noted within 2 weeks of continuous treatment, the patient should consult a doctor.\u003ci\u003e \u003cu\u003eParticular populations\u003c\/u\u003e \u003c\/i\u003e No dose adjustment is necessary in elderly patients or in patients with renal or hepatic impairment. \u003ci\u003e \u003cu\u003ePediatric population\u003c\/u\u003e \u003c\/i\u003e The use of \u003ci\u003eMAALOX REFLUX\u003c\/i\u003e it is not recommended in children and adolescents under 18 years due to insufficient data on safety and efficacy. \u003cu\u003eMethod of administration\u003c\/u\u003e The gastro-resistant tablets of \u003ci\u003eMAALOX REFLUX\u003c\/i\u003e 20 mg should not be chewed or crushed, and should be swallowed whole with liquid before a meal.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDo not store above 25°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePatients should be instructed to contact their doctor if: • they have unintentional weight loss, anemia, gastrointestinal bleeding, dysphagia, recurrent vomiting or bloody vomiting, as treatment with pantoprazole may relieve symptoms and delay the diagnosis of a serious condition. In these cases a malignant pathology must be excluded; • have previously had gastric ulcer or gastrointestinal surgery; • have been on continuous symptomatic treatment for indigestion or heartburn for 4 weeks or more; • have jaundice, hepatic impairment, or liver disease; • have any other serious medical condition that compromises general well-being; • are over 55 years old with new or recently changed symptoms. Patients with recurring symptoms related to indigestion or heartburn should consult their doctor at regular intervals. In particular, patients over 55 years of age who take any non-prescription medicine for indigestion or heartburn on a daily basis should inform their pharmacist or doctor. Patients should not concurrently take another proton pump inhibitor or H-antagonist\u003csub\u003e2\u003c\/sub\u003e. Patients who need to undergo endoscopy or breath tests should consult their doctor before taking this medicine. Patients should be informed that the tablets are not intended to provide immediate relief. Patients may begin to feel an improvement in symptoms after about a day of treatment with pantoprazole, but it may be necessary to take it for 7 days to achieve complete control of heartburn. Patients should not take pantoprazole as a preventive drug. \u003cu\u003eGastrointestinal infections caused by bacteria\u003c\/u\u003e Reduction in gastric acidity, due to any reason, including proton pump inhibitors, increases the gastric count of bacteria normally present in the gastrointestinal tract. Treatment with acid-reducing drugs causes a slight increase in the risk of gastrointestinal infections such as \u003ci\u003eSalmonella\u003c\/i\u003e, \u003ci\u003eCampylobacter\u003c\/i\u003e or \u003ci\u003eClostridium difficile\u003c\/i\u003e. \u003cu\u003eSubacute cutaneous lupus erythematosus (SCLE)\u003c\/u\u003e Proton pump inhibitors are associated with very infrequent cases of SCLE. In case of lesions, especially in areas of the skin exposed to the sun, and if accompanied by arthralgia, the patient should seek medical attention promptly and the doctor should consider discontinuing MAALOX REFLUX. Subacute cutaneous lupus erythematosus (SCLE) after prior treatment with a proton pump inhibitor may increase the risk of SCLE with other proton pump inhibitors. \u003cu\u003eSevere cutaneous adverse reactions (SCAR)\u003c\/u\u003e Severe skin reactions including Stevens-Johnson syndrome (SJS), Lyell syndrome, which may be fatal or life-threatening, and drug reaction with eosinophilia and systemic symptoms (DRESS) have been reported in association with pantoprazole treatment (see section 4.8). Patients should be informed about signs and symptoms of serious skin manifestations and monitored carefully. If SCARs are observed, discontinuation of treatment should be considered. \u003cu\u003eKounis syndrome\u003c\/u\u003e Cases of Kounis syndrome, a serious allergic reaction which can cause myocardial infarction and death, have been reported with the intake of pantoprazole (see section 4.8). Symptoms may include chest pain that occurs in association with an allergic reaction. Prompt medical treatment and surveillance are mandatory. \u003cu\u003eSoy lecithin\u003c\/u\u003e This medicine contains lecithin derived from soya oil. If the patient is allergic to peanuts or soy, he should not use this medicine. \u003cu\u003eMaltitol\u003c\/u\u003e This medicine contains maltitol. Patients with rare hereditary problems of fructose intolerance should not take this medicine. \u003cu\u003eSodium\u003c\/u\u003e This medicinal product contains less than 1 mmol sodium (23 mg) per tablet, i.e. essentially 'sodium-free'. \u003cu\u003eInterference with laboratory tests \u003c\/u\u003e An increased level of Chromogranin A (CgA) can interfere with diagnostic tests for neuroendocrine tumors. To avoid such interference, treatment with MAALOX REFLUX must be suspended for at least 5 days before CgA measurements (see section 5.1). If CgA and gastrin levels have not returned to the reference range after the initial measurement, measurements should be repeated 14 days after discontinuation of proton pump inhibitor treatment. This medicinal product is intended for short-term use only (up to 4 weeks) (refer to section 4.2). Patients should be warned of the additional risks with long-term use of the medicinal product and the need for prescription and periodic monitoring should be emphasised. The following additional risks are considered relevant in long-term treatment: \u003cu\u003eInfluence on the absorption of vitamin B12 \u003c\/u\u003e Pantoprazole, like all acid-blocking medicines, may reduce the absorption of vitamin B12 (cyanocobalamin) due to hypo- or achlorhydria. This should be considered in patients with reduced body stores or risk factors for reduced absorption of vitamin B12 in long-term therapy or if related symptoms are observed. \u003cu\u003eBone fractures \u003c\/u\u003e Proton pump inhibitors, especially when used at high doses and for prolonged periods (\u003e 1 year), may slightly increase the risk of hip, wrist and spine fractures, especially in the elderly population or in the presence of other recognized risk factors. Observational studies suggest that proton pump inhibitors may increase the overall risk of fractures by 10-40%. This increase may be partly due to other risk factors. Patients at risk of osteoporosis should receive care based on current clinical guidelines and should take adequate amounts of vitamin D and calcium.\u003cu\u003eHypomagnesemia \u003c\/u\u003e Severe hypomagnesemia has been reported in patients treated with PPIs such as pantoprazole for at least 3 months and, in many cases for patients treated for a year. Serious manifestations of hypomagnesaemia such as fatigue, tetany, delirium, convulsions, dizziness and ventricular arrhythmia may occur and may occur subtly and be underestimated. In most patients, hypomagnesemia improves after replenishment of magnesium stores and discontinuation of the PPI. For patients scheduled for prolonged treatment with PPIs or in combination with digoxin or medicinal products that may cause hypomagnesaemia (e.g. diuretics), healthcare professionals should consider measuring magnesium levels before initiating PPI treatment and periodically during treatment.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eEffect of pantoprazole on the absorption of other medicinal products\u003c\/u\u003e \u003ci\u003eMAALOX REFLUX\u003c\/i\u003e can reduce the absorption of active ingredients whose bioavailability depends on gastric pH (e.g. ketoconazole). \u003cu\u003eHIV protease inhibitors\u003c\/u\u003e Co-administration of pantoprazole with HIV protease inhibitors, such as atazanavir and nelfinavir whose absorption depends on the acidity of the intragastric pH, is contraindicated due to the significant reduction in their bioavailability (see section 4.3). \u003cu\u003eCoumarin anticoagulants (phenprocoumon or warfarin)\u003c\/u\u003e Although no interactions were observed in clinical pharmacokinetic studies during concomitant treatment with phenprocoumon or warfarin, some isolated cases of changes in International Normalized Ratio (INR) have been reported during concomitant treatment in the post-marketing period. Therefore, in patients treated with coumarin anticoagulants (e.g. phenprocoumon or warfarin), it is recommended to monitor the prothrombin time\/INR when starting treatment with pantoprazole, when stopping it or when it is administered discontinuously. \u003cu\u003eMethotrexate\u003c\/u\u003e In some patients, concomitant use of high-dose methotrexate (e.g. 300 mg) and proton pump inhibitors has been reported to increase methotrexate levels. Therefore, in cases where methotrexate is used at high doses, for example in the treatment of tumors and psoriasis, a temporary suspension of pantoprazole therapy should be considered. \u003cu\u003eOther interaction studies\u003c\/u\u003e Pantoprazole is metabolised in the liver by the cytochrome P450 enzyme system. Interaction studies with carbamazepine, caffeine, diazepam, diclofenac, digoxin, ethanol, glibenclamide, metoprolol, naproxen, nifedipine, phenytoin, piroxicam, theophylline and an oral contraceptive containing levonorgestrel and ethinyl estradiol have shown no clinically significant interactions. In any case, an interaction of pantoprazole with other substances that are metabolised by the same enzymatic system cannot be excluded. There were no interactions with concomitantly administered antacids.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eSafety profile summary \u003c\/u\u003e Approximately 5% of patients can be expected to experience adverse reactions. The most commonly reported adverse reactions are diarrhea and headache, both occurring in approximately 1% of patients. \u003cu\u003eTable of adverse reactions\u003c\/u\u003e The following adverse reactions have been observed with pantoprazole. Within the following table, adverse reactions are classified according to the MedRA frequency classification: very common (≥1\/10); common (≥1\/100, \u003c1\/10); uncommon (≥1\/1000, \u003c1\/100); rare (≥1\/10,000, \u003c1\/1000); very rare (\u003c1\/10,000), not known (frequency cannot be estimated from the available data). Within each frequency grouping, adverse reactions are reported in order of decreasing seriousness. \u003ci\u003eTable 1. Adverse reactions with pantoprazole in clinical studies and post-marketing experience\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003eBlood and lymphatic system disorders - Rare: Agranulocytosis. Very rare: Thrombocytopenia, Leukopenia, Pancytopenia.\u003c\/p\u003e\n\u003cp\u003eImmune system disorders - Rare: Hypersensitivity (including anaphylactic reactions and anaphylactic shock).\u003c\/p\u003e\n\u003cp\u003eMetabolism and nutrition disorders - Rare: Hyperlipidemia and increased lipids (triglycerides, cholesterol), weight changes. Not known: Hyponatremia, Hypomagnesaemia Hypocalcemia in association with hypomagnesaemia.\u003c\/p\u003e\n\u003cp\u003ePsychiatric disorders - Uncommon: Sleep disorders. Rare: Depression (and all aggravated forms). Very rare: Disorientation (and all aggravated forms). Not known: Hallucinations, Confusion (especially in predisposed patients, as well as the aggravation of these events in case of pre-existence).\u003c\/p\u003e\n\u003cp\u003eNervous system disorders - Uncommon: Headache, dizziness. Rare: Taste disturbances. Not known: Paresthesia.\u003c\/p\u003e\n\u003cp\u003eEye disorders - Rare: Vision disorders \/ blurred vision.\u003c\/p\u003e\n\u003cp\u003eCardiac disorders - Not known: Kounis syndrome.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders - Common: Fundic gland polyps (benign). Uncommon: Diarrhoea, Nausea\/vomiting, Abdominal distension and bloating, Constipation, Dry mouth, Abdominal pain and discomfort. Not known: Microscopic colitis.\u003c\/p\u003e\n\u003cp\u003eHepatobiliary disorders - Uncommon: Increased levels of liver enzymes (transaminases, γ-GT). Rare: Increased bilirubin. Not known: Hepatocellular injury, Jaundice, Hepatocellular failure.\u003c\/p\u003e\n\u003cp\u003eSkin and subcutaneous tissue disorders - Uncommon: Rash \/ rash \/ eruption, Pruritus. Rare: Urticaria, Angioedema. Not known: Steven-Johnson syndrome (SJS), Lyell syndrome, Erythema multiforme, Photosensitivity, Subacute cutaneous lupus erythematosus, Drug reaction with eosinophilia and systemic symptoms (DRESS) (see section 4.4).\u003c\/p\u003e\n\u003cp\u003eMusculoskeletal system and connective tissue disorders - Uncommon: Fractures of the wrist, hip and spine. Rare: Arthralgia, Myalgia.\u003c\/p\u003e\n\u003cp\u003eRenal and urinary disorders - Not known: Interstitial nephritis.\u003c\/p\u003e\n\u003cp\u003eReproductive system and breast disorders - Rare: Gynecomastia.\u003c\/p\u003e\n\u003cp\u003eGeneral disorders and conditions relating to the administration site - Uncommon: Asthenia, fatigue and malaise. Rare: Increased body temperature, Peripheral edema.\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at: http:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDoses of up to 240 mg administered intravenously over 2 minutes were well tolerated. Because pantoprazole is extensively protein bound, it is not readily dialyzable. In case of overdose with clinical signs of intoxication, apart from symptomatic and supportive treatment, no specific therapeutic recommendations can be made.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e There are no adequate data regarding the use of pantoprazole in pregnant women. Studies conducted on animals have shown reproductive toxicity. Preclinical studies have not shown any impairment of fertility or teratogenic effects (see section 5.3). The potential risk for humans is unknown. \u003ci\u003eMAALOX REFLUX\u003c\/i\u003e should not be used during pregnancy. \u003cu\u003eBreastfeeding \u003c\/u\u003e The presence of pantoprazole\/metabolites has been detected in breast milk. The effect of pantoprazole on newborns\/infants is unknown. \u003ci\u003eMAALOX REFLUX\u003c\/i\u003e should not be used during breastfeeding. \u003cu\u003eFertility\u003c\/u\u003e There was no evidence of impaired fertility following administration of pantoprazole in animal studies (see section 5.3).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eMAALOX REFLUX\u003c\/i\u003e does not or negligibly alter the ability to drive or use machinery. However, adverse drug reactions such as dizziness and visual disturbances may occur (see section 4.8). In such cases, patients should not drive or use machinery.\u003c\/p\u003e","brand":"Opella Healthcare","offers":[{"title":"Default Title","offer_id":51730210193735,"sku":"041056021","price":9.21,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/opella-healthcare-italy-srl-maalox-reflusso-20-mg-14-compresse-gastroresistenti-farmacia-dottor-tili-1213791053.jpg?v=1767154750"},{"product_id":"gaviscon-250-133-5-mg-24-compresse-masticabili-fragola","title":"Gaviscon 250 + 133.5 mg 24 chewable tablets strawberry","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptomatic treatment of occasional heartburn\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e \u003ci\u003eGaviscon 500 mg + 267 mg mint flavor chewable tablets\u003c\/i\u003e. \u003c\/b\u003e One tablet contains: \u003cu\u003eActive ingredients\u003c\/u\u003e: sodium alginate 500 mg; sodium bicarbonate 267 mg. Excipient with known effects: aspartame 7.5 mg sodium 126.5 mg \u003cb\u003e \u003ci\u003eGaviscon 250 mg + 133.5 mg mint flavor chewable tablets.\u003c\/i\u003e \u003c\/b\u003e One tablet contains: \u003cu\u003eActive ingredients\u003c\/u\u003e: sodium alginate 250 mg; sodium bicarbonate 133.5 mg. Excipient with known effects: aspartame 3.75 mg sodium 63.25 mg \u003cb\u003e \u003ci\u003eGaviscon 250 mg + 133.5 mg strawberry flavor chewable tablets\u003c\/i\u003e. \u003c\/b\u003e One tablet contains: \u003cu\u003eActive ingredients\u003c\/u\u003e: sodium alginate 250 mg, sodium bicarbonate 133.5 mg. Excipient with known effects: aspartame 8.80 mg sodium 63.25 mg \u003cb\u003e \u003ci\u003eGaviscon 500 mg\/10 ml + 267 mg\/10 ml oral suspension\u003c\/i\u003e \u003c\/b\u003e. 10ml contains: \u003cu\u003eActive ingredients\u003c\/u\u003e: sodium alginate 500 mg; sodium bicarbonate 267 mg. Excipients with known effects: methyl parahydroxybenzoate 40 mg propyl parahydroxybenzoate 6 mg benzyl alcohol 1.1 mg sodium 142.6 mg \u003cb\u003e \u003ci\u003eGaviscon 500 mg\/10 ml + 267 mg\/10 ml oral suspension mint flavour\u003c\/i\u003e. \u003c\/b\u003e 10ml contains: \u003cu\u003eActive ingredients\u003c\/u\u003e: sodium alginate 500 mg; sodium bicarbonate 267 mg. Excipients with known effects: methyl parahydroxybenzoate 40 mg propyl parahydroxybenzoate 6 mg sodium 142.6 mg For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e \u003ci\u003eMint flavor chewable tablets\u003c\/i\u003e: \u003c\/b\u003e Mannitol (E421), calcium carbonate, magnesium stearate, copovidone, aspartame (E951), acesulfame potassium, macrogol 20,000, mint flavouring. \u003cb\u003e \u003ci\u003eStrawberry flavor chewable tablets\u003c\/i\u003e: \u003c\/b\u003e Xylitol, mannitol (E421), calcium carbonate, macrogol 20,000, strawberry flavouring, aspartame (E951), magnesium stearate, red iron oxide. \u003cb\u003e \u003ci\u003eOral suspension\u003c\/i\u003e: \u003c\/b\u003e Calcium carbonate, carbomers, methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), sodium saccharin, fennel flavouring, sodium hydroxide, erythrosine, purified water. \u003cb\u003e \u003ci\u003eMint flavor oral suspension:\u003c\/i\u003e \u003c\/b\u003e Calcium carbonate, carbomers, methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), sodium saccharin, mint flavouring, sodium hydroxide, purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substances or to any of the excipients listed in section 6.1, such as methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216) (parabens).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003e \u003cu\u003eChewable tablets (strawberry flavor and mint flavour).\u003c\/u\u003e \u003c\/i\u003e Dosage. \u003cb\u003eAdults and adolescents (12-18 years)\u003ci\u003e:\u003c\/i\u003e \u003c\/b\u003e 1-2 tablets of 500 mg + 267 mg after meals and at bedtime; 2-4 tablets of 250 mg + 133.5 mg after meals and at bedtime. Method of administration: For oral administration. The tablets must be chewed well (they can be broken and chewed a little at a time). Afterwards you can drink some water. \u003ci\u003e \u003cu\u003eOral suspension\u003c\/u\u003e \u003c\/i\u003e. Dosage. \u003cb\u003eAdults and adolescents (12-18 years)\u003ci\u003e:\u003c\/i\u003e \u003c\/b\u003e 10-20 ml (second-fourth notch of the measuring cup or 2-4 measuring spoons or 1-2 single-dose sachets) after meals and at bedtime. Method of administration: For oral administration. Shake the suspension before use. Take the medicine orally without water. \u003cb\u003e \u003ci\u003eSpecial populations. \u003c\/i\u003e \u003c\/b\u003e \u003cb\u003eElderly:\u003c\/b\u003e it is not necessary to change the doses for this age group. \u003cb\u003ePatients with renal failure\u003c\/b\u003e: the reduced ability to eliminate the exogenous salt supplement provided by antacids in the urine can lead to potentially severe electrolyte imbalances (see section 4.4).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eOral suspension and mint flavor oral suspension: do not store above 30°C. Store in the original packaging. Do not refrigerate. Mint flavor oral suspension in sachets: do not store above 25°C. Store in the original packaging. Do not refrigerate. Mint flavor chewable tablets: do not store above 30°C. Store in the original packaging. Strawberry flavor chewable tablets: do not store above 25°C. Store in the original packaging.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn adolescents (12-18 years) use only in case of real need and under strict medical supervision. \u003cb\u003eKidney failure: \u003c\/b\u003e In case of renal insufficiency, the medicine should be used with caution since the exogenous salt supplement provided by antacids can cause potentially serious electrolyte imbalances. This medicine contains: \u003cb\u003eSodium\u003c\/b\u003e: • 126.5mg (5.5 mmol) of sodium for each 500 mg + 267 mg chewable tablet, equivalent to approximately 6% of the maximum daily intake recommended by the WHO which corresponds to 2 g of sodium for an adult. • 63.25 mg (2.75 mmol) of sodium for each 250 mg +133.5 mg chewable tablet, equivalent to approximately 3% of the maximum daily intake recommended by the WHO which corresponds to 2 g of sodium for an adult. • 142.6 mg (6.2 mmol) of sodium for each 10 ml dose of oral suspension and mint flavor oral suspension, equivalent to approximately 7% of the maximum daily intake recommended by the WHO which corresponds to 2 g of sodium for an adult. 391 mg sodium (17 mmol) corresponds to approximately 20% of the WHO recommended maximum daily dietary intake of 2 g for an adult; this medicine is therefore considered to be high in sodium. This should be taken into account in cases where a particularly low-salt diet is recommended, for example in some cases of congestive heart failure and renal impairment. \u003cb\u003eFootball\u003c\/b\u003e: Each 500 mg + 267 mg chewable tablet contains 160 mg (1.6 mmol) calcium carbonate. Each 250 mg +133.5 mg chewable tablet contains 80 mg (0.8 mmol) of calcium carbonate. Each 10 ml dose of oral suspension and mint flavor oral suspension contains 160 mg (1.6 mmol) of calcium carbonate. Each maximum recommended dose (2 tablets of 500 mg + 267 mg, 4 tablets of 250 mg +133.5 mg, 20 ml of oral suspension and mint flavor oral suspension) contains 320 mg of calcium carbonate. Caution should be exercised when treating patients with hypercalcemia, nephrocalcinosis, and recurrent calcium-containing renal stones. \u003cb\u003eAspartame: \u003c\/b\u003e Each 500 mg + 267 mg chewable tablet contains 7.5 mg of aspartame. Each 250 mg +133.5 mg mint flavor chewable tablet contains 3.75 mg of aspartame. Each 250 mg +133.5 mg strawberry flavor chewable tablet contains 8.8 mg of aspartame. Aspartame is a source of phenylalanine and may be harmful to patients with phenylketonuria. \u003cb\u003eParahydroxybenzoates: \u003c\/b\u003e The oral suspension and the mint flavor oral suspension contain methyl parahydroxybenzoate (40 mg\/10 ml of suspension) and propyl parahydroxybenzoate (6 mg\/10 ml of suspension) which may cause allergic reactions (even delayed) \u003cb\u003eBenzyl alcohol\u003c\/b\u003e: GAVISCON 500 mg\/10 ml + 267 mg\/10 ml oral suspension contains fennel flavour, which in turn contains benzyl alcohol. Each 10 ml dose of oral suspension contains 1.1 mg of benzyl alcohol. Benzyl alcohol can cause allergic reactions. Large volumes should be used with caution and only if necessary, especially in patients who are pregnant, breastfeeding, with hepatic or renal insufficiency due to the risk of accumulation and toxicity (metabolic acidosis). \u003cb\u003eDuration of treatment: \u003c\/b\u003e If symptoms do not improve after seven days, the clinical picture should be re-evaluated.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIt is advisable to place an interval of at least two hours between taking Gaviscon and other medicines, especially tetracyclines, fluoroquinolones, iron salts, thyroid hormones, chloroquine, bisphosphonates and estramustine (See also section 4.4).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBelow are the side effects of Gaviscon, organized according to the MedDRA system organic classification. They are divided by frequency (very common (≥ 1\/10), common (≥ 1\/100 to ≤ 1\/10), uncommon (≥ 1\/1,000 to ≤ 1\/100), rare (≥ 1\/10,000 to 1\/1,000), very rare (≤ 1\/10,000), not known (the frequency cannot be estimated on the basis of available data)).\u003c\/p\u003e\n\u003cp\u003eImmune system disorders - Frequency: Very rare. Adverse Reaction: anaphylactic or anaphylactoid reactions. Hypersensitivity reactions (such as urticaria).\u003c\/p\u003e\n\u003cp\u003eRespiratory, thoracic and mediastinal disorders - Frequency: Very rare. Adverse Reaction: respiratory symptoms such as bronchospasm.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders - Frequency: Very rare. Adverse Reaction: flatulence, nausea.\u003c\/p\u003e\n\u003cp\u003eGeneral disorders and conditions relating to the administration site - Frequency: Very rare. Adverse Reaction: edema.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e \u003cu\u003eReporting of suspected adverse reactions.\u003c\/u\u003e \u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eExperience with overdose is very limited. The only possible consequence of overdose is abdominal distension: in this case, resort to symptomatic treatment by adopting generic support measures.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ePregnancy:\u003c\/b\u003e Clinical studies on more than 500 pregnant women, as well as a large number of data from post-marketing experience, indicate that the active ingredients do not cause malformations or fetal\/neonatal toxicity. Gaviscon can be used during pregnancy if clinically necessary. \u003cb\u003eBreastfeeding:\u003c\/b\u003e No effect of the active ingredients has been shown on newborns\/infants breastfed by treated mothers. Gaviscon can be used during breastfeeding. \u003cb\u003eFertility: \u003c\/b\u003e Preclinical studies have shown that alginate has no negative effect on fertility and reproduction. Clinical data do not suggest that Gaviscon has an effect on human fertility.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eGaviscon has no or negligible influence on the ability to drive or use machines.\u003c\/p\u003e","brand":"Reckitt Benckiser","offers":[{"title":"Default Title","offer_id":51730211799367,"sku":"024352205","price":10.88,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/reckitt-benckiser-h-it-spa-gaviscon-250-133-5-mg-24-compresse-masticabili-fragola-farmacia-dottor-tili-1213791016.jpg?v=1767164987"},{"product_id":"deflux-forte-20-stick-monodose-reflusso-gastroesofageo","title":"Deflux Forte 20 single-dose sticks for gastroesophageal reflux","description":"\u003cp\u003e\u003cstrong\u003eDeflux Forte 20 single-dose gastroesophageal reflux sticks\u003c\/strong\u003e it's a \u003cstrong\u003einnovative food supplement\u003c\/strong\u003e designed to offer effective support against \u003cstrong\u003egastroesophageal reflux disorders\u003c\/strong\u003e, how \u003cstrong\u003eheartburn\u003c\/strong\u003e, \u003cstrong\u003eacid regurgitation\u003c\/strong\u003e e \u003cstrong\u003eindigestion\u003c\/strong\u003e. Its advanced formulation contains \u003cstrong\u003echondroitin sulfate\u003c\/strong\u003e, \u003cstrong\u003esodium alginate\u003c\/strong\u003e e \u003cstrong\u003esodium hyaluronate\u003c\/strong\u003e, ingredients known for their protective action on \u003cstrong\u003eesophageal mucosa\u003c\/strong\u003e and for the ability to reduce the typical symptoms of reflux. Thanks to the presence of \u003cstrong\u003emelatonin\u003c\/strong\u003e, Deflux Forte also helps to promote the general well-being of the digestive system.\u003c\/p\u003e\n\n\u003cp\u003eEach 10 ml single-dose stick is practical and easy to take, ideal for those looking for a quick and discreet solution to always carry with them. \u003cstrong\u003eDeflux Strong\u003c\/strong\u003e it is \u003cstrong\u003egluten free\u003c\/strong\u003e e \u003cstrong\u003elactose free\u003c\/strong\u003e, also suitable for those with food intolerances. The combined action of its components helps \u003cstrong\u003eprotect and restore the esophageal mucosa\u003c\/strong\u003e, effectively counteracting the symptoms of reflux and esophagitis. The product is particularly suitable for those who want a \u003cstrong\u003eanti-reflux treatment\u003c\/strong\u003e safe and easy to use, with a formula that respects the needs of those following specific diets.\u003c\/p\u003e\n\n\u003cp\u003eDeflux Forte 20 single-dose sticks represent a reliable choice for those who suffer from \u003cstrong\u003egastroesophageal reflux symptoms\u003c\/strong\u003e and look for a \u003cstrong\u003efood supplement\u003c\/strong\u003e of quality, capable of offering \u003cstrong\u003eprotection and relief\u003c\/strong\u003e in a practical and fast way.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Deflux Forte 20 single-dose gastroesophageal reflux sticks contain?\u003c\/h3\u003e\u003cp\u003ePurified water; stabilizer: glycerol; sodium chondroitin sulfate (600 mg), flavourings; thickener: sodium alginate; acidity regulator: citric acid; sodium hyaluronate; preservative: potassium sorbate; sweeteners: sucralose, neosperidin DC; melatonin.\u003c\/p\u003e\u003cp\u003eWithout \u003cstrong\u003egluten\u003c\/strong\u003e and without \u003cstrong\u003elactose\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does Deflux Forte 20 single-dose gastroesophageal reflux sticks contain?\u003c\/h3\u003e\u003cp\u003eAverage ingredients and contents (for 2 sticks):\u003cbr\u003ePurified water; stabilizer: glycerol; sodium chondroitin sulfate (600 mg), flavourings; thickener: sodium alginate; acidity regulator: citric acid; sodium hyaluronate; preservative: potassium sorbate; sweeteners: sucralose, neosperidin DC; melatonin.\u003cbr\u003eGluten-free and lactose-free.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Deflux Forte 20 single-dose gastroesophageal reflux sticks?\u003c\/h3\u003e\u003cp\u003eTake a single-dose stick after the 2 main meals.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Deflux Forte 20 single-dose gastroesophageal reflux stick?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eDo not use in case of hypersensitivity or allergy to one or more components.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eLegal warnings\u003c\/strong\u003e\u003cbr\u003eDo not exceed the recommended daily dose.\u003cbr\u003eKeep out of reach of children under three years of age.\u003cbr\u003eSupplements are not intended as substitutes for a varied and balanced diet and a healthy lifestyle.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Deflux Forte 20 single-dose gastroesophageal reflux sticks stored?\u003c\/h3\u003e\u003cp\u003eStore in a cool, dry place, away from light and direct sources of heat.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Deflux Forte 20 single-dose gastroesophageal reflux sticks?\u003c\/h3\u003e\u003cp\u003e20 single-dose sticks of 10 ml.\u003cbr\u003eNet weight: 200ml.\u003c\/p\u003e","brand":"Deca Laboratorio Chimico","offers":[{"title":"Default Title","offer_id":51749049106759,"sku":"947454296","price":24.07,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/deca-laboratorio-chimico-srl-deflux-forte-20-stick-monodose-reflusso-gastroesofageo-farmacia-dottor-tili-1213791270.jpg?v=1767157809"},{"product_id":"refalt-600-20-stick-pack-integratore-rame-ferro","title":"Refalt 600 20 copper + iron supplement sticks","description":"\u003cp\u003e\n\u003cstrong\u003eRefalt 600 20 copper + iron supplement stick pack\u003c\/strong\u003e it's a \u003cstrong\u003efood supplement\u003c\/strong\u003e innovative, formulated to offer complete support to \u003cstrong\u003edigestive well-being\u003c\/strong\u003e and the protection of \u003cstrong\u003eoropharyngeal mucosa\u003c\/strong\u003e. Each stick pack contains a synergistic combination of \u003cstrong\u003esodium alginate\u003c\/strong\u003e, \u003cstrong\u003ehyaluronic acid\u003c\/strong\u003e and extract of \u003cstrong\u003emauve\u003c\/strong\u003e, ingredients known for their \u003cstrong\u003eemollient and soothing action\u003c\/strong\u003e on \u003cstrong\u003edigestive system\u003c\/strong\u003e and on the throat. The presence of \u003cstrong\u003emauve\u003c\/strong\u003e helps to calm the \u003cstrong\u003eburning throat\u003c\/strong\u003e and the \u003cstrong\u003edry cough\u003c\/strong\u003e, while sodium alginate and hyaluronic acid promote the \u003cstrong\u003eprotection of the mucosa\u003c\/strong\u003e and relief from the hassles related to \u003cstrong\u003egastroesophageal reflux\u003c\/strong\u003e.\n\u003c\/p\u003e\n\u003cp\u003e\nThe practical formulation in \u003cstrong\u003esingle-dose sachets\u003c\/strong\u003e (stick pack) makes Refalt 600 ideal for daily use, even outside the home, always guaranteeing maximum hygiene and practicality. The product is \u003cstrong\u003egluten free\u003c\/strong\u003e and naturally devoid of \u003cstrong\u003elactose\u003c\/strong\u003e, also suitable for those with food intolerances. Refalt 600 is particularly suitable as \u003cstrong\u003ereflux supplement\u003c\/strong\u003e and for those who want a \u003cstrong\u003enatural soothing\u003c\/strong\u003e for the throat and digestive tract, thanks to the combined action of its active ingredients.\n\u003c\/p\u003e\n\u003cp\u003e\nThe presence of \u003cstrong\u003ecopper and iron\u003c\/strong\u003e it also contributes to normal energy metabolism and the correct functioning of the immune system, making Refalt 600 a precious ally for general well-being. Each package contains \u003cstrong\u003e20 stick packs\u003c\/strong\u003e 15 ml each, for a total of 300 ml of product.\n\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy use Refalt 600 20 copper + iron supplement sticks? What is it for?\u003c\/h3\u003e\u003cp\u003eDevice for oral use based on sodium alginate, hyaluronic acid and mallow extract, indicated for the relief of discomfort related to gastroesophageal reflux and for the protection of the oropharyngeal mucosa. It has an emollient and soothing action on the throat and digestive system.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Refalt 600 20 copper + iron supplement sticks contain?\u003c\/h3\u003e\u003cp\u003eWater, sodium alginate, sodium hyaluronate, d.e. mallow (Malva sylvestris L., folium), aroma; acidity regulator: citric acid; preservatives: sodium benzoate, potassium sorbate; sweeteners: sucralose, steviol glycosides from stevia.\u003c\/p\u003e\u003cp\u003eWithout \u003cstrong\u003egluten\u003c\/strong\u003e and naturally devoid of \u003cstrong\u003elactose\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does Refalt 600 20 copper + iron supplement sticks contain?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eAverage values for in 1 stick pack (15 ml) and in 2 stick packs (30 ml) and in 3 stick packs (45 ml)\u003c\/strong\u003e\u003cbr\u003eSodium alginate: 600 mg per in 1 stick pack (15 ml); 1.2 g per in 2 stick packs (30 ml); 1.8 g per in 3 stick packs (45 ml)\u003cbr\u003eHyaluronic acid: 100 mg per in 1 stick pack (15 ml); 200 mg per in 2 stick packs (30 ml); 300 mg per in 3 stick packs (45 ml)\u003cbr\u003eE.s. mauve: 100 mg per in 1 stick pack (15 ml); 200 mg per in 2 stick packs (30 ml); 300 mg per in 3 stick packs (45 ml)\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Refalt 600 20 copper + iron supplement sticks?\u003c\/h3\u003e\u003cp\u003eWe recommend taking 1 stick pack after main meals or as needed, up to a maximum of 3 sticks per day. Handle the stick before each use in order to homogenize its contents.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Refalt 600 20 copper + iron supplement sticks?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eDo not use in case of hypersensitivity to one or more ingredients contained. Do not use if the packaging is not intact and\/or after the expiry date.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eLegal warnings\u003c\/strong\u003e\u003cbr\u003eDo not exceed the recommended daily dose.\u003cbr\u003eKeep out of reach of children under three years of age.\u003cbr\u003eSupplements are not intended as substitutes for a varied and balanced diet and a healthy lifestyle.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Refalt 600 20 copper + iron supplement sticks stored?\u003c\/h3\u003e\u003cp\u003eStore at room temperature in a cool, dry place, away from direct sources of light and heat.\u003cbr\u003eThe expiry date refers to the product correctly stored and in intact packaging.\u003cbr\u003eValidity with intact packaging: 30 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Refalt 600 20 copper + iron supplement sticks?\u003c\/h3\u003e\u003cp\u003ePack of 20 sticks.\u003cbr\u003eNet weight: 300ml.\u003c\/p\u003e","brand":"Agaton","offers":[{"title":"Default Title","offer_id":51749066309959,"sku":"945035285","price":22.71,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/agaton-srl-refalt-600-20-stick-pack-integratore-rame-ferro-farmacia-dottor-tili-1213790662.jpg?v=1767161770"},{"product_id":"relux-hd-30-compresse-gastroprotette-antiacido","title":"Relux HD 30 gastro-protected antacid tablets","description":"\u003cp\u003e\n\u003cstrong\u003eRelux HD 30 gastro-protected antacid tablets\u003c\/strong\u003e it's a \u003cstrong\u003efood supplement\u003c\/strong\u003e formulated to offer complete support for digestive well-being and gastric protection. Each tablet contains a synergistic combination of \u003cstrong\u003elutein, zeaxanthin, vitamin C, vitamin E, zinc, lycopene from tomato extract and saffron extract\u003c\/strong\u003e, elements known for their antioxidant and protective properties. Thanks to the presence of \u003cstrong\u003evitamins C and E\u003c\/strong\u003e, Relux HD helps protect cells from oxidative stress, while \u003cstrong\u003ezinc\u003c\/strong\u003e contributes to the maintenance of normal visual ability. The \u003cstrong\u003elycopene\u003c\/strong\u003e and the\u003cstrong\u003esaffron extract\u003c\/strong\u003e they enrich the formula, offering further support against free radicals and promoting general well-being.\n\u003c\/p\u003e\n\u003cp\u003e\nLe \u003cstrong\u003egastro-protected tablets\u003c\/strong\u003e are designed to guarantee a \u003cstrong\u003eantacid action\u003c\/strong\u003e effective, protecting the gastric mucosa and promoting optimal digestion. The orange flavor makes taking it pleasant, while the buccal formulation allows you to take the tablet without water, simply dissolving it in the mouth or chewing it. Relux HD is ideal in case of \u003cstrong\u003edeficiency or increased need for these nutrients\u003c\/strong\u003e, offering valid help for those who want to support digestive health and stomach protection in a practical and safe way.\n\u003c\/p\u003e\n\u003cp\u003e\nThe package contains \u003cstrong\u003e30 tablets\u003c\/strong\u003e, perfect for daily and continuous use. Choose Relux HD for targeted integration that unites \u003cstrong\u003egastric protection, digestive well-being and antioxidant support\u003c\/strong\u003e in a single solution.\n\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Relux HD 30 gastro-protected antacid tablets used? What is it for?\u003c\/h3\u003e\u003cp\u003eFood supplement based on lutein, zeaxanthin, lycopene and saffron extract, enriched with vitamin C, vitamin E and zinc, formulated for visual well-being and the protection of cells from oxidative stress. Zinc contributes to the maintenance of normal vision.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Relux HD 30 gastroprotected antacid tablets contain?\u003c\/h3\u003e\u003cp\u003eMannitol, L-ascorbic acid, sorbitol, DL-alphatocopherol acetate 50% powder, lutein 20%, zinc lactate, orange flavour, zeaxanthin 5%, e.s. of Solanum lycopersicum L., fructus 5% lycopene, magnesium stearate, e.s. of Crocus sativus L. stigmas, silica dioxide, aspartame, sucralose, acesulfame K, sodium saccharin.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does Relux HD 30 gastro-protected antacid tablets contain?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eAverage values per daily dose (1 tablet)\u003c\/strong\u003e\u003cbr\u003eVitamin C: 180 mg (225% VNR*)\u003cbr\u003eLutein: 10 mg\u003cbr\u003eVitamin E: 30 mg (250% VNR*)\u003cbr\u003eZinc: 10 mg (100% VNR*)\u003cbr\u003eZeaxanthin: 2 mg\u003cbr\u003eE.s. of Crocus sativus L. stigmas (3% crocin, saffron): 15 mg\u003cbr\u003eE.s. of Solanum lycopersicum L. fructus: 20 mg\u003cbr\u003e5% lycopene: 1 mg\u003c\/p\u003e\u003cp\u003e*VNR: Nutrient Reference Values.\u003c\/p\u003e\u003cp\u003e*VNR: Nutrient Reference Values\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Relux HD 30 gastro-protected antacid tablets?\u003c\/h3\u003e\u003cp\u003eTake 1 buccal tablet per day.\u003cbr\u003eThe tablet can be chewed or dissolved in the mouth directly without water or even with a small amount of water.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Relux HD 30 gastroprotected antacid tablets?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eLegal warnings\u003c\/strong\u003e\u003cbr\u003eDo not exceed the recommended daily dose.\u003cbr\u003eKeep out of reach of children under three years of age.\u003cbr\u003eSupplements are not intended as substitutes for a varied and balanced diet and a healthy lifestyle.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Relux HD 30 gastro-protected antacid tablets stored?\u003c\/h3\u003e\u003cp\u003eStore in a cool, dry place.\u003cbr\u003eThe expiry date refers to the product correctly stored, in intact packaging.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Relux HD 30 gastroprotected antacid tablets?\u003c\/h3\u003e\u003cp\u003ePack of 30 tablets.\u003cbr\u003eNet Weight: 36g.\u003c\/p\u003e","brand":"Ntc","offers":[{"title":"Default Title","offer_id":51749066539335,"sku":"984515167","price":24.61,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/ntc-relux-hd-30-compresse-gastroprotette-antiacido-farmacia-dottor-tili-1258975971.jpg?v=1789559556"},{"product_id":"sodio-bicarbonato-viti-200-g-polvere-neutra","title":"Sodium bicarbonate Viti 200 g neutral powder","description":"\u003cp\u003e\n\u003cstrong\u003eSodium bicarbonate Viti 200 g neutral powder\u003c\/strong\u003e it is a versatile and high quality product, ideal for multiple uses in both the food and domestic sectors. Formulated by \u003cstrong\u003eMarco Viti\u003c\/strong\u003e, this product comes in size \u003cstrong\u003eneutral powder\u003c\/strong\u003e and stands out for its purity and practicality of use. The \u003cstrong\u003esodium hydrogen carbonate\u003c\/strong\u003e, the active ingredient of the product, is known for its beneficial properties in promoting the \u003cstrong\u003edigestive well-being\u003c\/strong\u003e and the functionality of the stomach, being particularly useful in case of \u003cstrong\u003eacidity and heartburn\u003c\/strong\u003e.\n\u003c\/p\u003e\n\u003cp\u003e\nThanks to its composition, \u003cstrong\u003eSodium bicarbonate Screws\u003c\/strong\u003e can be used as \u003cstrong\u003efood additive\u003c\/strong\u003e for the \u003cstrong\u003eleavening of desserts\u003c\/strong\u003e and baked goods, or for \u003cstrong\u003eeliminate bad odors\u003c\/strong\u003e in the kitchen and throughout the house. The neutral powder is easily soluble in water, making it also suitable for the preparation of oral solutions. The practical \u003cstrong\u003e200 g jar\u003c\/strong\u003e guarantees optimal conservation and precise dosing, ideal for daily use both in the kitchen and for the \u003cstrong\u003estomach well-being\u003c\/strong\u003e.\n\u003c\/p\u003e\n\u003cp\u003e\nChoose \u003cstrong\u003eSodium bicarbonate Viti 200 g neutral powder\u003c\/strong\u003e for a reliable, safe and multifunctional product, perfect for those looking for an effective solution for \u003cstrong\u003efood use\u003c\/strong\u003e, \u003cstrong\u003ehome use\u003c\/strong\u003e and for the \u003cstrong\u003edigestive well-being\u003c\/strong\u003e. Available in the best \u003cstrong\u003eonline pharmacies\u003c\/strong\u003e.\n\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy should we use Sodium bicarbonate Screws 200 g neutral powder? What is it for?\u003c\/h3\u003e\u003cp\u003eSodium bicarbonate powder for food use, used as a leavening agent in the kitchen and as a multipurpose household product, for example to neutralize odors in the home. The neutral powder is easily soluble in water, which facilitates its use in liquid preparations.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Sodium bicarbonate Screws 200 g neutral powder contain?\u003c\/h3\u003e\u003cp\u003eBaking soda.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eACTIVE INGREDIENTS AND EXCIPIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat is the composition of Sodium bicarbonate Screws 200 g neutral powder?\u003c\/h3\u003e\u003cp\u003eSodium bicarbonate Viti 200 g neutral powder contains sodium bicarbonate as an active ingredient.\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cp\u003eBaking soda.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does Sodium bicarbonate Screws 200 g neutral powder contain?\u003c\/h3\u003e\u003cp\u003eSodium bicarbonate Viti 200 g neutral powder contains sodium bicarbonate as an active ingredient.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eNUTRITIONAL CHARACTERISTICS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the nutritional values of Sodium bicarbonate Viti 200 g neutral powder?\u003c\/h3\u003e\u003cp\u003eWhat does Sodium bicarbonate Screws 200 g neutral powder contain? Sodium bicarbonate Viti 200 g neutral powder contains sodium bicarbonate as an active ingredient.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Sodium bicarbonate Screws 200 g neutral powder?\u003c\/h3\u003e\u003cp\u003eThe dosage and methods of use of Sodium bicarbonate Viti 200 g neutral powder must be followed according to the instructions of the doctor or pharmacist. It is advisable to follow the recommended doses shown on the packaging or in the information leaflet.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Sodium bicarbonate Viti 200 g neutral powder?\u003c\/h3\u003e\u003cp\u003eDo not exceed the recommended doses. Keep out of reach of children. Do not use in case of known hypersensitivity to the active ingredient.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003ePREGNANCY AND BREASTFEEDING\u003c\/h2\u003e\n\u003ch3\u003eCan sodium bicarbonate Screws 200 g neutral powder be used during pregnancy and breastfeeding?\u003c\/h3\u003e\u003cp\u003eIf you are pregnant or breastfeeding, consult your doctor before use.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Sodium bicarbonate Screws 200 g neutral powder?\u003c\/h3\u003e\u003cp\u003ePack of 200 g of neutral powder.\u003c\/p\u003e","brand":"Marco Viti","offers":[{"title":"Default Title","offer_id":51749069750599,"sku":"944135110","price":4.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/marco-viti-farmaceutici-spa-sodio-bicarbonato-viti-200-g-polvere-neutra-farmacia-dottor-tili-1213790723.jpg?v=1767162248"},{"product_id":"sodio-bicarbonato-viti-500-g-polvere","title":"Sodium bicarbonate Viti 500 g powder","description":"\u003cp\u003e\n\u003cstrong\u003eSodium bicarbonate Viti 500 g powder\u003c\/strong\u003e it is a versatile and high quality product, ideal for multiple uses in both the food and domestic sectors. Made by \u003cstrong\u003eMarco Viti\u003c\/strong\u003e, a brand synonymous with reliability and safety, this \u003cstrong\u003esodium bicarbonate in crystalline powder\u003c\/strong\u003e It stands out for its purity and easy solubility in water. Thanks to its properties \u003cstrong\u003eantacid\u003c\/strong\u003e, is particularly suitable for countering \u003cstrong\u003eheartburn and heartburn, gastric reflux, indigestion and gastritis\u003c\/strong\u003e, promoting a more peaceful and rapid digestion.\n\u003c\/p\u003e\n\u003cp\u003e\nThe packaging from \u003cstrong\u003e500 g\u003c\/strong\u003e guarantees long life and ease of use, making the product perfect even as \u003cstrong\u003efood supplement\u003c\/strong\u003e or for the \u003cstrong\u003eleavening of desserts\u003c\/strong\u003e in the kitchen. The \u003cstrong\u003eSodium bicarbonate Screws\u003c\/strong\u003e it is also appreciated for its effectiveness in\u003cstrong\u003eeliminate bad odors\u003c\/strong\u003e and for cleaning the house, confirming itself as an indispensable ally for those looking for solutions \u003cstrong\u003enatural and safe\u003c\/strong\u003e for the care of the person and the home environment. Choose the quality and versatility of \u003cstrong\u003eSodium bicarbonate Viti 500 g powder\u003c\/strong\u003e for 360 degree daily well-being.\n\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy do you use Sodium bicarbonate Screws 500 g powder? What is it for?\u003c\/h3\u003e\u003cp\u003eIndicated as an antacid to counteract occasional heartburn, acidity, gastric reflux and indigestion.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Sodium bicarbonate Viti 500 g powder contain?\u003c\/h3\u003e\u003cp\u003eSodium bicarbonate.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eACTIVE INGREDIENTS AND EXCIPIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat is the composition of Sodium bicarbonate Viti 500 g powder?\u003c\/h3\u003e\u003cp\u003eEach dose contains sodium bicarbonate as the active ingredient.\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cp\u003eSodium bicarbonate.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does Sodium bicarbonate Viti 500 g powder contain?\u003c\/h3\u003e\u003cp\u003eEach dose contains sodium bicarbonate as the active ingredient.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eNUTRITIONAL CHARACTERISTICS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the nutritional values of Sodium bicarbonate Viti 500 g powder?\u003c\/h3\u003e\u003cp\u003eWhat does Sodium bicarbonate Viti 500 g powder contain? Each dose contains sodium bicarbonate as the active ingredient.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Sodium bicarbonate Screws 500 g powder?\u003c\/h3\u003e\u003cp\u003eThe dosage and methods of use of Sodium bicarbonate Viti 500 g powder must be followed according to the instructions of the doctor or pharmacist. It is advisable to dissolve the indicated quantity in water before taking.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eDOSAGE\u003c\/h2\u003e\n\u003ch3\u003eHow to take Sodium bicarbonate Viti 500 g powder?\u003c\/h3\u003e\u003cp\u003eThe dosage and methods of use of Sodium bicarbonate Viti 500 g powder must be followed according to the instructions of the doctor or pharmacist. It is advisable to dissolve the indicated quantity in water before taking.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Sodium bicarbonate Viti 500 g powder?\u003c\/h3\u003e\u003cp\u003eDo not exceed the recommended doses. Keep out of reach of children. If you are pregnant or breastfeeding, consult your doctor before use. Do not use in case of known hypersensitivity to the active ingredient.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Sodium bicarbonate Viti 500 g powder?\u003c\/h3\u003e\u003cp\u003ePack of 500 g powder.\u003c\/p\u003e","brand":"Marco Viti","offers":[{"title":"Default Title","offer_id":51749069816135,"sku":"944135122","price":6.14,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/marco-viti-farmaceutici-spa-sodio-bicarbonato-viti-500-g-polvere-farmacia-dottor-tili-1213790722.jpg?v=1767162347"},{"product_id":"tamacid-pro-digestivo-20-stick-solubili-15-g","title":"Tamacid Pro digestive 20 soluble sticks 15 g","description":"\u003cp\u003e\u003cstrong\u003eTamacid Pro digestive 20 soluble sticks 15 g\u003c\/strong\u003e it's a \u003cstrong\u003efood supplement\u003c\/strong\u003e innovative, formulated to promote \u003cstrong\u003edigestive function\u003c\/strong\u003e and the well-being of the gastrointestinal system. Thanks to the presence of \u003cstrong\u003esodium alginate\u003c\/strong\u003e, \u003cstrong\u003ehyaluronic acid\u003c\/strong\u003e, \u003cstrong\u003etamarind juice\u003c\/strong\u003e and exclusive \u003cstrong\u003eplant extracts\u003c\/strong\u003e, Tamacid Pro helps regulate the \u003cstrong\u003egastrointestinal motility\u003c\/strong\u003e and to facilitate the\u003cstrong\u003eelimination of gases\u003c\/strong\u003e, contributing to \u003cstrong\u003econtrol of gastric acidity\u003c\/strong\u003e and offering an emollient and soothing action on the entire digestive system.\u003c\/p\u003e\n\n\u003cp\u003eThe advanced formula with \u003cstrong\u003eGingigel PRO\u003c\/strong\u003e and natural ingredients such as ginger, emblica officinale and astragalus, is designed to offer complete support also for \u003cstrong\u003eoropharyngeal mucosa\u003c\/strong\u003e et al \u003cstrong\u003etone of voice\u003c\/strong\u003e. Each 15 g soluble stick is practical to take and ideal after main meals, for quick and targeted relief. Tamacid Pro is the ideal choice for those looking for a \u003cstrong\u003edigestive\u003c\/strong\u003e effective, natural and easy to use, in a format of \u003cstrong\u003e20 sticks\u003c\/strong\u003e perfect for everyday use.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy do you use Tamacid Pro digestive 20 soluble sticks 15 g? What is it for?\u003c\/h3\u003e\u003cp\u003eFood supplement based on sodium alginate, hyaluronic acid, tamarind juice and plant extracts, formulated to promote digestive function and the well-being of the gastrointestinal system, with an emollient and soothing action. Ginger, emblica officinale and astragalus extracts also offer support to the oropharyngeal mucosa.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Tamacid Pro digestive 20 soluble sticks 15 g contain?\u003c\/h3\u003e\u003cp\u003eGingigel Pro [water, ginger glyceric extract (Zingiber officinalis Rosc., rhizome), naringin, sodium citrate, potassium citrate; thickener: xanthan gum), fructose, glycerol, sodium alginate, flavouring; preservatives: sodium lactate, lactic acid, potassium sorbate; hyaluronic acid, tamarind juice, e.s. of emblica (Emblica officinalis, fructus), d.e. of astragalus (Astragalus Verus Olivier, gummi).\u003c\/p\u003e\u003cp\u003eWithout \u003cstrong\u003egluten\u003c\/strong\u003e e \u003cstrong\u003elactose\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does Tamacid Pro digestive 20 soluble sticks 15 g contain?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eAverage values for maximum daily dose of 2 sticks (equal to 30 g)\u003c\/strong\u003e\u003cbr\u003eGingigel Pro: 6 ml\u003cbr\u003eof which ginger e.g.: 1,660 mg\u003cbr\u003eof which sodium citrate: 1,000 mg\u003cbr\u003eof which potassium citrate: 300 mg\u003cbr\u003eof which naringin: 50 mg\u003cbr\u003eSodium alginate: 840 mg\u003cbr\u003eHyaluronic acid: 80 mg\u003cbr\u003eTamarind juice: 30 mg\u003cbr\u003eAstragalus: 30 mg\u003cbr\u003eEmblica officinale: 30 mg\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Tamacid Pro digestive 20 soluble sticks 15 g?\u003c\/h3\u003e\u003cp\u003eThe recommended dosage is 1 stick pack (equal to 15 g of product) for a maximum of 2 times a day, preferably after the main meals. Take the contents of the stick directly without water. Avoid drinking water for 30 minutes after taking it.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Tamacid Pro digestive 20 soluble sticks 15 g?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eFood supplement for adults.\u003cbr\u003eDo not take in case of hypersensitivity to one of the components.\u003cbr\u003eDo not consume after the shelf life has expired. The end of validity date refers to the product correctly stored in intact packaging.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eLegal warnings\u003c\/strong\u003e\u003cbr\u003eDo not exceed the recommended daily dose.\u003cbr\u003eKeep out of reach of children under three years of age.\u003cbr\u003eSupplements are not intended as substitutes for a varied and balanced diet and a healthy lifestyle.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Tamacid Pro digestive 20 soluble sticks 15 g stored?\u003c\/h3\u003e\u003cp\u003eStore in a cool, dry place, away from heat sources, at a controlled temperature not exceeding 25°C.\u003cbr\u003eValidity with intact packaging: 24 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Tamacid Pro digestive 20 soluble sticks 15 g?\u003c\/h3\u003e\u003cp\u003ePack of 20 stick packs.\u003cbr\u003eNet weight: 300g.\u003c\/p\u003e","brand":"Levante","offers":[{"title":"Default Title","offer_id":51749071618375,"sku":"985661356","price":20.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/levante-srl-tamacid-pro-digestivo-20-stick-solubili-15-g-farmacia-dottor-tili-1213790710.jpg?v=1767162586"},{"product_id":"maalox-reflurapid-40-compresse-masticabili-antiacido","title":"Maalox RefluRapid 40 chewable antacid tablets","description":"\u003cp\u003e\n\u003cstrong\u003eMaalox RefluRapid 40 chewable antacid tablets\u003c\/strong\u003e is a medical device specifically formulated for \u003cstrong\u003etreatment of gastroesophageal reflux\u003c\/strong\u003e and related symptoms, such as \u003cstrong\u003eheartburn\u003c\/strong\u003e, \u003cstrong\u003eheartburn\u003c\/strong\u003e, \u003cstrong\u003estomach acidity\u003c\/strong\u003e, acid regurgitation and poor digestion. Thanks to its targeted action, \u003cstrong\u003eMaalox RefluRapid\u003c\/strong\u003e offers a \u003cstrong\u003equick relief\u003c\/strong\u003e from the discomfort caused by reflux, protecting the esophageal mucosa and contributing to \u003cstrong\u003emucosal regeneration\u003c\/strong\u003e itself.\n\u003c\/p\u003e\n\u003cp\u003e\nIts advanced formula contains \u003cstrong\u003esodium alginate\u003c\/strong\u003e, \u003cstrong\u003esodium bicarbonate\u003c\/strong\u003e e \u003cstrong\u003ecalcium carbonate\u003c\/strong\u003e, ingredients known for their ability to \u003cstrong\u003eneutralize the acidity\u003c\/strong\u003e e \u003cstrong\u003eblock reflux\u003c\/strong\u003e acid, creating a protective barrier that prevents gastric juices from rising into the esophagus. Le \u003cstrong\u003echewable tablets\u003c\/strong\u003e they are practical to take and guarantee immediate action, also ideal for those who suffer from \u003cstrong\u003eheartburn during pregnancy\u003c\/strong\u003e or nocturnal reflux symptoms.\n\u003c\/p\u003e\n\u003cp\u003e\n\u003cstrong\u003eMaalox RefluRapid\u003c\/strong\u003e it is gluten and lactose free, also suitable for those with food intolerances. The package contains 40 tablets, designed for practical and prolonged use. Choose Maalox RefluRapid for a \u003cstrong\u003eeffective treatment of gastroesophageal reflux\u003c\/strong\u003e and for \u003cstrong\u003erapidly reduce heartburn and stomach acidity\u003c\/strong\u003e, improving the quality of your daily life.\n\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Maalox RefluRapid 40 chewable antacid tablets used? What is it for?\u003c\/h3\u003e\u003cp\u003eMedical device based on sodium alginate, sodium bicarbonate and calcium carbonate, indicated for the relief of the symptoms of gastroesophageal reflux such as heartburn, heartburn, acidity and acid regurgitation; creates a protective barrier that counteracts the ascent of gastric juices into the esophagus.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Maalox RefluRapid 40 chewable antacid tablets contain?\u003c\/h3\u003e\u003cp\u003eSodium alginate, sodium bicarbonate, sodium carbonate, calcium carbonate, sorbitol, vegetable magnesium stearate, hydroxypropyl cellulose, flavouring, silicon dioxide, sucralose, steviol glycosides.\u003c\/p\u003e\u003cp\u003eWithout \u003cstrong\u003egluten\u003c\/strong\u003e e \u003cstrong\u003elactose\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does Maalox RefluRapid 40 chewable antacid tablets contain?\u003c\/h3\u003e\u003cp\u003eSodium alginate, sodium bicarbonate, sodium carbonate, calcium carbonate, sorbitol, vegetable magnesium stearate, hydroxypropyl cellulose, flavouring, silicon dioxide, sucralose, steviol glycosides.\u003cbr\u003eGluten and lactose free.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Maalox RefluRapid 40 chewable antacid tablets?\u003c\/h3\u003e\u003cp\u003eAdults and children over 12 years: 2 or 4 tablets after main meals and at bedtime. The tablets must be chewed well. Their intake can also be followed by the ingestion of water.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Maalox RefluRapid 40 chewable antacid tablets?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eKeep out of the reach and sight of children. Do not use the product after the expiry date indicated on the package.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Maalox RefluRapid 40 chewable antacid tablets stored?\u003c\/h3\u003e\u003cp\u003eStore at a temperature between 8°C and 25°C, in a dry place, protected from light and away from heat sources.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Maalox RefluRapid 40 chewable antacid tablets?\u003c\/h3\u003e\u003cp\u003ePack containing 40 tablets.\u003c\/p\u003e","brand":"Opella Healthcare","offers":[{"title":"Default Title","offer_id":51821904396615,"sku":"935131211","price":12.93,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/opella-healthcare-italy-srl-maalox-reflurapid-40-compresse-masticabili-antiacido-farmacia-dottor-tili-1213790938.jpg?v=1767167487"},{"product_id":"medireflux-20-stick-reflusso-gastroesofageo","title":"Medireflux 20 sticks for gastroesophageal reflux","description":"\u003cp\u003e\u003cstrong\u003eMedireflux 20 gastroesophageal reflux sticks\u003c\/strong\u003e it's a \u003cstrong\u003emedical device\u003c\/strong\u003e innovative, specifically formulated for \u003cstrong\u003etreatment of gastroesophageal reflux\u003c\/strong\u003e and related symptoms such as \u003cstrong\u003ereflux esophagitis, acid regurgitation, heartburn (heartburn), stomach acid, difficulty and pain in swallowing\u003c\/strong\u003e. Thanks to his \u003cstrong\u003emechanical action\u003c\/strong\u003e, Medireflux creates a protective barrier that prevents the return of acids and food to the esophagus, contributing to \u003cstrong\u003eincrease gastric pH\u003c\/strong\u003e and others \u003cstrong\u003eprotect the esophageal mucosa\u003c\/strong\u003e by the corrosive action of gastric acids.\u003c\/p\u003e\n\n\u003cp\u003eThe formulation of Medireflux contains \u003cstrong\u003emagnesium alginate, calcium carbonate, potassium bicarbonate, sodium hyaluronate and chondroitin sulfate\u003c\/strong\u003e, ingredients known for their effectiveness in \u003cstrong\u003ereduce the symptoms of gastric reflux\u003c\/strong\u003e and encourage \u003cstrong\u003erepair of the gastroesophageal mucosa\u003c\/strong\u003e. The practical format in \u003cstrong\u003esingle-dose oral sticks\u003c\/strong\u003e allows for quick and easy intake, ideal both at home and away. Medireflux is \u003cstrong\u003egluten-free and lactose-free\u003c\/strong\u003e, also suitable for those with food intolerances.\u003c\/p\u003e\n\n\u003cp\u003eMedireflux 20 stick is indicated as \u003cstrong\u003eadjuvant in the normalization processes of the gastroesophageal mucosa\u003c\/strong\u003e and can be used at any time of the day, especially after meals and before bed, for a \u003cstrong\u003eQuick relief from reflux symptoms\u003c\/strong\u003e. Its effectiveness is supported by a composition designed to offer a \u003cstrong\u003eimmediate and long-lasting protection\u003c\/strong\u003e against the discomfort of gastric reflux.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Medireflux 20 gastroesophageal reflux stick used? What is it for?\u003c\/h3\u003e\u003cp\u003eMedical device in single-dose oral sticks, based on magnesium alginate, calcium carbonate and sodium hyaluronate, indicated for the treatment of gastroesophageal reflux and related symptoms such as acid regurgitation, heartburn, acidity and difficulty swallowing; creates a mechanical barrier that protects the esophageal mucosa from the action of gastric acids.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Medireflux 20 gastroesophageal reflux stick contain?\u003c\/h3\u003e\u003cp\u003eWater, magnesium alginate, calcium carbonate, potassium bicarbonate, sodium hyaluronate, chondroitin sulphate, flavourings; preservatives: methyl p-hydroxybenzoate, ethyl p-hydroxybenzoate; sweeteners: steviol glycosides, sucralose.\u003c\/p\u003e\u003cp\u003eWithout \u003cstrong\u003egluten\u003c\/strong\u003e.\u003cbr\u003eWithout \u003cstrong\u003elactose\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Medireflux 20 gastroesophageal reflux stick?\u003c\/h3\u003e\u003cp\u003eFor adults and children over 12 years of age: 1-2 stick packs taken as is directly in the mouth, after meals before bedtime. To be repeated twice during the day or according to a different doctor's opinion.\u003cbr\u003eShake before use and use the stick pack immediately after opening.\u003cbr\u003eIt can be used at any time of the day. It is advisable not to ingest food or drink for at least 30 minutes after use.\u003cbr\u003eThe duration of use depends on the evolution of symptoms. Do not use for more than 30 days and, if symptoms persist, consult a doctor. If necessary for the purpose of improvement it can be taken for a prolonged period.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Medireflux 20 gastroesophageal reflux stick?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eThe product is for oral use.\u003cbr\u003eDo not use in case of hypersensitivity or individual allergy to one or more components of the product.\u003cbr\u003eAsk your doctor for advice before using the product during pregnancy or in children under three years of age.\u003cbr\u003eDo not use if the packaging or stick pack is damaged.\u003cbr\u003eDo not exceed the recommended daily dose.\u003cbr\u003eUse the product according to the instructions for use.\u003cbr\u003eIn case of concomitant use with other medicines, ask your doctor for advice.\u003cbr\u003eKeep out of reach of children.\u003cbr\u003eDisposable medical device: do not reuse.\u003cbr\u003eThere are no known side effects associated with the use of the product. The tests carried out so far have not highlighted any sensitization phenomena or adverse events. If they appear, consult your doctor.\u003cbr\u003eDo not throw the stick pack into the environment after use.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Medireflux 20 gastroesophageal reflux stick stored?\u003c\/h3\u003e\u003cp\u003eStore at temperatures below 25°C, in a cool, dry place, away from heat sources.\u003cbr\u003eDo not use beyond the expiry date.\u003cbr\u003eThe expiry date refers to the product correctly stored.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Medireflux 20 gastroesophageal reflux stick?\u003c\/h3\u003e\u003cp\u003ePack of 20 stick packs of 10.8 g.\u003cbr\u003eNet weight 216 g.\u003c\/p\u003e","brand":"Medisin","offers":[{"title":"Default Title","offer_id":51821904691527,"sku":"980914257","price":22.71,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/medisin-srl-medireflux-20-stick-reflusso-gastroesofageo-farmacia-dottor-tili-1213790931.jpg?v=1767167590"},{"product_id":"neobianacid-20-bustine-anti-reflusso","title":"NeoBianacid 20 anti-reflux sachets","description":"\u003cp\u003e\u003cstrong\u003eNeoBianacid 20 anti-reflux sachets\u003c\/strong\u003e it's a \u003cstrong\u003enatural medical device\u003c\/strong\u003e class III, specifically formulated to offer effective relief from the symptoms of \u003cstrong\u003egastroesophageal reflux\u003c\/strong\u003e, how \u003cstrong\u003estomach acidity\u003c\/strong\u003e, \u003cstrong\u003eburning\u003c\/strong\u003e, \u003cstrong\u003egastric pain\u003c\/strong\u003e, \u003cstrong\u003eacid regurgitation\u003c\/strong\u003e, \u003cstrong\u003eirritative cough\u003c\/strong\u003e e \u003cstrong\u003edysphonia\u003c\/strong\u003e. Thanks to its targeted action, it is also indicated for combating disorders related to \u003cstrong\u003egastritis\u003c\/strong\u003e, \u003cstrong\u003edyspepsia\u003c\/strong\u003e e \u003cstrong\u003edigestive difficulties\u003c\/strong\u003e, how \u003cstrong\u003eheaviness\u003c\/strong\u003e e \u003cstrong\u003ebloating after meals\u003c\/strong\u003e, both in the case of recurrent episodes and following excessive eating.\u003c\/p\u003e\n\n\u003cp\u003eThe formula of \u003cstrong\u003eNeoBianacid\u003c\/strong\u003e is based on \u003cstrong\u003ePolyprotect\u003c\/strong\u003e, an exclusive complex of \u003cstrong\u003eplant polysaccharides\u003c\/strong\u003e (mallow, marshmallow and aloe vera extracts) e \u003cstrong\u003enatural minerals\u003c\/strong\u003e (limestone and nahcolite), enriched by a flavonoid fraction of \u003cstrong\u003echamomile\u003c\/strong\u003e e \u003cstrong\u003eliquorice\u003c\/strong\u003e. This mix acts by creating a protective barrier on the gastric and esophageal mucosa, promoting\u003cstrong\u003esoothing action\u003c\/strong\u003e and protective against the aggression of gastric acids. The product is \u003cstrong\u003e100% natural\u003c\/strong\u003e, biodegradable, free of synthetic substances, GMOs, gluten and lactose, and uses ingredients from \u003cstrong\u003eorganic farming\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eNeoBianacid 20 anti-reflux sachets\u003c\/strong\u003e it is also suitable during pregnancy, during breastfeeding and in children over 6 years. It can be used both for the treatment and prevention of symptoms, also in association with pharmacological therapies or during periods of stress. The practical single-dose package makes it ideal for simple and immediate use, wherever you are. Choose \u003cstrong\u003eNeoBianacid\u003c\/strong\u003e for one \u003cstrong\u003enatural and safe protection of the gastric mucosa\u003c\/strong\u003e, with quality assurance \u003cstrong\u003eAboca\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is NeoBianacid 20 anti-reflux sachets used? What is it for?\u003c\/h3\u003e\u003cp\u003eMedical device based on Poliprotect (mallow, marshmallow, aloe vera and natural minerals extracts), indicated for the relief of the symptoms of gastroesophageal reflux such as acidity, heartburn, gastric pain and acid regurgitation, and for disorders related to gastritis and digestive difficulties; creates a protective barrier that promotes a soothing action on the gastric and esophageal mucosa.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does NeoBianacid 20 anti-reflux sachets contain?\u003c\/h3\u003e\u003cp\u003eA 1.55 g sachet contains: natural complex Poliprotect 528 mg, based on polysaccharides (Lpme extractive fractions of mallow* and marshmallow*; dehydrated leaf gel of Aloe vera* - 105 mg) and minerals (limestone and nahcolite 423 mg), Lpme extractive flavonoid fraction of chamomile* and liquorice* - 46 mg, cane sugar*, gum arabica, natural mint flavour.\u003cbr\u003e*Ingredient from organic farming.\u003c\/p\u003e\u003cp\u003eWithout \u003cstrong\u003egluten\u003c\/strong\u003e e \u003cstrong\u003elactose\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does NeoBianacid 20 anti-reflux sachets contain?\u003c\/h3\u003e\u003cp\u003e\n100% natural, biodegradable product with ingredients from organic farming containing Poliprotect, a plant and mineral complex. It does not contain synthetic, semi-synthetic or genetically modified substances and the manufacturing processes with which it is obtained do not use solvents or other chemically synthesized substances.\n\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use NeoBianacid 20 anti-reflux sachets?\u003c\/h3\u003e\u003cp\u003eTake the contents of one sachet, letting it dissolve slowly in your mouth according to the following instructions:\u003cbr\u003e- in case of occasional symptoms: take 1 sachet as needed;\u003cbr\u003e- as a treatment for gastroesophageal reflux, pain and digestion difficulties: 1 sachet after meals and 1 in the evening before going to bed. In addition, the product can also be taken as needed several times throughout the day, even at close range;\u003cbr\u003e- in association with proton pump inhibitors and H2 antagonists and during periods of suspension of therapy: take the product as needed or according to the doctor's instructions. It is recommended not to exceed the intake of 8 sachets per day. The product can also be taken for prolonged periods. The product can also be taken by children, starting from 6 years of age, with the same dosage.\u003cbr\u003e100% natural, biodegradable product with ingredients from organic farming containing Poliprotect, a plant and mineral complex. It does not contain synthetic, semi-synthetic or genetically modified substances and the manufacturing processes with which it is obtained do not use solvents or other chemically synthesized substances.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of NeoBianacid 20 anti-reflux sachets?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eKeep out of reach of children. Do not use if there is individual hypersensitivity or allergy to one or more components. If symptoms persist, consult your doctor. It is advisable to take the product at least two hours after taking drugs, in particular tetracyclines. The glycyrrhizin content due to liquorice is lower than what is reported to cause a possible increase in blood pressure. Due to its mechanism of action it can be used both in association with proton pump inhibitors and H2 antagonists and in periods of suspension of treatment, according to the doctor's indications.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is NeoBianacid 20 anti-reflux sachets stored?\u003c\/h3\u003e\u003cp\u003eStore in a cool, dry place, away from heat sources and away from light.\u003cbr\u003eThe expiry date refers to the intact and correctly stored product.\u003cbr\u003eValidity with intact packaging: 24 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of NeoBianacid 20 anti-reflux sachets?\u003c\/h3\u003e\u003cp\u003ePack of 20 single-dose granular sachets of 1.55 g each.\u003c\/p\u003e","brand":"Aboca","offers":[{"title":"Default Title","offer_id":51821906919751,"sku":"926876830","price":16.28,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/aboca-spa-societa-agricola-neobianacid-20-bustine-anti-reflusso-farmacia-dottor-tili-1213790902.jpg?v=1767168208"},{"product_id":"refluzero-20-compresse-reflusso-gastrico","title":"Refluzero 20 tablets for gastric reflux","description":"\u003cp\u003e\u003cstrong\u003eRefluzero 20 gastric reflux tablets\u003c\/strong\u003e it's a \u003cstrong\u003emedical device\u003c\/strong\u003e formulated to offer a \u003cstrong\u003erapid and effective symptomatic treatment of gastroesophageal reflux disorders\u003c\/strong\u003e, how \u003cstrong\u003eheartburn\u003c\/strong\u003e, \u003cstrong\u003eheartburn\u003c\/strong\u003e, \u003cstrong\u003eacid regurgitation\u003c\/strong\u003e, \u003cstrong\u003eepigastric pain\u003c\/strong\u003e, \u003cstrong\u003eirritative cough\u003c\/strong\u003e e \u003cstrong\u003edysphonia\u003c\/strong\u003e. Thanks to his \u003cstrong\u003emechanical action\u003c\/strong\u003e, Refluzero works quickly by reducing symptoms related to\u003cstrong\u003egastric acidity\u003c\/strong\u003e and to the\u003cstrong\u003ehyperacidity\u003c\/strong\u003e, favoring the \u003cstrong\u003edigestive comfort\u003c\/strong\u003e and the \u003cstrong\u003eprotection of the esophageal mucosa\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003cp\u003eIts innovative composition, based on \u003cstrong\u003echondroitin sulphate sodium salt, aluminum hydroxide, calcium carbonate and high molecular weight sodium hyaluronate\u003c\/strong\u003e, creates a protective barrier that limits the contact of gastric acids with the esophageal mucosa, helping to quickly reduce the typical discomfort of reflux. \u003cstrong\u003eRefluzero 20 tablets\u003c\/strong\u003e it is free of gluten, lactose and derivatives, making it also suitable for those with food intolerances.\u003c\/p\u003e\n\n\u003cp\u003eIdeal for those looking for a \u003cstrong\u003eRapid and long-lasting relief from the symptoms of gastroesophageal reflux\u003c\/strong\u003e, Refluzero is indicated for both adults and children over 12 years of age, offering a practical and safe solution for \u003cstrong\u003edaily digestive well-being\u003c\/strong\u003e. The 1,100 mg tablet format guarantees ease of use and maximum effectiveness \u003cstrong\u003etreatment of gastric disorders\u003c\/strong\u003e more common.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Refluzero 20 gastric reflux tablets used? What is it for?\u003c\/h3\u003e\u003cp\u003eMedical device based on chondroitin sulphate, aluminum hydroxide, calcium carbonate and sodium hyaluronate, indicated for the symptomatic treatment of gastroesophageal reflux disorders such as heartburn, heartburn, acid regurgitation, epigastric pain, irritative cough and dysphonia.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Refluzero 20 gastric reflux tablets contain?\u003c\/h3\u003e\u003cp\u003eChondroitin sulphate sodium salt, sucrose, aluminum hydroxide, calcium carbonate; anti-caking agents: mono-di-tri-glycerides of fatty acids, silicon dioxide, high molecular weight sodium hyaluronate; aroma; sweetener: ammonium glycyrrhizinate.\u003c\/p\u003e\u003cp\u003eThe product does not contain \u003cstrong\u003egluten, lactose\u003c\/strong\u003e and derivatives.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does Refluzero 20 gastric reflux tablets contain?\u003c\/h3\u003e\u003cp\u003eChondroitin sulphate sodium salt, sucrose, aluminum hydroxide, calcium carbonate; anti-caking agents: mono-di-tri-glycerides of fatty acids, silicon dioxide, high molecular weight sodium hyaluronate; aroma; sweetener: ammonium glycyrrhizinate.\u003cbr\u003eThe product does not contain \u003cstrong\u003egluten, lactose\u003c\/strong\u003e and derivatives.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Refluzero 20 gastric reflux tablets?\u003c\/h3\u003e\u003cp\u003eAdults and children over 12 years: 1-2 tablets after main meals and before going to bed, or as needed if symptoms such as pain and heartburn appear, according to medical advice.\u003cbr\u003eChildren over 6 years of age: we recommend using the product only after consulting your doctor. 1 tablet, after main meals and\/or before going to bed, or as needed if symptoms such as pain and heartburn appear.\u003cbr\u003eIf necessary, the tablet can be divided in half, using the pre-fracture line.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Refluzero 20 gastric reflux tablets?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eContraindications: renal failure, hypophosphatemia, known hypersensitivity to one of the components.\u003cbr\u003ePregnancy and breastfeeding: use the product after consulting your doctor.\u003cbr\u003eDo not exceed the recommended dose. If symptoms persist, consult your doctor. Do not use the product after the expiry date shown on the package. Keep out of reach of children.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/h2\u003e\n\u003ch3\u003eWhen should Refluzero 20 tablets gastric reflux not be used and what side effects can it cause?\u003c\/h3\u003e\u003cp\u003eContraindications: renal failure, hypophosphatemia, known hypersensitivity to one of the components.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Refluzero 20 gastric reflux tablets stored?\u003c\/h3\u003e\u003cp\u003eStore in a cool, dry place and away from heat sources.\u003cbr\u003eThe expiry date refers to the product in intact packaging and correctly stored.\u003cbr\u003eValidity with intact packaging: 24 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Refluzero 20 gastric reflux tablets?\u003c\/h3\u003e\u003cp\u003e20 tablets of 1,100 mg.\u003c\/p\u003e","brand":"Malesci","offers":[{"title":"Default Title","offer_id":51821910098247,"sku":"983034315","price":17.96,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/malesci-refluzero-20-compresse-reflusso-gastrico-farmacia-dottor-tili-1254211062.jpg?v=1786729000"},{"product_id":"xamamina-reflusso-25-bustine-anti-acido-gastroprotettore","title":"Xamamina reflux 25 sachets anti-acid gastroprotective","description":"\u003cp\u003e\n\u003cstrong\u003eXamamina Reflux 25 anti-acid gastroprotective sachets\u003c\/strong\u003e it's a \u003cstrong\u003emedical device\u003c\/strong\u003e innovative, designed to offer a \u003cstrong\u003eRapid relief from gastroesophageal reflux symptoms\u003c\/strong\u003e and pharyngolaryngeal. Thanks to its advanced formulation, it acts with a mechanical action that helps to reduce \u003cstrong\u003eheartburn, acidity, acid regurgitation, reflux cough\u003c\/strong\u003e and other related disorders such as belching, abdominal tension and dysphonia. Ideal for those looking for a \u003cstrong\u003eeffective gastroprotector\u003c\/strong\u003e and practical, Xamamine Reflux also promotes the re-epithelization of the \u003cstrong\u003egastroesophageal mucosa\u003c\/strong\u003e and pharyngolaryngeal, contributing to the \u003cstrong\u003edigestive well-being\u003c\/strong\u003e.\n\u003c\/p\u003e\n\u003cp\u003e\nThe package contains \u003cstrong\u003e25 single-dose sachets\u003c\/strong\u003e from \u003cstrong\u003epleasant taste of strawberry grapes and red fruits\u003c\/strong\u003e, perfect for practical and discreet use at any time of the day. The formula is enriched with \u003cstrong\u003enatural ingredients\u003c\/strong\u003e such as magnesium alginate, simethicone, honey, extracts of Althaea officinalis and Papaver rhoeas, and D-panthenol, which work synergistically to protect the mucosa and reduce the residence time of gastric contents in the stomach. \n\u003c\/p\u003e\n\u003cp\u003e\n\u003cstrong\u003eXamamine Reflux\u003c\/strong\u003e it is \u003cstrong\u003egluten-free and lactose-free\u003c\/strong\u003e, also suitable for those with food intolerances. Produced by \u003cstrong\u003eDompé\u003c\/strong\u003e, a leading company in the sector, represents a reliable solution for those who want to effectively combat the \u003cstrong\u003egastroesophageal reflux disorders\u003c\/strong\u003e and improve the quality of daily life.\n\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Xamamine reflux 25 anti-acid gastroprotector sachets used? What is it for?\u003c\/h3\u003e\u003cp\u003eMedical device with mechanical action, indicated for rapid relief from the symptoms of gastroesophageal and pharyngolaryngeal reflux such as heartburn, acidity, acid regurgitation, reflux cough, belching and abdominal tension; it also promotes the re-epithelization of the gastroesophageal and pharyngolaryngeal mucosa.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Xamamine reflux contain 25 anti-acid gastroprotector sachets?\u003c\/h3\u003e\u003cp\u003eMagnesium alginate, simethicone, fructose, xanthan gum, honey, D-panthenol, fluid extracts of Althaea officinalis and Papaver rhoeas, zinc oxide, sodium bicarbonate, sodium hydroxide, sodium methyl p-oxybenzoate, sodium propyl p-oxybenzoate, natural flavors, erythrosine (E127), purified water.\u003c\/p\u003e\u003cp\u003eWithout \u003cstrong\u003egluten\u003c\/strong\u003e e \u003cstrong\u003elactose\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Xamamine reflux 25 anti-acid gastroprotector sachets?\u003c\/h3\u003e\u003cp\u003eAdults and children over 12 years: 20 ml after meals and at bedtime or according to different medical advice.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Xamamina reflux 25 anti-acid gastroprotector sachets?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003e- Do not use in case of known hypersensitivity to the components of the product.\u003cbr\u003e- Do not exceed the recommended doses, follow the instructions for use.\u003cbr\u003e- In case of adverse reactions, stop treatment and consult your doctor.\u003cbr\u003e- Do not use the product if the packaging is not intact.\u003cbr\u003e- It is advisable to leave an interval of at least one hour between taking the product and taking the medicines.\u003cbr\u003e- To take it during pregnancy or during the breastfeeding period, consult your doctor.\u003cbr\u003e- Keep out of reach of children.\u003cbr\u003e- Do not use the product after the expiry date. The expiry date refers to the product in intact packaging and correctly stored.\u003cbr\u003e- The product may be more or less viscous, without any deterioration in its quality.\u003cbr\u003eThe presence of natural substances can affect the organoleptic characteristics of the product; variations in color and\/or flavor can therefore be detected without any deterioration in its quality.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Xamamine reflux 25 anti-acid gastroprotector sachets stored?\u003c\/h3\u003e\u003cp\u003eStore at a temperature not exceeding 30°C.\u003cbr\u003eValidity with intact packaging: 30 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Xamamine reflux 25 anti-acid gastroprotector sachets?\u003c\/h3\u003e\u003cp\u003ePack containing 25 sachets.\u003c\/p\u003e","brand":"Dompé","offers":[{"title":"Default Title","offer_id":51821917176135,"sku":"986967521","price":23.25,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/dompe-farmaceutici-spa-xamamina-reflusso-25-bustine-anti-acido-gastroprotettore-farmacia-dottor-tili-1213790495.jpg?v=1767160331"},{"product_id":"gastroschoum-reflusso-omeprazolo-20-mg-14-capsule-rigide","title":"Gastroschoum Reflux Omeprazole 20 mg 14 Hard Capsules","description":"\u003cp\u003e\u003cstrong\u003eGastroschoum Reflux Omeprazole 20 mg 14 Hard Capsules\u003c\/strong\u003e it's a \u003cstrong\u003eover-the-counter drug\u003c\/strong\u003e indicated for the treatment of \u003cstrong\u003egastric reflux symptoms\u003c\/strong\u003e in adults, as \u003cstrong\u003eheartburn\u003c\/strong\u003e e \u003cstrong\u003eacid regurgitation\u003c\/strong\u003e. Each hard capsule contains \u003cstrong\u003e20 mg omeprazole\u003c\/strong\u003e, active ingredient belonging to the category of \u003cstrong\u003eproton pump inhibitors (PPIs)\u003c\/strong\u003e, among the most used and clinically documented for \u003cstrong\u003ereduce the production of gastric acid\u003c\/strong\u003e and quickly alleviate ailments related to\u003cstrong\u003estomach acidity\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eThanks to its targeted action on \u003cstrong\u003eproton pump\u003c\/strong\u003e, Gastroschoum Reflux works directly at the source of the problem: most patients get a \u003cstrong\u003eComplete relief from heartburn within 7 days\u003c\/strong\u003e with one \u003cstrong\u003esingle capsule per day\u003c\/strong\u003e, taken on an empty stomach at least 30 minutes before meals. The \u003cstrong\u003epack of 14 hard capsules\u003c\/strong\u003e it is ideal for a \u003cstrong\u003ecomplete two-week treatment cycle\u003c\/strong\u003e, practical to store and simple to take.\u003c\/p\u003e\n\u003cp\u003eGastroschoum Reflux \u003cstrong\u003eomeprazole 20 mg\u003c\/strong\u003e It is indicated for adults who suffer from \u003cstrong\u003egastroesophageal reflux\u003c\/strong\u003e, \u003cstrong\u003estomach acidity\u003c\/strong\u003e e \u003cstrong\u003eoccasional burning\u003c\/strong\u003e.\u003c\/p\u003e\n\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Gastroschoum Reflux Omeprazole 20 mg 14 Hard Capsules used? What is it for?\u003c\/h3\u003eGastroSchoum Reflux is indicated for \u003cstrong\u003etreatment of reflux symptoms\u003c\/strong\u003e (for example \u003cstrong\u003eheartburn\u003c\/strong\u003e, \u003cstrong\u003eacid regurgitation\u003c\/strong\u003e) in adults.\n\u003ch2\u003eACTIVE INGREDIENTS AND EXCIPIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat is the composition of Gastroschoum Reflux Omeprazole 20 mg 14 Hard Capsules?\u003c\/h3\u003eEach capsule contains \u003cstrong\u003e20 mg omeprazole\u003c\/strong\u003e. Excipients with known effects: each hard capsule contains \u003cstrong\u003e225 mg sodium\u003c\/strong\u003e. For the full list of excipients, see section 6.1.\u003cbr\u003e\u003cbr\u003e\u003cb\u003e\u003ci\u003eCapsule contents:\u003c\/i\u003e\u003c\/b\u003e sodium hydrogen carbonate (E500ii), sodium starch glycolate (Type A), sodium stearyl fumarate (E485). \u003cb\u003e\u003ci\u003eCapsule:\u003c\/i\u003e\u003c\/b\u003e gelatine (E441), red iron oxide (E172), titanium dioxide (E171).\n\u003ch2\u003eDOSAGE\u003c\/h2\u003e\n\u003ch3\u003eHow is Gastroschoum Reflux Omeprazole 20 mg 14 Hard Capsules taken?\u003c\/h3\u003e\u003cb\u003eAdults:\u003c\/b\u003e the recommended dose is \u003cstrong\u003e20 mg (one capsule) once a day for 14 days\u003c\/strong\u003e. You may need to take the capsules for 2-3 consecutive days to achieve improvement in symptoms. Most patients get a \u003cstrong\u003eComplete relief from heartburn within 7 days\u003c\/strong\u003e. Once complete disappearance of symptoms has been achieved, treatment should be discontinued.\u003cbr\u003e\u003cbr\u003e\u003cb\u003e\u003ci\u003eParticular populations.\u003c\/i\u003e\u003c\/b\u003e\u003cbr\u003e\u003cb\u003eRenal impairment:\u003c\/b\u003e no dosage adjustment is necessary in patients with impaired renal function (see section 5.2).\u003cbr\u003e\u003cb\u003eHepatic impairment:\u003c\/b\u003e patients with impaired liver function should consult a doctor before taking omeprazole (see section 5.2).\u003cbr\u003e\u003cb\u003eElderly:\u003c\/b\u003e no dose adjustment is necessary in elderly patients (see section 5.2).\u003cbr\u003e\u003cb\u003ePediatric population:\u003c\/b\u003e The use of GastroSchoum Reflux is not recommended for children and adolescents under \u003cstrong\u003e18 years of age\u003c\/strong\u003e.\u003cbr\u003e\u003cbr\u003e\u003ci\u003e\u003cu\u003eMethod of administration:\u003c\/u\u003e\u003c\/i\u003e GastroSchoum Reflux must be taken \u003cstrong\u003eon an empty stomach\u003c\/strong\u003e, at least \u003cstrong\u003e30 minutes before eating\u003c\/strong\u003e and at least two hours after the last meal. The capsule should be swallowed whole with half a glass of water and \u003cstrong\u003eit should not be chewed or opened\u003c\/strong\u003e.\n\u003ch2\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/h2\u003e\n\u003ch3\u003eWhen should Gastroschoum Reflux Omeprazole 20 mg 14 Hard Capsules not be used and what side effects can it cause?\u003c\/h3\u003eHypersensitivity to omeprazole, substituted benzimidazoles or to any of the excipients listed in section 6.1. Omeprazole like others \u003cstrong\u003eproton pump inhibitors (PPIs)\u003c\/strong\u003e must not be used concomitantly with nelfinavir (see section 4.5).\u003cbr\u003e\u003cbr\u003eThe most common side effects (1-10% of patients) are \u003cstrong\u003eheadache, abdominal pain, constipation, diarrhea, flatulence and nausea\/vomiting\u003c\/strong\u003e. Below is the complete classification by frequency according to MedDRA.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eClassification by systems and organs\u003c\/b\u003e - \u003cb\u003eFrequency\u003c\/b\u003e - \u003cb\u003eAdverse Reaction\u003c\/b\u003e\u003cbr\u003e\u003cb\u003ePathologies of the blood and lymphatic system\u003c\/b\u003e - Rare - Leukopenia, thrombocytopenia\u003cbr\u003e\u003cb\u003ePathologies of the blood and lymphatic system\u003c\/b\u003e - Very rare - Agranulocytosis, pancytopenia\u003cbr\u003e\u003cb\u003eImmune system disorders\u003c\/b\u003e - Rare - Hypersensitivity reactions such as fever, angioedema, anaphylactic reaction\/shock\u003cbr\u003e\u003cb\u003eMetabolism and nutrition disorders\u003c\/b\u003e - Rare - Hyponatremia\u003cbr\u003e\u003cb\u003eMetabolism and nutrition disorders\u003c\/b\u003e - Not known - Hypomagnesemia, hypocalcaemia, hypokalaemia\u003cbr\u003e\u003cb\u003ePsychiatric disorders\u003c\/b\u003e - Uncommon - Insomnia\u003cbr\u003e\u003cb\u003ePsychiatric disorders\u003c\/b\u003e - Rare - Agitation, confusion, depression\u003cbr\u003e\u003cb\u003ePsychiatric disorders\u003c\/b\u003e - Very rare - Aggression, hallucinations\u003cbr\u003e\u003cb\u003eNervous system disorders\u003c\/b\u003e - Common - Headache\u003cbr\u003e\u003cb\u003eNervous system disorders\u003c\/b\u003e - Uncommon - Dizziness, paraesthesia, drowsiness\u003cbr\u003e\u003cb\u003eNervous system disorders\u003c\/b\u003e - Rare - Taste disturbances\u003cbr\u003e\u003cb\u003eEye pathologies\u003c\/b\u003e - Rare - Blurred vision\u003cbr\u003e\u003cb\u003eEar and labyrinth disorders\u003c\/b\u003e - Uncommon - Dizziness\u003cbr\u003e\u003cb\u003eRespiratory, thoracic and mediastinal disorders\u003c\/b\u003e - Rare - Bronchospasm\u003cbr\u003e\u003cb\u003eGastrointestinal disorders\u003c\/b\u003e - Common - Abdominal pain, constipation, diarrhoea, flatulence, nausea\/vomiting, fundic gland polyps (benign)\u003cbr\u003e\u003cb\u003eGastrointestinal disorders\u003c\/b\u003e - Rare - Dry mouth, stomatitis, gastrointestinal candidiasis\u003cbr\u003e\u003cb\u003eGastrointestinal disorders\u003c\/b\u003e - Not known - Microscopic colitis\u003cbr\u003e\u003cb\u003eHepatobiliary disorders\u003c\/b\u003e - Uncommon - Increased liver enzymes\u003cbr\u003e\u003cb\u003eHepatobiliary disorders\u003c\/b\u003e - Rare - Hepatitis with or without jaundice\u003cbr\u003e\u003cb\u003eHepatobiliary disorders\u003c\/b\u003e - Very rare - Hepatic failure, encephalopathy\u003cbr\u003e\u003cb\u003ePathologies of the skin and subcutaneous tissue\u003c\/b\u003e - Uncommon - Dermatitis, pruritus, rash, urticaria\u003cbr\u003e\u003cb\u003ePathologies of the skin and subcutaneous tissue\u003c\/b\u003e - Rare - Alopecia, photosensitivity, AGEP, DRESS\u003cbr\u003e\u003cb\u003ePathologies of the skin and subcutaneous tissue\u003c\/b\u003e - Very rare - Erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis (TEN)\u003cbr\u003e\u003cb\u003ePathologies of the skin and subcutaneous tissue\u003c\/b\u003e - Not known - Subacute cutaneous lupus erythematosus (SLE)\u003cbr\u003e\u003cb\u003ePathologies of the musculoskeletal system\u003c\/b\u003e - Rare - Arthralgia, myalgia\u003cbr\u003e\u003cb\u003ePathologies of the musculoskeletal system\u003c\/b\u003e - Very rare - Muscle weakness\u003cbr\u003e\u003cb\u003eRenal and urinary disorders\u003c\/b\u003e - Rare - Tubulointerstitial nephritis (with possible progression to renal failure)\u003cbr\u003e\u003cb\u003ePathologies of the reproductive system\u003c\/b\u003e - Very rare - Gynecomastia\u003cbr\u003e\u003cb\u003eSystemic pathologies\u003c\/b\u003e - Uncommon - Malaise, peripheral edema\u003cbr\u003e\u003cb\u003eSystemic pathologies\u003c\/b\u003e - Rare - Increased sweating\u003cbr\u003e\u003cb\u003e\u003cu\u003eReporting of suspected adverse reactions.\u003c\/u\u003e\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\n\u003ch2\u003eINTERACTIONS\u003c\/h2\u003e\n\u003ch3\u003eWhich medicines or foods can modify the effect of Gastroschoum Reflux Omeprazole 20 mg 14 Hard Capsules?\u003c\/h3\u003e\u003cb\u003eNelfinavir, atazanavir:\u003c\/b\u003e the concomitant administration of omeprazole with nelfinavir is contraindicated. Co-administration with atazanavir is not recommended.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eClopidogrel:\u003c\/b\u003e coadministration reduces exposure to the active metabolite of clopidogrel. As a precaution, concomitant use should be discouraged.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eDigoxin:\u003c\/b\u003e Concomitant treatment with omeprazole may increase the bioavailability of digoxin. Therapeutic monitoring is recommended, especially in elderly patients at high doses.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eSubstances metabolised by CYP2C19:\u003c\/b\u003e Omeprazole is a moderate inhibitor of CYP2C19. The metabolism of substances such as R-warfarin, cilostazol, diazepam and phenytoin may be reduced with increased systemic exposure.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eMethotrexate:\u003c\/b\u003e in the presence of high doses of methotrexate, it may be necessary to consider temporary discontinuation of omeprazole.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eVoriconazole:\u003c\/b\u003e concomitant treatment leads to a more than two-fold increase in omeprazole exposure. Dose adjustment is generally not required.\n\u003ch2\u003ePREGNANCY AND BREASTFEEDING\u003c\/h2\u003e\n\u003ch3\u003eCan Gastroschoum Reflux Omeprazole 20 mg 14 Hard Capsules be used during pregnancy and breastfeeding?\u003c\/h3\u003e\u003cb\u003ePregnancy:\u003c\/b\u003e The results of three prospective epidemiological studies (more than 1,000 exposed children) indicate that there are no adverse effects of omeprazole on pregnancy or on the health of the fetus\/newborn. Omeprazole can be used during pregnancy.\u003cbr\u003e\u003cb\u003eBreastfeeding:\u003c\/b\u003e Omeprazole is excreted in breast milk but is unlikely to affect the baby when used at therapeutic doses.\u003cbr\u003e\u003cb\u003eFertility:\u003c\/b\u003e Animal studies with orally administered omeprazole do not indicate effects on fertility.\n\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Gastroschoum Reflux Omeprazole 20 mg 14 Hard Capsules?\u003c\/h3\u003eIn the presence of suspicious symptoms (e.g. significant and unwanted weight loss, recurrent vomiting, dysphagia, haematemesis or melena) and when gastric ulcer is suspected or present, the presence of a neoplasm should be excluded before instituting treatment.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eClopidogrel:\u003c\/b\u003e as a precaution the concomitant use of omeprazole and clopidogrel should be avoided (see section 4.5).\u003cbr\u003e\u003cbr\u003e\u003cb\u003eSerious cutaneous adverse reactions (SCAR):\u003c\/b\u003e including Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), drug reaction with eosinophilia and systemic symptoms (DRESS) and acute generalized exanthematous pustulosis (AGEP), which may be life-threatening or fatal, have been reported very rarely in association with omeprazole treatment.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eSubacute cutaneous lupus erythematosus (SLE):\u003c\/b\u003e Proton pump inhibitors are associated with extremely infrequent cases of SCLE. In the presence of skin lesions, especially on the parts exposed to sunlight, the patient must immediately contact a doctor.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eRenal impairment:\u003c\/b\u003e Acute tubulointerstitial nephritis (TIN) has been observed in patients taking omeprazole. Omeprazole should be discontinued if TIN is suspected.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eInterference with laboratory tests:\u003c\/b\u003e an increased level of Chromogranin A (CgA) can interfere with diagnostic tests for neuroendocrine tumors. Omeprazole treatment should be discontinued for at least 5 days before CgA measurements.\u003cbr\u003e\u003cbr\u003e\u003cb\u003eSodium:\u003c\/b\u003e this medicine contains \u003cstrong\u003e225 mg sodium per capsule\u003c\/strong\u003e, equivalent to 11.2% of the maximum daily amount of 2 g recommended by the WHO for an adult.\u003cbr\u003e\u003cbr\u003ePatients should be instructed to consult a doctor if: they have had a previous gastric ulcer or gastrointestinal surgery; have been on continuous symptomatic treatment for 4 or more weeks; have jaundice or severe liver disease; are over 55 years of age with new or recently changed symptoms.\u003cbr\u003e\u003cbr\u003eData on overdose in humans are limited. Symptoms described include nausea, vomiting, dizziness, abdominal pain, diarrhea and headache. In case of overdose it is advisable to resort to symptomatic treatment by adopting generic support measures.\u003cbr\u003e\u003cbr\u003eGastroSchoum Reflux has negligible effects on the ability to drive or use machines. However, in case of dizziness or visual disturbances, caution is recommended.\n\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Gastroschoum Reflux Omeprazole 20 mg 14 Hard Capsules stored?\u003c\/h3\u003eStore at \u003cstrong\u003etemperature below 25°C\u003c\/strong\u003e. Store in the original package in order to protect the medicine from moisture.\n\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Gastroschoum Reflux Omeprazole 20 mg 14 Hard Capsules?\u003c\/h3\u003e14 Hard Capsules\n\u003ch2\u003eDRUG LEGAL TEXT\u003c\/h2\u003e\n\u003cp\u003eContent responsibility\u003c\/p\u003e\u003cp\u003eThis sheet contains information that is not intended to replace a doctor's diagnosis or advice, as only the doctor can draw up any prescription and give therapeutic indications. All contents must be understood and are of an exclusively informative nature and aimed exclusively at bringing to the attention of customers or potential customers in the pre-purchase phase of the products sold through this site. In case of pathologies, disorders or allergies it is always best to consult your doctor first.\u003c\/p\u003e\u003cp\u003ePlease note\u003c\/p\u003e\u003cp\u003eThe product names, ingredients and percentages indicated in the descriptions are purely indicative and may be subject to changes or updates by the manufacturing companies. Due to the impossibility of adapting to these updates in real time, the photos and technical information of the products included on Dottortili.com may differ from those shown on the label or otherwise disseminated by the manufacturing companies. The only identification element appears to be the ministerial code MINSAN. The online pharmacy Dottortili.com does not guarantee the truthfulness and timeliness of the information published and declines any responsibility for any errors, omissions or failure to update the same. Dottortili.com assumes no responsibility for damages of any nature that may arise from access to the information published.\u003c\/p\u003e\u003cp\u003eData source: Farmadati Italia\u003c\/p\u003e\u003cp\u003eWebsite: www.farmadati.it\u003c\/p\u003e\u003cp\u003eThe Farmadati Italia database is used by almost all pharmacies, parapharmacies, herbalist shops, health shops, large-scale retail trade, computerized doctors, etc. thanks to the guarantee of historical reliability, seriousness and professionalism of the company on the national territory.\u003c\/p\u003e\u003cp\u003eThe Farmadati Italia S.r.l management system complies with the requirements of the UNI EN ISO 9001:2015 standards for quality management systems and UNI CEI ISO\/IEC 27001:2017 for information security management systems.\u003c\/p\u003e","brand":"Zentiva","offers":[{"title":"Default Title","offer_id":54001922572615,"sku":"051151025","price":6.8,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/zentiva-italia-srl-gastroschoum-reflusso-omeprazolo-20-mg-14-capsule-rigide-farmacia-dottor-tili-1240520100.webp?v=1779809950"}],"url":"https:\/\/www.dottortili.com\/en-eu\/collections\/farmaci-e-dispositivi-antiacidi-e-antireflusso.oembed?page=3","provider":"Farmacia Dottor Tili","version":"1.0","type":"link"}